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SUMMARY 
 
Alveolar echinococcosis (AE) is a severe and life-threatening disease caused by the metacestode 
larva of the fox-tapeworm Echinococcus multilocularis. Parasite entry into the host evokes an 
early and potentially parasiticidal Th1 immune response that is gradually replaced by a 
permissive Th2 response. An immunoregulatory environment has also been reported in the host 
as the disease progresses. As a result of   immunomodulation, E. multilocularis larvae persist in 
the host for decades without being expelled, and thus almost act like a perfect transplant. Very 
little is currently known on the molecular basis of the host immunomodulation by E. 
multilocularis. In this work, in vitro cultivation systems were used to assess the influence of 
metabolites released by the parasite larvae (E/S products) on host immune effector cells.  
E/S products of cultivated larvae that respresent the early (primary cells) and chronic 
(metacestode vesicles) phase of AE induced apoptosis and tolerogenic properties (poor 
responsiveness to LPS stimulation) in host dendritic cells (DC) whereas those of control larvae 
(protoscoleces) failed to do so. These findings show that the early infective stage of E. 
multilocularis induces tolerogenicity in host DC, which is most probably important for 
generating an immunosuppressive environment at an infection phase in which the parasite is 
highly vulnerable to host attacks. Interestingly, metacestode E/S products promoted the 
conversion of naïve CD4+ T-cells into Foxp3+ regulatory T-cells in vitro, whereas primary cell 
and protoscolex E/S products failed to do it. Since Foxp3+ regulatory T-cells are generally 
known to mediate immunosuppression, the present finding indicates that Foxp3+ regulatory T-
cells, expanded by E/S products of the metacestode larva, could play a role in the parasite-driven 
immunomodulation of the host observed during AE. Furthermore, a substantial increase in 
10 
 
number and frequency of suppressive Foxp3+ regulatory T-cells could be observed within 
peritoneal exudates of mice following intraperitoneal injection of E. multilocularis metacestodes, 
indicating that Foxp3+ regulatory T-cells could also play an important role in E. multilocularis-
driven immunomodulation in vivo. Interestingly, a parasite activin ortholog, EmACT, secreted 
by metacestodes, was shown to expand host regulatory T-cells in a TGF-β-dependent manner, 
similarly to mammalian activin A. This observation indicated that E. multilocularis utilizes 
evolutionarily conserved TGF-β superfamily ligands, like EmACT, to expand host regulatory T-
cells. Taken together, the present findings suggest EmACT, a parasite activin secreted by the 
metacestode and capable of expanding host regulatory T-cells, as an important player in the host 
immunomodulation by E. multilocularis larvae. 
Another parasite factor EmTIP, homologous to mammalian T-cell immunomodulatory protein 
(TIP) was characterized in this work. EmTIP could be detected in the secretions of the parasite 
primary cells and localized to the intercellular space within the parasite larvae. EmTIP blockade 
inhibited the proliferation of E. multilocularis primary cells and the formation of metacestode 
vesicles indicating a major role for parasite development. Furthermore, EmTIP evoked a strong 
release of IFN-γ by CD4+ T-cells hence suggesting that the secretion of this factor as a result of 
its role in parasite development could “secondarily” induce a potentially protective Th1 
response.   
In conclusion, this work identified two molecules, EmACT and EmTIP, with high 
immunomodulatory potential that are released by E. multilocularis larvae. The data presented do 
provide insights into the mechanisms of parasite-driven host immunomodulation during AE that 
are highly relevant for the development of anti-parasitic immune therapies.  
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ZUSAMMENFASSUNG 
 
Die Alveoläre Echinokokkose (AE) ist eine lebensbedrohliche Zoonose, die durch das 
Metazestoden-Larvenstadium des Fuchsbandwurms Echinococcus multilocularis ausgelöst wird. 
Nach Eintritt des Parasiten in den Zwischenwirt wird zunächst eine potentiell anti-parasitische, 
Th1-dominierte Immunantwort ausgelöst, welche anschließend in der chronischen Phase graduell 
durch eine permissive, Th2-dominierte Antwort ersetzt wird. Als Ergebnis einer zugrunde 
liegenden Immunmodulation durch den Parasiten können Echinococcus-Larven für Jahre bis 
Jahrzehnte im Wirt persistieren und verhalten sich ähnlich einem perfekt transplantierten Organ. 
Über die molekulare Basis der Immunmodulation durch den Parasiten ist derzeit wenig bekannt. 
In dieser Arbeit wurden geeignete Kultursysteme für verschiedene E. multilocularis 
Larvenstadien verwendet, um den Einfluss exkretorisch/sekretorischer Metaboliten (E/S-
Produkte) auf Wirts-Immuneffektor-Zellen zu studieren. 
E/S-Produkte kultivierter Larven, die die frühe (Primärzellen) und chronische (Metazestode) 
Phase der Infektion repräsentieren induzierten Apoptose und tolerogene Eigenschaften in 
Dendritischen Zellen (DC) des Wirts, während solche von Kontroll-Larven (Protoskolizes) keine 
derartigen Effekte zeigten.  Dies zeigt, dass die frühen infektiösen Stadien von E. multilocularis 
in DC ein tolerierendes Milieu erzeugen, welches sehr wahrscheinlich die initiale Etablierung 
des Parasiten in einer Phase begünstigt, in der er höchst sensitiv gegenüber Wirtsangriffen ist. 
Interessanterweise förderten E/S-Produkte des Metazestoden in vitro die Konversion von CD4+ 
T-Zellen in Foxp3+, regulatorische T-Zellen (Treg) während E/S-Produkte von Primärzellen 
oder Protoskolizes dies nicht vermochten. Da Foxp3+ Tregs generell als immunosuppressorisch 
bekannt sind, deuten diese Daten an, dass der Metazestode aktiv eine Induktion von Tregs 
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herbeiführt, um eine permissive Immunsuppression während einer Infektion zu erreichen. Eine 
substantielle Zunahme von Anzahl und Frequenz Foxp3+ Tregs konnte zudem in Peritoneal-
Exsudaten von Mäuuen nach intraperitonealer Injektion von Parasitengewebe gemessen werden, 
was anzeigt, dass eine Expansion von Foxp3+ Tregs auch während der in vivo Infektion von 
Bedeutung ist. 
Interessanterweise konnte in dieser Arbeit ein Activin-Orthologes des Parasiten, EmACT, 
identifiziert werden, weleches vom Metazestoden sekretiert wird und ähnlich wie humanes 
Activin in der Lage ist, eine TGF-β-abhängige Expansion von Tregs in vitro zu induzieren. Dies 
zeigt an, dass E. multilocularis evolutionsgeschichtlich konservierte Zytokine nutzt, um aktiv die 
Wirts-Immunantwort zu beeinflussen. Zusammenfassend deuten die gewonnenen Daten auf eine 
wichtige Rolle Foxp3+ Tregs, welche u.a. durch EmACT induziert werden, im immunologischen 
geschehen der AE hin. 
Ein weiterer Parasiten-Faktor, EmTIP, mit signifikanten Homologien zum T-cell 
Immunomodulatory Protein (TIP) des Menschen wurde in dieser Arbeit näher charakterisiert. 
EmTIP konnte in der E/S-Fraktion von Primärzellen nachgewiesen werden und induzierte die 
Freisetzung von IFN-γ in CD4+ T-Helferzellen. Durch Zugabe von anti-EmTIP-Antikörpern 
konnte zudem die Entwicklung des Parasiten zum Metazestoden in vitro gehemmt werden. 
EmTIP dürfte daher einerseits bei der frühen Parasiten-Entwicklung im Zwischenwirt eine Rolle 
spielen und könnte im Zuge dessen auch die Ausprägung der frühen, Th-1-dominierten 
Immunantwort während der AE begünstigen. 
Zusammenfassend wurden in dieser Arbeit zwei E. multilocularis E/S-Faktoren identifiziert, 
EmACT und EmTIP, die ein hohes immunmodulatorisches Potential besitzen. Die hier 
13 
 
vorgestellten Daten liefern neue, fundamentale Einsichten in die molekularen Mechanismen der 
Parasiten-induzierten Immunmodulation bei der AE und sind hoch relevant für die Entwicklung 
anti-parasitischer Immuntherapien.     
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1-INTRODUCTION 
1.1 Overview of helminth infections.  
Helminthiases are the most prevalent parasitic diseases affecting close to a third of the people 
worldwide [1]. They prevail in the tropics and are mostly poverty-associated [1]. These 
parasitoses are caused by a diverse group of metazoan invertebrates namely helminths or 
parasitic worms [1] which have colonized humans for hundreds of thousands of years. One of the 
oldest evidence of human helminthiasis is provided in the Egyptian medical papyri, the Ebers 
papyrus, referring to intestinal worms [1]. These evidences are strongly supported by paleo-
parasitological analyses which reveal calcified helminth eggs in mummies dating from 1200 BC 
[1]. The burden of parasitic helminths has raised a considerable interest throughout the ages 
resulting in a better understanding nowadays of the medically relevant classes of helminths. 
Parasitic helminths have been clustered into two major phyla characterized by elongated, flat or 
round bodies. In medically oriented schemes this subdivision comprises (i) The nematodes (also 
known as roundworms) which include the major intestinal worms (also known as soil-
transmitted helminths) and the filarial worms that cause lymphatic filariasis and onchocerciasis, 
and (ii) the platyhelminths (also known as flatworms) which include the flukes (also known as 
trematodes), such as the schistosomes, and the tapeworms (also known as the cestodes), such as 
the pork tapeworm that causes cysticercosis or the fox-tapeworm, the subject of the present 
study, that causes Alveolar echinococcosis (AE).  
 
1.2 The fox-tapeworm Echinococcus multilocularis.  
1.2.1 Phylogeny. 
Parasitic cestodes including the fox-tapeworm Echinococcus multilocularis are metazoans and 
tissue-forming organisms that can establish an infection in mammalian hosts.  Figure 1 provides 
a consensus view of the phylogenetic position of Echinococcus multilocularis, its 
interrelationships with other helminths and the shared ancestry with its mammalian hosts based 
on molecular and morphological estimates.  
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 Figure 1: Position of Echinococcus multilocularis in the tree of life (adapted from [2]). The 
phylogenetic position of the fox tapeworm Echinococcus multilocularis, the Schistosomes of the class of trematoda, 
the nematodes of the genus ascaris and the murine and human hosts of such parasitic helminths are shown. LUCA: 
Last Universal Common Ancestor. 
 
The fox-tapeworm Echinococcus multilocularis belongs to the Taenidae family of the class of 
parasitic cestodes within the phylum Platyhelminthes (Fig. 1). It is closely related, molecularly 
and morphologically, to the dog tapeworm Echinococcus granulosus and to a lower extent to the 
pork tapeworm Taenia solium which are altogether encompassed within the class of parasitic 
cestodes [2]. Another medically relevant class of platyhelminths is that of the trematodes, 
represented in Fig. 1 by the genus Schistosoma. Trematodes like schistosomes show several 
morphological and molecular similarities with parasitic cestodes as they both belong to the 
flatworms/platyhelminths phylum as opposed to the distantly related phylum of roundworms or 
nematodes (Fig. 1).  
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1.2.2 Epidemiology.  
Alveolar echinococcosis is rare in humans [3] and the progression of the disease rather appears as 
an exception in exposed hosts [3]. The disease is confined to the northern latitudes (Fig. 2). 
 
 
 
 
 
 
 
 
 
Figure 2: Global Distribution of Alveolar echinococcosis [4,4,4]. Alveolar echinococcosis is shown 
primarily confined to northern latitudes. A complete picture for all the geographical foci might not be represented 
here because of incomplete or lacking data for some areas. 
 
Its causative agent, the fox-tapeworm Echinococcus multilocularis, has a scattered geographic 
distribution in the northern hemisphere, with endemic regions in central Europe, most of 
northern and central Eurasia and parts of North America. Eurasia, parts of Turkey, Iran and 
possibly northern India (report of 1 human case) seem to represent the southern limits of the 
range of E. multilocularis, but little information is available in this respect [4]. In North America, 
the range of the cestode reaches from Alaska southward to the States of Nebraska, Iowa, Illinois, 
Indiana and Ohio (4). Two autochthonous human cases of AE were reported from a mountainous 
region of northern Tunisia, which might be an indication of the occurrence of E. multilocularis in 
northern Africa, but further information is not available [5].  
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A critical aspect of E. multilocularis distribution is the geographical spreading of the parasite [4]. 
In central Europe, endemic areas were known to exist in only four countries by the end of the 
1980s, but recent studies revealed a much wider geographic range, including at least twelve 
countries (Austria, Belgium, the Czech Republic, Denmark,  France, Germany, Liechtenstein, 
Luxembourg, the Netherlands, Poland, the Slovak Republic and Switzerland) [4]. A new focus 
was detected in 1999 on the Norwegian Islands of Svalbard [4] and in 2012 in the Netherlands 
[4]. Although it is not known whether these new foci are a result of increased surveillance, there 
are nevertheless indications for emerging risk factors, such as increasing parasite prevalence in 
foxes [6], growing human and fox populations [7]. As a direct consequence of the latter, human 
and fox habitats initially separated started to overlap as evidenced by an increasing number of 
foxes reported in/near cities [7]. The current estimates suggest an annual incidence of 20,000 new 
human cases worldwide with 91% of them occurring in the people´s republic of China [8] and 
0.3% (~60)  in Germany [9].  The prevalence of AE in central Europe approximates 2-40 cases 
per 100,000 inhabitants [10]. 
 
1.2.3 Life cycle.  
 
 
 Figure 3: Developmental stages of Echinococcus multilocularis (adapted from [11]).  
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E. multilocularis transitions from three larval stages to an adult form (Fig. 3). The obligate two-
host parasitic cycle of the parasite is predominantly sylvatic (Fig. 4). 
 
 
 
Figure 4: Life cycle of Echinococcus multilocularis [11,12].  (1) The adult worm resides within the 
gut of the definitive hosts and sheds gravid proglottids containing eggs along with faeces. (2) Eggs are released in 
the environment after the proglottids have dried out contaminating food, water or attaching to pets fur. (2) Eggs are 
accidentally taken up by rodents or humans. Upon ingestion, eggs hatch and release the oncosphere that gets 
activated and penetrates the intermediate human (3) or rodent (4) host intestinal epithelium to lodge by passive 
drainage to the liver forming metacestodes. (5) In the rodent but rarely the human host, protoscoleces form from the 
germinal layer of the metacestodes. (6) The enclosed protoscoleces are taken up by definitive hosts as they predate 
voles. Once in the definitive carnivorous host, the protoscoleces excist, get activated and anchored to the small 
intestine so as to mature into adult worms.  
 
In the carnivorous definitive hosts, the adult worms of 2-4 mm in size parasitize the posterior 
small intestine for up to twelve months. In Europe, the red fox represents the main definitive host 
but could, albeit to a lesser extent, be dogs or cats [12]. After a prepatent period of nearly 4 
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weeks, the adult distal segments or gravid proglottids of the adult worm containing eggs are 
passed in the faeces of the definitive host to reach the environment.  Different species of rodents 
are involved in the parasitic cycle as next recipients. They get infected by oral uptake of eggs 
which contain the oncosphere larvae. Equally at risk, suburban human populations and especially 
farm workers [13] can acquire the infection by the ingestion of eggs. Following the action of 
enzymes in the stomach and small intestine, the oncospheres are released from the eggs and are 
activated by intestinal enzymes and bile salts [11]. Equipped with hooks and penetration gland 
secretions, the activated oncospheres penetrate the wall of the small intestine, gain access to a 
venule or lacteal, to be passively transported to the liver, where some are retained [11]. Others 
reach the lungs, and a few may be transported further to the kidneys, spleen, muscles, brain or 
other organs [11]. Once directed, presumably by organ-specific signals few weeks post ingestion 
[11], the oncosphere undifferentiated germinal cells  initiate a transformation process  into a fluid 
filled bladder-like structure enclosed within an outer carbohydrate and high molecular glycan-
rich laminated layer and an inner cellular germinal layer: the metacestode larvae or cyst [11,14]. 
All mammals (including man) in which metacestodes develop after infection with eggs are 
referred to as ‘intermediate hosts’. The metacestode vesicles via the cells of its germinal layer 
then infiltratively grow within the intermediate host tissues forming daughter cysts, expanding 
like a tumor leading to the condition termed alveolar echinococcosis (AE) [11]. From the 
epidemiological point of view, it is useful to differentiate  between ‘intermediate hosts’, which 
play a role in the perpetuation of the cycle, and ‘aberrant or accidental hosts’ which represent a 
‘blind alley’ for the parasite as the latter are not involved in disease transmission [11]. This may 
be because metacestodes fail to become fertile in these hosts [11] thus leading to an interruption 
of the transmission cycle. With a few rare exceptions, humans belong to the group of ‘aberrant 
hosts’ [11] whereas in several species of rodents, buds are then formed in the germinal layer of 
the metacestode vesicles and grow toward the fluid filled cavity of the hydatid cyst [11]. The 
buds later become stalked and vacuolated [11]. A new process of budding is initiated from the 
inner layer of the cells of these cavities, which leads to the formation of hypobiotic protoscoleces 
within the cyst now fertile [11]. As a result of natural predator-prey relationships, the 
intermediate hosts (rodents) are devoured by carnivorous definitive hosts permitting the uptake 
of the protoscoleces in the definitive host’s gastro-intestinal tract. The protoscoleces will then 
excyst, evaginate and become activated as a result of the low pH of the stomach and bile salts of 
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the intestine [11]. The activated protoscoleces will then attach to the intestinal mucosa initiating 
the formation of proglottids and ensuing egg production [11]. 
 
1.2.4 Clinical manifestations of AE. 
Caused in the intermediate hosts (humans, rodents) by metacestodes of E. multilocularis and 
characterized by a tumor-like, infiltrative and destructive growth with the potential to induce 
serious disease, the condition known as AE was elucidated by the German pathologist Rudolf 
Virchow in 1855 [15].  Since then, a large body of studies has drawn a rather comprehensive 
picture for the clinical course of the disease [16,17]. An initial asymptomatic incubation period 
of 5 to 15 years duration is followed by a subsequent chronic phase primarily featured by 
cholestatic jaundice (about a third of the cases) and/or epigastric pain (about a third of the cases) 
and incidentally detected in the other third of patients during medical examination for symptoms 
such as fatigue, weight loss or hepatomegaly [16,17]. Consistent with the symptoms, the primary 
site of metacestode development is almost exclusively found to be the liver [15–17] as depicted 
in Fig. 5.  
 
 
Figure 5: Livers of hosts (intermediate) infested with E. multilocularis larvae.  Human (A, [12]) 
and mouse (B, [18]) livers extensively colonized by metacestode larvae.  
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The right lobe is predominantly infected, but the liver hilus together with one or two lobes may 
also be involved. Extrahepatic primarily locations are rare. During the infection, secondary 
echinococcosis (= metastasis formation) may occur in variety of adjacent or distant organs where 
the parasite cysts will establish new niches and grow, aggravating the medical condition 
[2,12,16–18]. 
 
1.2.5 Prevention and control of alveolar echinococcosis. 
When no intervention measures are taken, the fatality rate is high as illustrated by a follow-up of 
a series of 66 individuals with AE from Germany (period 1960-1972), 70% died within 5 years 
and 94% within 10 years after diagnosis of the disease [16] . However, data obtained from more 
recent series (diagnosis after 1983) show an improvement of the survival rate due to improved 
control measures [16,17]. This is further supported by an increased  life expectancy at diagnosis 
in Europe from averagely 3 years in the 1970s to 20 years in 2005 [8]. Early diagnosis and 
improved treatment have been instrumental in this progress [8] and continue nowadays to gather 
considerable attention in anti-AE research agendas.  
 
1.2.5.1 Diagnosis. 
The diagnosis of AE in individual patients is based on a consensus approach directed by the 
guidelines of the WHO-Informal Working Group on echinococcosis [16,19] i.e. from clinical 
examination to epidemiological data, imaging techniques, histopathology and/or nucleic acid 
detection, and serology as summarized in table 1. 
 
1.2.5.2 Treatment. 
Once confirmed, AE treatment is planned in a multidisciplinary discussion, taking all elements 
of available pre-treatment imaging into account [16,19]. The probability of effective cure 
strongly depends on the time point of diagnosis and ensuing therapeutical measures [16,19]. 
Surgery is the basic form of treatment for early AE [16,19], but radical resection of parasite 
material is almost impossible and recurrences therefore cannot be excluded [16,19,20]. Therefore 
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supportive chemotherapy [21] has been introduced to improve the first line surgical therapy. In 
advanced stages of AE, radical resection is impossible and long-term chemotherapy with 
benzimidazoles (BZs) and palliative surgical measurements, e.g., hepaticojejunostomy, drainage 
of necrotic cavities, or portocaval shunts, may prevent complications and improve the survival 
rate [22]. Two BZ derivatives, mebendazole (MBZ) and albendazole (ABZ) have been 
introduced for chemotherapy against AE in humans [22–25]. Benzimidazoles are known to cause 
degenerative alterations in the tegument and intestinal cells of the parasite by binding to the  
Table 1: Approaches for immunodiagnosis of AE in humans (adapted from [16,19]). 
Primary Antibody test  (ELISA) 
of patients serum using E. multilocularis antigens (Em2, Em18, EmAP, C-Ag, Em10) for detection of IgG – High 
sensitivity 
Seronegative Seropositive 
Asymptomatic and no 
Imaging evidences 
(Ultrasonography, 
Computed tomography) 
Imaging evidences of  parasite cysts  
 
/ 
 
 
 
Repeated Serological 
examinations and Imaging 
after 3 and 6 months to 
exclude risk 
Asymptomatic 
 
In depth imaging 
Needle biopsy and PCR 
Immunohistology 
If lesions calcified >Repeated 
Serological examinations and 
Imaging after 6 months to 
confirm parasite death 
 
Symptomatic 
 
 
 
 
 
Consider 
Treatment 
Secondary IgG4 antibody test 
(ELISA) for verification and 
exclusion of false positive 
using Em2plus ELISA kit – 
High specificity 
Western Blot patterns to 
discriminate with E. 
granulosus infection 
 
 
Treatment 
 
colchicine-sensitive site of beta-tubulin, thus inhibiting its polymerization or assembly into 
microtubules [26]. The loss of the cytoplasmic microtubules leads to impaired uptake of glucose 
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by the larvae and depletes the glycogen stores [26]. Degenerative changes in the endoplasmic 
reticulum, the mitochondria of the germinal layer, and the subsequent release of lysosomes result 
in decreased production of adenosine triphosphate (ATP), which is the energy source required 
for the survival of the helminth [26]. Due to diminished energy production, the parasite is 
immobilized and slowly dies [26]. Indirectly, the metabolic blockade and the ensuing  
disintegration of the tegument renders the larvae more antigenic thus better targeted, attacked 
and destroyed by the host immune system, since not efficient anymore at eluding/evading the 
host immune recognition [27]. Although long-term application of MBZ caused complete death of 
the parasite in one Alaskan study  [28], complete eradication of the parasitic mass by BZs cannot 
be achieved in the majority of patients [29]. In summary, there is circumstantial evidence from 
the clinical outcomes of treated patients that BZs should rather be considered parasitostatic in 
vivo. Moreover, BZ derivatives, principally ABZ have been reported to be teratogenic [30] and to 
cause neurological deficit, gastrointestinal disorders, bone marrow suppression, agranulocytosis 
or aplastic anemia which may be permanent [22,31,32]. The risk of developing some of these 
side effects seems to be increased in patients with liver disease, including echinococcal cysts 
[33]. Because of the double-edged sword of chemotherapy with BZs and the severity of the 
disease, it is important to regularly monitor AE-patients [22]. Comparison of the survival of 
patients on chemotherapy with that of untreated historical controls shows that the 10-year 
survival rate of the treated group has increased from <10% to 85-90%  [22]. Increased survival 
rates might not only be associated with chemotherapy but also with early diagnosis, improved 
surgery, and medical care of the patients [22]. As for chemotherapy, Praziquantel has also been 
used but experimental data obtained from animal models indicate that it failed to show efficacy 
against the metacestode stage of E. multilocularis in contrast to BZs [34,35].  Praziquantel is 
however highly efficient against E. multilocularis protoscoleces and adult worms [36–38] and is 
thereby commonly used for deworming carnivorous host in endemic areas as an anti-AE 
transmission-blocking measure [37,39,40].  
 
1.2.5.3 Vaccination.  
Concerns raised by the parasitostatic rather than parasiticidal effect of  benzimidazole-
derivatives in patients with AE and the limitations of these drugs have driven a growing interest 
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of the scientific community in the development of a vaccine for populations at risk. Compelling 
evidences suggesting the feasibility of vaccines against Echinococcus sp. in particular and 
cestodes in general are summarized into 4 major points: 
(i) after infection with oncospheres the host develops strong immunity to re-infection [41].       
(ii) the oncosphere and early developing larvae are highly susceptible to immune attack whereas 
mature metacestodes are relatively resistant [42,43].                                                                    
(iii) immunity to infection can be transferred to naive recipients following injection of infected 
host serum [42].                                                                                                                             
(iv) high levels of immunity to egg challenge can be stimulated by immunization of naive hosts 
with non-living extracts of the parasites [44,45]. 
An important role for oncosphere diffusible antigens as host protective antigens was gradually 
unveiled for cestodiasis as per observations that the use of oncosphere diffusible antigens or E/S 
products could confer a complete protection against infection by cestode eggs in animals [44,46]. 
Lightlowers and collaborators [47] then initiated the design of a vaccine against echinococcosis. 
Experimentating on the closely related tapeworm E. granulosus, they identified an oncosphere  
antigen Eg95, with a fibronectin type III  domain, able to confer  96-100%  protection against 
infection to sheeps over a year period [47]. A closely related antigen named Em95 from E. 
multilocularis could similarly show up to 83% protection against infection with eggs in mice 
[48].  The Em95 oncospheral antigen constitutes hitherto the most promising candidate for the 
development of a vaccine against human AE.  
Despite the efforts and achievements in the development of better control measures for AE, the 
lack of early prophylactic tools for patients at risk (asymptomatic but seropositive), the 
ineffectiviteness of area-specific vaccination, the parasitostatic rather than parasiticidal character 
of the available chemotherapy are altogether warranting more attention from the scientific 
community. On the one hand, such undertakings, if successful, would help alleviate the current 
burden of the disease. On the other hand, since AE manifests in patients like a slow-growing 
cancer where the parasite larvae establish and persist for decades within the host tissues in the 
face of the immune system like perfect transplants, the informations that could be gained from a 
better understanding of the interactions between E. multilocularis larvae and the host immune 
system are invaluable. This is especially true when considering the high incidence of non-
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communicable immunopathologies (allergic and autoimmune diseases) in developed countries 
[49] that could certainly benefit from such knowledge on how to keep detrimental immune 
responses in check. To set the stage for such a quest on mechanisms used by E. multilocularis to 
survive within its host, it is paramount to first know the current picture of the host immune 
response to E. multilocularis.  
 
1.3 Host immune response to Echinococcus multilocularis. 
1.3.1 The host immune system. 
The physiologic function of the immune system is defense against infectious microbes resumed 
into 4 major tasks (Fig. 6): recognition of the pathogen, effector functions, immune regulation 
(contraction) and immunological memory [50]. 
 
 
 
Figure 6: Phases of the immune response (adapted from [50])  
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1.3.1.1 Recognition of the pathogen. 
Phagocytes of the myeloid lineage (neutrophils, macrophages and DC) gather to the site of 
infection and engulf the invaders or its derived antigens [51]. Unlike the neutrophils that are 
relatively short lived and are produced solely in response of an inflammatory signal, 
macrophages and DC reside within the host tissues and permanently circulate throughout the 
body for surveillance [51,52]. These phagocytes are poised to transform upon challenge by 
pathogen signatures or pathogen-associated-molecular-patterns (PAMPs) [51] like 
lipopolysaccharide (LPS) from the gram-negative cell wall, peptidoglycan and lipotechoic acids 
from the gram-positive cell wall, the sugar mannose (a terminal sugar common in microbial 
glycolipids and glycoproteins but rare in those of humans), bacterial and viral unmethylated CpG 
DNA, bacterial flagellin, the amino acid N-formylmethionine found in bacterial proteins, double-
stranded and single-stranded RNA from viruses, glucans from fungal cell walls or DAMPs 
(damage-associated molecular patterns) from damaged tissue [53]. These phagocytes become 
activated as a result of the recognized threat [51,52]. Considerably important in this process, DC, 
which provide the link to the propagation of the defense mechanisms i.e. the activation of the 
adaptive immune response [50,52], will phenotypically and functionally alter their profile 
[52,54]. From their immature state, poised to engulf invader antigens with a minimal level of 
expression of activation markers (MHC, CD80, CD86, CCR7), these latter will then change to a 
minimal level of phagocytosis, a higher surface expression of migration markers (e.g. CCR7) and 
activation markers (CD80, CD86) exposing the molecular signature of the invader (antigen 
epitopes coupled to increasingly expressed surface MHC molecules) [52,54]. Driven by their 
chemokine receptor (CCR7) in response to the chemokine gradient (CCL19 and CCL21), 
antigen-loaded DC now mature, migrate to the T-cell area of the draining lymph node to 
principally present the antigen to naïve CD4+ T-cells [52,54]. The process of antigen 
presentation requires 3 major signals (Fig. 7) that will direct the T-cell polarization and influence 
the ensuing effector functions [52,55–57]: 
i-The interaction between the MHC-coupled Ag and the T-cell receptor as signal 1 or recognition 
signal where the strength of the interaction defines the immunogenicity of the ensuing response 
[52,55–57].                                                                                                                                      
ii- the interaction between the costimulatory molecules,  upregulated at the surface of the mature 
DC (e.g. CD80, CD86) as signal 2 or verification signal and the T-cell costimulatory receptor 
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(e.g. CD28) [52,55–57]; Failure to provide this verification signal would lead to T-cell inertia or 
as commonly termed T-cell anergy [58–60].                                                                                 
iii- the release by DC of soluble mediators or cytokines as signal 3 that will together with the 
strength of the signal 1 and 2 polarize the naïve T-cells towards activated T-cells poised to install 
and propagate adequate immune effector mechanisms [55,57]. 
 
 
 
Figure 7: “Three signals theory” of T-cell polarization by DC (adapted from [55]). Shown is an 
ideal setting of T-cell priming with the distinct interactions between the mature DC and the T cell i.e. antigen 
presentation (signal 1), co- stimulatory molecule upregulation (signal 2) and cytokine secretion (signal 3).  
 
1.3.1.2 Effector functions. 
The level of antigen presentation, the rate of expression of costimulatory molecules and the 
cytokine profile of challenged DC are altogether crucial to direct the polarization of naïve T-cells 
towards a particular effector function [55,57] and therefore define the type of T-cell response 
(Fig. 8). The release of Interleukin 12p70 is important as a cytokine for the onset of CD4+ T 
helper 1 cells [54,55,61,62]. T helper 1 cell responses intervene in cases of bacterial or viral 
infections preferentially, releasing soluble mediators like IFN-γ and in a CD154-dependent 
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manner increase the cytotoxic potential of CD8+ cytotoxic T cells, neutrophils and macrophages 
[61]. Secondly, Th1 cells migrate into B-cell follicles to promote CD154-dependent B-cell clonal 
expansion and Antibody (Ab) production which altogether synergizes via a coordinated cellular 
mediated response to arrest the development of the intruder [61].  
 
 
Figure 8: Model of DC-driven T-cell priming from the effector to the regulatory phases of 
the immune response (adapted from [50–55,57,58,61]).  
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In instances of encounters with macroparasites (helminths) or allergens, DC rather show a weak 
signal 1 and 2 and have been collectively described by the poor release of IL-12p70 and T helper 
2 responses [63]. IL-6 a pleiotropic cytokine has been shown in several settings to participate in 
DC-driven polarization of naïve T cells into Th2 [64–68] and stimulate B-cell growth [62]. Th2 
cells principally produce IL-4 and IL-5 [61]. Whereas IL-4 induces B-cell switching to IgE 
production, IL-5 activates Eosinophils [61,62]. IgE and Eosinophils are important to eliminate a 
wide range of helminth parasites [69]. As shown in Figure 8, Th2 cells activate B-cells, stimulate 
the antibody production and limit inflammatory responses overall driving macroparasite eviction 
and minimizing tissue damage primarily via mediators of the humoral immune response 
(antibodies, cytokines, major basic proteins etc...) [61,69,70]. 
When opportunistic commensals like Candida spp. or Staphylococcus spp. are encountered but 
also when the altered “self” appears threatening to the host himself during the initiation of 
autoimmune diseases i.e. in a highly inflammatory setting, DC are releasing IL-6 [71] and  CD4+ 
T-cells are producing TGF-β [72] which jointly direct the onset of Th17 cells [61]. A recent study 
demonstrated a TGF-β-independent mechanism of Th17 cell onset with IL-6, IL-23 and IL-1β as 
sufficient actors [73]. Th17 cells secrete IL-17 which fosters the recruitment of neutrophils and 
macrophages to the infected tissues and IL-22 which prompt the release of anti-microbial peptide 
by IL-22R+ cells potentiating the response at mucosal sites like lungs and gut [74–76]. The high 
early influx of inflammatory cells driven by IL-17 to host tissues [76], the driving cause of auto-
immunity is also the attribute of Th17 cells (Fig. 8). 
Following pathogen eradication (i.e. loss of antigen) or tissue damage from persisting and 
detrimental immune response, the host coordinates a dynamic removal of immune effector cells 
in order to temper the ongoing inflammatory processes and restore homeostasis [58]. 
 
1.3.1.3 Immune regulation.  
Unchecked Th1, Th2 or Th17 immune effector functions can lead to severe immunopathology 
thus prove disastrous for the host [77]. The observation that immune effector cells are rapidly 
dying by negligence following antigen removal and that this phenomenon can be antagonized in 
a timely manner by re-introduction of antigen supports a causal link between antigen clearance 
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and T-cell contraction [58,78]. Intriguingly, in instances of chronic infection where the invader 
antigens are still present, the contraction of the immune effector functions may also be initiated 
by the host as an attempt to restore homeostasis and avoid exacerbated and tissue damaging 
responses [79]. The emerging consensus is that the termination of immune responses begins 
ideally with invader clearance but additionally can be set on by untoward immune reactivity 
appearing as a threat to the host integrity [58,79,80]. In either case, the expanded T-cells need to 
be removed, bringing the immune system to a new homeostatic status. Early studies on T-cell 
apoptosis have proposed that programmed death of activated T-cells serves as a suicidal 
retrenchment mechanism which counterposes the proliferation of T-cells in a clonally specific 
manner [78,81–85]. Indeed, a significant increase of apoptotic T-cells coincides with the 
contraction phase of the immune response substantiating this assumption [78,82–85]. The decline 
of activated helper T-cells translates into a shrinking of the inflammatory events as per the 
disappearing antigen or the excessive tissue damage [78,81]. Additionally, DC which are short-
lived become more prone to apoptosis as a result of lack of supportive immune effector 
cytokines or repeated antigen exposure in case of antigen persistence therefore considerably 
antagonizing the ongoing immune response [58,86,87]. As suggested by several studies, immune 
sentinels like DC might additionally take up apoptotic bodies from degenerating cells and as a 
result appear less maturation-sensitive (lower MHC, CD80, CD86) releasing immunoregulatory 
mediators and priming naïve T-cells in tolerogenic ways [88–90].  As a consequence, the 
strength of the T-cell priming by DC is diminished and primed T helper cells become more prone 
to anti-inflammatory responses and eventually predisposed to convert into immune suppressor T-
cells or regulatory T-cells [87–90]. Finally, apoptotic bodies-loaded DC at a tolerogenic state 
potent source of regulatory cytokines (IL-10, TGF-β etc...) [87–90] and T-cell antagonizing 
enzymes like IDO (Indoleamine 2,3-dioxygenase) [91,92] would continue to support T-cell 
contraction and expansion of regulatory T-cells [88–92] so as to restore immune homeostasis 
(Fig. 8). Regulatory T-cells are instrumental in the restoration of immune homeostasis. From the 
production of inhibitory cytokines like IL-10, IL-35 and TGF-β, the granzyme/perforin-
dependent cytolysis of effector cells, the metabolic disruption by IL-2 deprivation, cAMP-
mediated inhibition, CD39/CD73-driven generation of immunosuppressive adenosine to the 
negative regulation of DC, these cells veto ongoing immune effector mechanisms [93]. 
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It is now firmly established that there are CD4+CD25+ natural (or constitutive) and inducible (or 
adaptive) populations of regulatory T-cells, which probably have complementary and 
overlapping functions in immune homeostasis [94,95]. Natural regulatory T-cells congenitally 
generated from the thymus, expand concomitantly to the developing immune response and enter 
peripheral tissues where they repress self-reactive effector T-cells [94,95]. Foxp3 is the 
transcription factor that specifies the regulatory T-cell  lineage [96]. Regulatory T-cells can also 
be generated in the periphery. Termed inducible regulatory T cells, they are separated into T 
regulatory 1 cells, T helper 3 cells and inducible Foxp3+ regulatory T-cells [95,97]. Indeed IL-
10- or TGF-β-secreting regulatory T-cells, which are known as T regulatory 1 (Tr1) or T helper 3 
(Th3) cells respectively, are generated from naive T-cells in the periphery after encounter with 
antigen presented by tolerogenic DC [95,97]. 
Human and murine Tr1 cells can be induced in vitro by chronic activation of CD4+ T-cells in the 
presence of IL-10, co-culture with tolerogenic DC or with immunosuppressive drugs, vitamin D3 
and Dexamethasone [97,98]. These Tr1 cells are poorly proliferative with a low level of IL-2 
production but have a higher propensity to release IL-10 and TGF-β amid an absence of IL-4 
production [94,98,99]. Adoptively-transferred Tr1 cells show strong potency in resolving 
inflammatory disorders in vivo [99].  
Thelper 3 cells are still poorly understood. They can be readily generated in vitro by high TGF-β 
levels and are also poised to release TGF-β [94,95,100,101]. Mainly found at mucosal sites 
where it is assumed that TGF-β is released by apoptotic cells, Th3 cells can rescue IL-2 deficient 
animals from autoimmunity by driving the onset of Foxp3+ Tregs [100,101]. Their strict 
separation from Foxp3+ regulatory T-cells is still ambiguous.  
Foxp3+ regulatory T-cells induced in the periphery by the onset of Foxp3 expression in actively 
primed naïve T-cells represent the most studied class of inducible regulatory T-cells 
[94,95,97,102–105]. Generated by sub-immunogenic priming of naïve T-cells [106–108] via 
activation of the TGF-β pathway [103,109] and potentiated by IL-2 [110,111], Foxp3+ regulatory 
T-cells have been widely associated to the limitation of immune effector functions [110–112]. 
Upon binding of the TGF-β type II receptor and signal transduction to the cytoplasmic Smads 
which translocate to the nucleus and lead to the up-regulation of the transcription factor Foxp3, 
T-cells become potent immune suppressor cells [113].     
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Although poorly known, some other types of regulatory cells might be instrumental in the 
termination of immune responses namely, CD8+ regulatory T-cells [95,114–116] and IL-10-
producing regulatory B-cells [117,118]. All these regulatory cells may act altogether [58,119–
121] and in conjunction with several other mechanisms like upregulation of inhibitory receptors 
on immune cells and B-cell decay in the absence of helper T-cells [58] to provoke the loss of 
most of the immune effector cells  and thereby restore immune homeostasis during the 
contraction phase. Other regulatory cells might contribute to immunological tolerance and are 
discussed in more details elsewhere [118–120,122–125]. The above description is tailored to 
give enough background for the present work and might not entails all mechanisms of 
immunological tolerance which could be at play for the restoration of immune homeostasis 
following an immune response. Importantly, some effector cells are retained after the contraction 
phase providing the raw material for immunological memory [126].  
 
1.3.1.4 Immunological memory. 
Not only does the immune system, its adaptive arm in particular, foster the removal/containment 
of infectious agents but ultimately prevent re-infection with the same pathogen [50,126]. It has 
now become clear that as the most important consequence of adaptive immunity, immunological 
memory enables the host to respond more rapidly and effectively to pathogens that have been 
encountered previously [50,126]. These subsequent responses to a given pathogen qualitatively 
differ considerably from the first or primary response [50,126]. This is noticeable in humoral 
immunity where plasma B-cells alter the characteristics of the antibodies produced at pathogen 
secondary or tertiary encounters as judged by a faster pool of highly specific antibodies [126]. 
This feature of memory i.e. preformed antibody-secreting B-cells poised to respond rapidly and 
fiercely is also present for cellular immune effectors T-cells [126]. These cells which similarly to 
memory B-cells are also long-lived are set to respond promptly to the antigens previously 
encountered [126]. CD4+ T cells play a central role in the design of this cellular memory 
response as they both direct the formation of CD4+ and CD8 + memory T-cells [126]. Of note, 
the artificial induction of protective immunity by vaccination, which stems from the principle of 
immunological memory, is arguably the most outstanding accomplishment of immunology [127]. 
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1.3.2 Immunity and susceptibility to Echinococcus multilocularis. 
An exciting but yet-complex issue is that of the immunological events governing the interactions 
between E. multilocularis larvae and their hosts. It has become clear over the past decade that 
upon entry of eggs, hatching and activation of oncospheres within the intermediate human or 
rodent host gut, a mucosal humoral response occurs as illustrated by a rise in IgG and principally 
IgA specific antibodies [128]. IgA responses in the mucosa have been hypothesized to target the 
parasite oncosphere by attenuating parasite-host interactions thus interfering with parasite 
feeding and survival on the one hand and on the other hand possibly playing a part in the 
tolerance necessary for the early oncosphere survival within the intestine [128].   The observation 
that following penetration of the intestinal epithelium by the activated oncospheres, the mucosal 
permeability decreases and the level of intestinal antibodies declines [128] argued for the first 
possibility, supporting a role for local antibodies production as a host attempt to control 
Echinococcus multilocularis oncospheres within the gut.  
Next, passively drained via the portal vein or lymphatics [11], activated oncospheres elicit an 
IFN-γ-dominated response [129,130], illustrative of a Th1 immune response [131] favoring cell-
mediated immunity (Fig. 9). The consensus now emerging is that the early Th1 immune effector 
functions are detrimental to the oncosphere establishment within the host and efficiently counter 
the development of the metacestode larvae [132–137]. Exciting but still not clinically effective 
approaches have stemmed from this observation, using pro-Th1 immune stimulants like BCG 
[138–140]and more specifically IL-12 [133] or interferons [132,137,141] to control the disease 
onset and progression.  
In some limited instances following exposure to eggs,  the disseminated oncospheres, principally 
lodged in the liver, initiate a metamorphosis into metacestodes [11] gradually shifting the host 
response towards a IL-4high, IL-5high, and IL-10high dominated Th2 profile [142–145]. This 
humoral response of the host characterized majorly by IL-5 production [142] and increased IgE 
levels [146–148] amid a very infrequent hypereosinophilia [142,146,149,150] has now been 
epidemiologically and clinically associated to the condition known as Alveolar echinococcosis 
[142–146,149,151]. In fact, from observations on humans and murine studies, it is now 
comprehensively assumed that cell-mediated Th1 immune response is protective whereas 
humoral Th2 immune response is rather permissive during AE [152–154].  
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Figure 9: Kinetics of the intermediate host immune response to Echinococcus multilocularis 
larvae (adapted from [155]). Activated oncosphere triggers an early parasiticidal Th1 immune response that 
progressively switches to a permissive Th2 response coinciding with the metacestode vesicles formation and 
proliferation. The effective control of the disease and parasite removal/death associates with a parasiticidal Th1 
immune effector functions.  
In this respect, it was initially observed that the control of AE was dependent on cell-mediated 
immune responses as evidenced on the one side by the intense granulomatous infiltration 
observed in the periparasitic area of lesions in experimentally infected mice [156] and on the 
other side by the fact that Immunodeficient athymic nude [157] and SCID mice [158] as well as 
HIV-co-infected patients [159,160] exhibited high susceptibility to infection and disease. Then, 
by using transgenic mice a central role for CD4+ T-cells was unveiled in the control of murine 
AE [161]. Accordingly, a comparison of lesions from susceptible vs. resistant human patients 
unambiguously showed an association of CD4+ T-cells with abortive lesions and CD8 + T-cells 
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with progressive masses [162]. Finally, attempts to artificially boost Th1 immune effector 
functions ameliorated AE prognosis in humans and mice altogether pointing at  type 1 immune 
effector functions in particular as instrumental to control AE [132–134,136–140] contrarily to 
permissive Th2-related humoral effector functions [142,143,145,151,161,163,164]. 
In some rodents, the metacestodes become fertile and produce protoscoleces that are released 
within the definitive carnivorous host when the latter devours the infected rodent(s) [11]. 
Protoscoleces instruct a strong mucosal IgA [165] which strongly depends on IL-4 and innate 
cytokines like IL-10 and IL-6 [166] characteristic of the Th2 immune response within the gut of 
the definitive hosts [165]. This mucosal response, as shown for intestinal helminths, fosters the 
worm containment and expulsion [167].  
As AE progresses, a superimposition of a regulatory immune response has been demonstrated in 
the intermediate human and murine hosts (Fig. 8) [144,145,163,164,168]. This regulatory 
response probably blunts the efficiency of the immune response and thereof fosters the parasite 
growth and development towards a chronic stage of infection [152,153].  Regulatory cytokines 
like TGF-β and IL-10 abound in the periparasitic environment and circulate at higher rates in the 
bloodstream of infected patients supporting the assumption of such a regulatory network during 
AE [151,163,164,168]. This is further consolidated by the observation that AE-infected hosts 
exhibit a reduced immune reactivity when compared to healthy controls [162,163,169–172]. 
Although larvae somatic products would clearly account in part for the host immunomodulation 
observed during AE [173–176], current evidences point at a central role for E. multilocularis 
larvae excretory/secretory (E/S) products in this process. First, the observation that following 
chemotherapy or spontaneous calcification, dying/dead E. multilocularis larvae failed to 
maintain the alterations of the host immune response associated with progressive AE 
[170,177,178] resulting in a reversion of the permissive Th2 into a parasiticidal Th1 [141,179] 
and ultimately, the ability of collected E/S products from the parasite larvae to alter the host 
immune effector cells similarly to the full larvae [169,180] altogether compels to acknowledge 
the parasite larvae E/S products as the major source of E. multilocularis immunomodulators. 
However, the influence of E. multilocularis E/S products on the host immune response has yet to 
be investigated. Since the immune axis DC-CD4+ T-cell is central to the onset of host immune 
responses [54,181], there is consequently an urgent need to study the effects of E. multilocularis 
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larvae E/S products on this axis. If not for a recent study using crude extracts of metacestode 
vesicles to stimulate human DC in vitro [182] where the latter failed to mature in response to the 
parasite products, very little is currently known in this regard. In this study [182], and a couple of 
other studies using the late protoscoleces [183–185] for studying parasite-driven host alterations 
which govern the infection of the intermediate hosts by E. multilocularis larvae, one could not 
exclude the presence of contaminating host remnants within parasite material. Protoscoleces are 
arguably the most accessible Echinococcus multilocularis larvae [11,22]. This accessibility 
would therefore explain their frequent use in host stimulation assays ignoring their natural 
occurrence at a dormant state within fertile cysts of some infected rodents unable to directly 
interact with the host interior milieu [11,22]. Clearly, the initial point of contact between 
protoscoleces and the carnivorous host is the lumen of the gut [11,22]. A breakthrough came with 
the work of Spiliotis and collaborators [186] who coined the establishment of sophisticated 
cultivation systems enabling the isolation and axenic maintenance of each of the parasite larvae. 
 
1.4 Maintenance of E. multilocularis larvae in the laboratory. 
E. multilocularis offers a unique model for in vitro maintenance of parasitic cestodes in the sense 
that its larvae exhibit a rapid growth, and naturally colonize rodents in contrast to other cestodes 
like E. granulosus (dog tapeworm) or T. solium (pork tapeworm) [186].  The development of in 
vitro cultivation systems for E. multilocularis larvae were undertaken in the 1990s by Hemphill 
and Gottstein [187] and Jura et al [188] using co-cultivation of host feeder cells and metacestode 
vesicles. These systems failed to provide a suitable platform for the assessment of the parasite 
larvae E/S products. Spiliotis and collaborators [189] then achieved a major breakthrough by 
defining a liquid medium system for long term maintenance of E. multilocularis metacestodes. 
Using culture medium conditioned with host feeder cell metabolites, an axenic maintenance of 
the metacestode vesicles could be achieved for the first time [189]. Interestingly, by digesting the 
cellular matrices and releasing cells from the germinal layer of the metacestodes, this system 
permitted the isolation of parasite primary cells. The parasite cells proved to be a suitable model 
for the post-oncospheral development towards the metacestode vesicles, as judged by their 
ability to completely regenerate into infective metacestodes in vitro [190] and in vivo (my own 
observation). Furthermore, transcriptome analyses demonstrated that regenerating primary cells 
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express factors, originally described as being oncosphere-specific [191]. The axenization 
procedure developed in this system also proved to be useful for the decontamination of E. 
multilocularis protoscoleces following isolation [186].  Thanks to these cultivation systems, the 
E. multilocularis genome is now completed [192] and the larval stage-specific transcriptome is 
currently underway. Equipped with both these cultivation systems for isolation of host-free 
parasite material [186]  and the wealth of knowledge provided by the E. multilocularis genome 
sequencing project [191], I initiated the present work to try understand the basis of the host 
immunomodulation by E. multilocularis, the role of the parasite E/S products in this process and 
the molecular means underlying such a role. 
 
1.5 Objectives.  
Alveolar echinococcosis is a life-threatening disease in humans. A striking feature of the disease 
is the asymptomatic persistence of parasitic larvae in the host for decades, almost like a perfect 
transplant. A strong regulation of the host immune system has therefore been suggested. This is 
supported by the observation that immune cells of AE patients have an impaired reactivity. 
Understanding how E. multilocularis larvae modulate the host immune response could prove 
valuable not only for developing novel anti-AE intervention measures but could ultimately 
provide novel means to control detrimental immune responses and associated pathologies 
(allergies, autoimmunities, transplant rejections). Given the scarcity of information on the 
molecular bases of the host immunomodulation by E. multilocularis, the present work sought to:  
- characterize the effects of E/S products of Echinococcus multilocularis larvae on DC  
- characterize the effects of E/S products of Echinococcus multilocularis larvae on CD4+ T-cell 
polarization with regards to regulatory T-cell expansion    
- identify and characterize candidate proteins released by the parasite larvae that could influence 
the host immune system.  
In combination, these objectives are meant to help understand how E. multilocularis through its 
larvae E/S products affect the host immune response. 
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2-MATERIALS AND METHODS  
2.1 Material. 
2.1.1 Equipment. 
Developer for radiographic films (Agfa Graphics Germany, Duesseldorf) 
ELISA reader Multiscan Ex Primary EIA V.2.1-0 (Thermo) 
FACSCalibur TM (Beckton Dickinson) 
Gel documentation system: MidiDoc (Herolab, Wiesloch) 
Gel electrophoresis camber (Bio-Rad, Muenchen) 
Heating block: DB-3 (Techne, Cambridge, UK), Heizblock (Liebisch, Bielefeld) 
Heating stirrer: Typ RCT (Jahnke & Kunkel, Staufen i. Br.) 
HERA safe (Heraeus, Thermo Electron, Langenselbold) 
Incubator: Heraeus (Thermo Electron, Langenselbold) 
Leica IRB (Leica Microsystems, Wetzlar) 
Macs columns adapter (Miltenyi Biotec) 
Mikro 200 table centrifuge (Hettich, Tuttlingen) 
Micro scales: R160P (Sartorius, Goettingen) 
Microtom 2065 (Leica Microsystems, Wetzlar ) 
Mini-PROTEAN II System (BioRad, Muenchen) 
MoFlo® high-speed sorter (Cytomation) 
MSC advantage laminar flow (Thermo Scientific, Braunschweig) 
NanoDrop 1000 (PeqLab Biotechnologie, Erlangen) 
Neubauer chamber ( 0.1 mm, 0.0025 mm2; (Hartenstein, Wuerzburg) 
Nuaire laminar flow (Nuaire) 
Power Pack P24 and P25 (Biometra, Goettingen) 
Refrigerated Centrifuge 3K30 (Sigma-Aldrich, Muenchen) 
Research Plus pipette set (Eppendorf, Hamburg) 
Scale: 10-1000 g (Sartorius, Goettingen) 
Selectomat S2000 autoclave (Muenchner Medizin Mechanik, Muenchen) 
G24 shaking incubator (New Brunswick Scientic, Edison, N.J., USA) 
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Spectrophotometer U-2000 (Hitachi, NY, USA) 
Tecan ELISA reader (Tecan Group, Crailsheim) 
T-Gradient Thermocycler (Biometra, Goettingen) 
TH30 shaking incubator (Hartensein, Wuerzburg) 
Trio-ThermoblockTM heated lid (Biometra, Goettingen) 
Trio-ThermoblockTM oil (Biometra, Goettingen) 
UV transilluminator (UVT-28MP, HeroLab) 
Vacuum pump (ILMVAC, Ilmenau) 
Vortex mixer: L46 (Gesellschaft fuer Laborbedarf, Wuerzburg) 
 
2.1.2 Consumables. 
0.2 µm Syringe Filters (SARSTEDT) 
96-well plates (Sarstedt, Nuembrecht) 
12-well plates (Nunc, Roskilde, Denmark) 
24-well plates (Nunc, Roskilde, Denmark) 
96-well plates (Sarstedt, Nuembrecht)  
Cell Strainer, 70µm (BD Biosciences) 
Filtropur Bottle Top Filters (BT50, SARSTEDT) 
Macs columns, MS (Miltenyi Biotec) 
Microtom sample adapter (Rudens Plastinindusti, Hestra, Sweden) 
Nitrocellulose membran (GE Healthcare, Muenchen) 
PD-10 column (GE Healthcare, Muenchen) 
Radiographic film (Fujifilm Europe, Duesseldorf) 
Safe-Lock Tubes 0,5, 1,5 and 2 ml (Eppendorf, Hamburg) 
Semi-micro cuvettes (Sarstedt, Nuembrecht) 
Sterilfilter (Nalgene, New York, USA) 
Sterile tubes, 15 and 50 ml (Greiner, Nuertingen) 
Superfrost Plus slides (Thermo Scientific, Braunschweig) 
Syringes and canula, sterile (Braun Melsungen AG, Melsungen) 
Tissue culture flasks 25 cm2 (Sarstedt, Nuembrecht) 
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Tissue culture flasks 75 cm2 (Sarstedt, Nuembrecht) 
Tissue culture flasks 175 cm2 (Sarstedt, Nuembrecht) 
Tissue culture inserts, 1µm (Greiner Bio-One) 
Vacutainer ® Blood Collection Tubes (BD Biosciences) 
Whatman blotting paper (GE Healthcare, Muenchen) 
X-Ray film HyperfimTM -MP (Amersham, Braunschweig) 
 
2.1.3 Chemicals, media, commercially available kits and enzymes. 
7-Amino-actinomycin D (7-AAD, BD PharmingenTM) 
Agarose (ROTH, Karlsruhe) 
Albumin fraction V (pH 7) Blotting grade (BSA) (AppliChem, Darmstadt) 
Ammonium peroxodisulfate (APS), (Carl Roth, Karlsruhe) 
Aqua demin. (VE-water) 
Ampuwa/double distilled H2O (Fresenius, Bad Homburg) 
Ampicillin (Sigma-Aldrich, Muenchen) 
Annexin V staining solution (BD Biosciences) 
Antarctic Phosphatase (New England Biolabs Inc., Schwalbach) 
AS601245 (Calbiochem, Merck, Darmstadt) 
Bacto agar (Difco Laboratories, Augsburg) 
Bathocuproine disulfonic acid (Sigma-Aldrich, Muenchen) 
ß-Mercaptoethanol (Sigma-Aldrich, Muenchen) 
Chloroform (Merck, Darmstadt) 
Carboxyfluorescein diacetate N-succinimidyl ester (CFSE, Invitrogen) 
CD25 MicroBead Kit (Miltenyi Biotec) 
Color Plus Prestained Protein Marker (10- 230 kDa) (NEB, Schwalbach) 
Colorimetric Cell Proliferation ELISA BrdU (Roche, Grenzach) 
Dimethyl sulfoxide (DMSO) (Sigma-Aldrich, Muenchen) 
DNeasy Isolation Kit (Qiagen) 
dNTP lyophilised (ROTH, Heidelberg) 
DMEM- GlutaMAXTM (DMEM) (Invitrogen, Darmstadt) 
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EasySepTM Mouse CD4+ T cell Enrichment Kit (STEMCELLTM Technologies) 
Fetal Bovine Serum (FBS, Biochrom) 
Fetal Calf Serum (PAA Laboratories) 
LPS (Sigma) 
Luria-Broth (LB; Invitrogen, Darmstadt) 
L-Cystein (Sigma Aldrich, Muenchen) 
L-Glutamine (Sigma) 
Mouse IFN-γ ELISA Set  (BD OptEIA™ ,  BD Biosciences) 
Mouse IL-6 ELISA Set  (BD OptEIA™ ,  BD Biosciences) 
Mouse IL-10 ELISA Set  (BD OptEIA™ ,  BD Biosciences) 
Mouse IL-12 (p70) ELISA Set  (BD OptEIA™ ,  BD Biosciences) 
NucleoSpin® Extract II (Macherey-Nagel, Dueren) 
NucleoSpin® Plasmid Kit (Macherey-Nagel, Dueren) 
Oligonucleotides (Sigma, Muenchen) 
Omniscript® RT Kit (QIAGEN, Hilden) 
OVA peptide (323-339, Sigma) 
pBAD/TOPO®ThioFusionTM Expression Kit (Invitrogen, Darmstadt) 
Penicillin (Sigma) 
Penicillin/Streptomycin (Invitrogen, Darmstadt) 
Phusion® DNA Polymerase (New England Biolabs) 
Pierce® BCA Protein Assay Kit (Thermo Scientific, Braunschweig) 
Pierce® ECL westen blot substrate (Thermo Scientific, Braunschweig) 
Ponceau S (Sigma) 
ProBondTM Nickel-Chelating Resin (Invitrogen, Darmstadt) 
Proteinase K (AppliChem, Darmstadt) 
pSecTag2/Hygro A mammalian expression vector (Invitrogen) 
Restriction enzymes (New England Biolabs Inc., Schwalbach) 
Rotiphorese® Gel 30 (37,5:1) (Carl Roth, Karlsruhe) 
Rotiphorese® Gel 40 (Carl Roth, Karlsruhe) 
RPMI-1640 (GIBCO BRL) 
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SB431245 (Sigma) 
SOC (Invitrogen, Darmstadt) 
Streptomycin (Sigma) 
T4 DNA Ligase (New England Biolabs Inc., Schwalbach) 
Taq-Polymerase (New England Biolabs Inc., Schwalbach) 
Tavanic® (Tava, active component levofloxacin, 5mg/ml) (Aventis) 
Technovit® 8100 (Heraeus Kulzer Technik, Wehrheim) 
TEMED (N,N,N’,N’-Tetramethylethylendiamin) (Merck, Darmstadt) 
TGF-β1 (Human, R&D Systems) 
TGF-β1 (Porcine, R&D Systems) 
Treg Detection Kit, mouse (Miltenyi Biotec) 
Triton® X-100 (Sigma-Aldrich, Muenchen) 
Trizol® Reagent (Invitrogen, Darmstadt) 
Trypan Blue (Biochrom, Berlin) 
Trypsin/EDTA (0,05%/0,02% (w/v)/ PBS w/o Ca2+, Mg2+) (Biochrom, Berlin) 
Tween® 20 (Merck, Darmstadt) 
 
2.1.4 Antibodies. 
2.1.4.1 Primary antibodies. 
Anti-CD3 (eBioscience) 
Anti-CD11c (Caltag Laboratories) 
Anti-CD19 (BD PharmingenTM) 
Anti-CD86 (eBiosciences) 
Anti-MHC II (eBioscience) 
Anti-TGF-β (1D11, R&D Systems) 
Normal Rabbit IgG (Santa Cruz Biotechnolocies) 
 
2.1.4.2 Secodary antibodies (peroxydase-conjugated). 
Anti-mouse-IgG (Jackson ImmunoResearch) 
Anti-rabbit-IgG (Jackson ImmunoResearch) 
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2.1.5 Softwares, online bioinformatics tools and databases. 
Bepipred Linear Epitope Prediction based Tool (tools.Immunoepitope.org) 
BD CellQuestTM (BD Biosciences) 
BioEdit 7.1.3 
Excel 2007 
Flowjo (Treestar, USA) 
GraphPad Prism® 6.0.0 
GeneDB (http://www.genedb.org/) 
ImageJ (http://rsb.info.nih.gov/ij/) 
MEGA 4 (Molecular Evolutionary Genetics Analysis) 
SMART (http://smart.embl-heidelberg.de/) 
Uniprot (http://www.uniprot.org/) 
 
2.1.6 Animals. 
Animals were bred in the animal facilities of the Institute for Hygiene and Microbiology (IHM) 
and of the Institute for Virology and Immunobiology (VIM), University of Würzburg, Würzburg, 
Germany, or at Charles River.   
 
Meriones unguiculatus 
Commonly termed Jirds or gerbils, they represent highly susceptible species of rodent to 
experimental infection with E. multilocularis larvae and were used throughout these studies for 
in vivo maintenance of the parasite. 
 
 C57BL/6 mice 
An inbreed strain of Mus musculus: C57BL subline number 6 or commonly termed Black 6. 
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OT-II C57BL/6 mice 
These mice are transgenicly altered so that the T-cell receptor of CD4 T-cells is specific for the 
recognition of OVA peptide (amino acids 323-339). They were kindly provided by Francis 
Carbone, Melbourne, Australia [193].   
 
OT-II×RAG-1(-/-) C57BL/6 mice 
These are transgenic mice resulting from the crossing between OT-II mice and  RAG-1(-/-) mice 
(devoid of mature B and T cells), giving rise to mice having for only mature CD4+ T cells those 
whose TCR is altered to recognize OVA peptide. These mice were a generous gift from Thomas 
Winkler, Erlangen, Germany [194]. 
 
2.2 Effects of E/S products of Echinococcus multilocularis larvae on 
murine DC. 
2.2.1 Ethics statement. 
All experiments were in compliance with European and German regulations on the protection of 
animals (Tierschutzgesetz). Ethical approval of the study was obtained from the local ethics 
committee of the government of Lower Franconia (Regierung von Unterfranken, 55.2-2531.01-
31/10). 
 
2.2.2 In vivo maintenance of Echinococcus multilocularis larval tissue. 
All starting with E. multilocularis metacestode tissue, isolated from naturally infected hosts 
(small rodents or human patients), the larvae can be maintained for years in laboratory rodents 
(Meriones unguiculatus) through serial intraperitoneal passages as described previously [195].  
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2.2.3 In vitro cultivation of E. multilocularis larval tissue. 
2.2.3.1 Isolation of parasite homogenate.  
Parasite tissue was extracted with a fresh pair of tweezers and scalpel from the viscera of 
intraperitoneally infected Jirds (Meriones unguiculatus) or infected human tissues. In order to 
render the material suitable for in vitro maintenance, the material was  homogenized and sieved 
as previously described [186]. The parasitic tissue homogenate obtained was subsequently used 
for the in vitro purification/expansion of the various parasite larvae or alternatively injected into 
jirds´peritoneum for in vivo propagation (section 2.2.2). 
 
2.2.3.2 Cultivation media. 
2.2.3.2.a Co-cultivation (DMEM10). 
Dulbecco´s Modified Eagle´s Medium, 4.5g glucose/L (DMEM + GlutamaxTM, GIBCO) 
supplemented with 10% Fetal Bovine Serum Superior (Biochrom AG), 100ug/ml 
Penicillin/streptomycin (PenStrep solution, Biochrom AG) and 20ug/ml Levofloxacin (Tavanic, 
Sanofi-Aventis, Deutschland GmbH). 
 
2.2.3.2.b Axenic maintenance for E/S collection (DMEM10redox).  
Dulbecco´s Modified Eagle´s Medium, 4.5 g glucose/L (DMEM + GlutamaxTM, GIBCO) 
supplemented with 10% Fetal Bovine Serum Superior (Biochrom AG), 100ug/ml 
Penicillin/streptomycin (PenStrep solution, Biochrom AG), 20ug/ml Levofloxacin (Tavanic, 
Sanofi-Aventis, Deutschland GmbH), 143 µM ß-mercapthoethanol (Sigma-Aldrich, cat. M6250), 
10 µM Bathocuproine disulfonic acid (Sigma, cat. B-35) and 100 µM L-Cysteine (Sigma, cat. C-
1276). 
 
46 
 
2.2.3.2.c Axenic cultivation (A4). 
To generate A4 medium, DMEM10redox (Section 2.2.3.2b) was used to grow rat hepatoma cells 
(106 cells in 100ml medium for 7 days). The conditioned DMEM10redox  was then collected, 
filtered over a bottle top filter (Filtropur BT50, SARSTEDT) and store at -20oC until use. 
 
2.2.3.3 Generation, expansion and maintenance of parasite larvae. 
Upon obtention of parasite homogenate from infected hosts (section 2.2.3.1), and three washing 
steps in PBS (1 X): 
- Protoscoleces were isolated as previously described [196]. Briefly, the parasite homogenate was 
filtered once through a nylon mesh of 150 μm pore size, thus separating protoscoleces from large 
pieces of metacestode tissue. The flow through was then filtered through a nylon mesh of 30 μm 
pore size, retaining the protoscoleces and allowing the single cells and small cell clumps in the 
flowthrough to be washed away. Protoscoleces were then washed off the nylon mesh with sterile 
PBS and separated from equally sized metacestodes by microscope-aided, manual picking with a 
pipette tip. For maintenance, protoscoleces were resuspended in DMEM10Redox and sealed in 
Nitrogen filled Ziploc freezer bag prior to incubation at 37oC, 5%CO2.The medium was 
replaced twice per week until subsequent applications. 
- Metacestodes were expanded by resuspending the homogenate in DMEM10 with 106 host 
feeder cells (Rat Reuber RH- hepatoma cells, ATCC no. CRL-1600) followed by incubation at 
37oC, 5%CO2 with frequent medium and feeder cells replacement. 6-8 weeks post maintenance 
in co-culture, metacestode vesicles were obtained and thoroughly washed. Broken and tiny cysts 
(<5mm) were selected out and the remaining cysts were transferred to DMEM10redox for axenic 
maintenance with medium change twice per week. 
- Primary cells were isolated from the germinal layer of axenically maintained metacestode 
vesicles as previously described [186,190]. Metacestode vesicles of at least 6-8 weeks of age and 
kept under axenic conditions were thoroughly washed in PBS (1 X). The cysts were then broken 
and the hydatid fluid released was washed away with PBS. The broken cysts were then digested 
for 30 minutes in 8 volumes of Trypsin/Ethylenediamine tetraacetic acid (Biochrom, cat. L2143) 
at 37oC with intermittent agitation to favor germinal layer cells detachment [186]. Following 
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digestion, the cyst lysates were filtered through a nylon mesh of 150 μm pore size, selectively 
retaining large pieces of metacestode tissue. The flow through was then filtered through a nylon 
mesh of 30 μm pore size, separating the diffusing parasite germinal cells from remnants of the 
cyst carbohydrate rich layer. For maintenance, primary cells were resuspended in DMEM10Redox 
and sealed in nitrogen filled Ziploc freezer bag prior to incubation at 37oC, 5%CO2.The medium 
was replaced twice per week until subsequent applications.  
 
2.2.4 PCR-based assessment of host cell remnants. 
After one week of axenic cultivation (i.e. in DMEM10redox), the different parasite larvae were 
analyzed for contamination with jird remnants. In doing so, chromosomal DNA was isolated 
from each larva as well as from liver tissue of a non-infected Jird using the DNeasy isolation kit 
(Qiagen). The total amount of DNA was assessed on a UV spectrophotometer (NanoDrop® ND-
1000, PEQLAB) and 10ng was used per PCR reaction. Part of the parasite specific gene elp 
(erzin-radixin-moesin-like; [197]) was amplified using the primers Em10-15 (5´-TCC TTA CCT 
TGC AGT TTT GT- 3´) and Em10-16 (5´-TTG CTG GTA ATC AGT CGA TC- 3´). To test 
host-DNA contamination, part of the mongolian jird β-tubulin encoding gene was amplified 
(137) using primers Tub12-Up (5´-CAA CGT CCA ACA CCG AGT CA-3´) and Tub12-ST (5´-
CTG GGC AGT GCG GCA ACC A-3´) [198]. PCRs were performed using Taq Polymerase 
(NEB) with 5 pmoles of each primer and a protocol of 30 cycles of 30 s at 94°C, 30 s at 58°C, 
and 2 min at 72°C. PCR-products were then separated on a 1.5% agarose gel and stained with 
ethidium bromide. 
 
2.2.5 Normalization of Echinococcus multilocularis larvae biomasses. 
Once qualitatively assessed for purity thus absence of host remnants (section 2.2.4), 40ml of 
metacestode vesicles were processed for germinal cells isolation. 1/12th, 1/6th and 1/3rd of the 
isolated cells were seeded in axenic culture (section 2.2.3.2.c) so as to monitor the in vitro 
kinetics of regeneration into metacestode vesicles. The amount of cells capable of forming de 
novo metacestodes within a time frame comparable to the in vivo situation was determined. This 
amount of cells was used as reference for the parasite biomass to be used for stimulation assays. 
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An equivalent biomass of in vitro cultivated metacestode vesicles and protoscoleces was 
determined by comparing their level of beta-actin expression to that of the reference amount of 
parasite cells. Briefly, upon a week of axenic cultivation, material of all three larval stages was 
passed through a pipette tip and washed in PBS (1X). The various homogenates were then 
treated with 50 µl of 2 X STOP mix (2ml 0.5M Tris-HCl pH 6.8, 1.6ml glycerol, 1.6ml 20% 
SDS, 1.4ml H2O, 0.4ml 0.05% (w/v) bromophenol blue, 7 µl ß-mercaptoethanol per 100 µl) and 
boiled for 10 min at 100oC. 10µl of each larvae protein mix were separated by SDS-PAGE and 
analyzed by Western blotting using an antibody directed against ß-actin (Cell signaling 
technology®, cat. No 4967) of a variety of metazoan organisms. Images were subsequently 
analyzed for the relative expression of ß-actin using the Image-J program 
(http://rsb.info.nih.gov/ij/ ; [199]). The relative expressions transcribed as values of area under 
the curve (AUC) were used to normalize the β-actin content from one sample to another. 
Additionally, the total protein content from the normalized amount of each larval stage was 
determined. Briefly, material from each larvae were lysed using a high-speed benchtop 
homogenizer (FastPrep®-24, MP Biomedicals) and the total amount of protein determined using 
the bicinchoninic acid assay (Pierce ® BCA Protein Assay Kit, ThermoScientific, prod # 23228) 
as per the manufacturer instructions. 
 
2.2.6 Preparation of Echinococcus multilocularis E/S products. 
A comparable amount of axenically cultivated parasite material, normalized for β-actin/protein 
content, from each of the three larval stages was then extensively washed with PBS (1X) and 
resuspended in DMEM10redox under axenic conditions (section 2.2.3.3). After 48 h of culture, 
the supernatant containing the larvae E/S products was collected and filter through a 0.2 μm-
membrane (Filtropur S filter, SARSTEDT). The total amount of proteins was then determined 
using the bicinchoninic acid assay (Pierce ® BCA Protein Assay Kit, ThermoScientific, prod # 
23228). The protein concentrations across the collected larval E/S products were normalized 
using ddH2O then the samples aliquoted and stored at -80oC until use.  
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2.2.7 Generation of murine bone marrow-derived dendritic cells. 
Dendritic cells were obtained by GM-CSF-driven differentiation of mice bone marrow precursor 
cells as previously described [200]. Briefly, C57BL/6 mice (Charles River/Wiga, Sulzfeld, 
Germany) aged 6-14 weeks and bred within the animal facility of the Institute of Virology and 
Immunobiology, University of Würzburg, under specific pathogen-free conditions were 
sacrificed using CO2 asphyxiation. Femurs and tibiae were removed and purified from the 
surrounding muscle tissue. Thereafter the marrow were flushed with PBS (1X), resuspended by 
gently pipetting and washed once in medium. It should be cautioned here, as previously defined 
[200], that the medium used was R10 medium composed of RPMI-1640 (GIBCO BRL) 
supplemented with 100U/ml Penicillin (Sigma), 100µg/ml Streptomycin (Sigma), 2mM L-
glutamine (Sigma), 50µM ß-mercaptoethanol (Sigma) and 10% heat-inactivated and filtered 
(0.22 µm, Millipore) fetal calf serum (FCS, PAA Laboratories). Once resuspended, the bone 
marrow precursor cells were counted using the trypan blue (Biochrom) exclusion test on a 
bright-line Neubauer counting chamber. 2 x 106 precursor cells were cultured in R10 medium 
supplemented with 10% GM-CSF-containing supernatant from a previously defined cell line 
[201] as already performed [200]. At day 8, non-adherent cells representing at a high frequency 
newly differentiated DC (70-89% CD11c+) were harvested, washed once in R10 medium prior 
to stimulation assays.  
 
2.2.8 Isolation of murine splenocytes. 
Single cell suspensions were obtained from the spleen of C57BL/6 mice by mechanically 
squeezing the tissue with glass slides in cold PBS (1X) and filtered through a 70µm nylon cell 
strainer (BD Biosciences). Red blood cells in the filtrate were lysed with 1.4% NH4Cl for 5 
minutes at 37oC. The filtrate was then washed in R10 medium and the splenocytes obtained were 
counted using the trypan blue (Biochrom) exclusion test on a bright-line Neubauer counting 
chamber. 
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2.2.9 Human red blood cells preparation. 
Blood was drawn from 2 volunteers in (BD Vacutainer® Blood Collection tubes, BD 
Biosciences) by a physician upon informed consent. The heparinized blood samples were gently 
spun at 300g for 10 minutes, the plasma discarded and the whole blood cells were resuspended in 
PBS (1/10) prior to hemolytic tests.  
 
2.2.10 Assessment of the influence of Echinococcus multilocularis larvae E/S 
products on host cells. 
2.2.10.1 Dendritic cell stimulation. 
A comparable amount of cultivated parasite material from each larval stage was washed thrice in 
R10 medium then used throughout the stimulation process. Tissue culture inserts (1µm, Greiner 
Bio-One) with or without larvae were added to DC cultures (106 cells /ml) in R10 medium and 
kept at 37oC under 5% CO2 for different time points before analysis. Alternatively, collected E/S 
products were used instead of full larvae. In parallel, LPS (0.1µg/ml, E. coli 0127:B8) was used 
to generate a positive control for DC maturation whereas UV-irradiation of DC (9000mW/cm2, 
313nm) stood as a reference for apoptosis.  For restimulation experiments, inserts containing 
parasite larvae were removed 24 hours post stimulation, DC were harvested and re-plated at an 
equal number of living cells (5x105 cells / ml) in R10 medium with or without LPS (0.1µg/ml, E. 
coli 0127:B8) for additional 48 hours. Upon completion, DC viability was assessed by trypan 
blue exclusion test (Biochrom) on a bright-line Neubauer counting chamber and the cells stained 
for flow cytometric analyses. 
 
2.2.10.2 Red Blood cell stimulation (Hemolytic test). 
A hemolysis assay was used to determine the potential of the parasite secretions to lyse red blood 
cells from humans with heparinized red blood cells being suspended in PBS. Erythrocytes were 
incubated in the presence of collected parasite secretions in comparison to DMEM10redox 
(negative control) and an equal volume of H2O (positive control). Then, after 48 hours of 
incubation at 37oC, the blood samples were centrifuged at 1000g for 5 min, and the supernatants 
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were separated from the pellet. The absorbance was measured at 540 nm. The hemolytic activity 
was defined as per Valdez et al [202] by the ratio: Sample absorbance / H2O absorbance. 
 
2.2.10.3 Splenocyte stimulation. 
With reference to DC stimulation assays, a comparable amount of cultivated metacestode 
vesicles washed thrice in R10 medium was used to stimulate murine splenocytes. Tissue culture 
inserts (1µm, Greiner Bio-One) with or without the parasite cysts were added to splenocytes 
cultures (106 cells /ml) in R10 medium and kept at 37oC under 5% CO2 for up to 72 hours. Upon 
completion, cell viability was assessed by trypan blue exclusion test (Biochrom) on a bright-line 
Neubauer counting chamber and an equal number of living splenocytes stained for flow 
cytometric analyses. 
 
2.2.10.4 Flow cytometry. 
2.2.10.4.a Dendritic cells. 
To assess the level of maturation, DC surface staining was performed using fluorochrome-
conjugated antibodies (anti-mouse) directed against the surface lineage marker CD11c (PE-
Cy5.5, Caltag Laboratories), the major histocompatibility complex class II molecules MHC II 
(PE, eBioscience) and the costimulatory CD86 (FITC, eBioscience). After 30 min of incubation 
at 4oC in the dark with a cocktail of CD11c, MHC II and CD86 antibodies, DC were washed 
twice with FACS buffer (1x PBS supplemented with 3% heat-inactivated and filtered FCS and 
0.1%NaN3) and acquired on a cytometer (FACSCaliburTM, Beckton Dickinson) equipped with 
CellQuest software. Results were further analyzed on FlowJo software (Tree Star, USA). 
To monitor the level of DC apoptosis, annexin-V (FITC, BD Pharmingen) targeting 
phosphatidylserine and the nucleic acid stain, 7-AAD (BD Pharmingen) were used. DC were 
resuspended in 50µl of 1 x annexin-V binding buffer (BD Pharmingen). Next, 5 µl of 7-AAD 
and 2 µl of Annexin V-FITC were added to the tubes before incubation for 15 minutes at room 
temperature. DC were then resuspended in 200 µl of 1 x annexin-V binding buffer and acquired 
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on a cytometer (FACSCaliburTM, Beckton Dickinson) equipped with CellQuest software. Results 
were further analyzed on FlowJo software (Tree Star, USA). 
 
2.2.10.4.b Splenocytes. 
Splenocytes surface staining was performed using fluorochrome-conjugated antibodies (anti-
mouse) directed against the B-cell surface lineage marker and T-cell exclusion marker CD19 
(PE-Cy5, BD Pharmingen).After 30 min of incubation at 4oC in the dark with CD19 antibody, 
splenocytes were washed twice with FACS buffer (1x PBS supplemented with 3% heat-
inactivated and filtered FCS and 0.1%NaN3) and acquired on a cytometer (FACSCaliburTM, 
Beckton Dickinson) equipped with CellQuest software. Results were further analyzed on FlowJo 
software (Tree Star, USA). 
 
2.2.10.5 Measurement of cytokine release by dendritic cells. 
Following DC stimulation, the production of IL-6, IL-10 and IL-12p70 was assessed in the 
culture supernatants using sandwich enzyme-linked immunosorbent assays (ELISA, OptEIA 
kits, BD Pharmigen) according to the manufacturer´s instructions with the following pre-defined 
detection limits (39pg/ml, 19pg/ml and 19pg/ml for IL-6, IL-10 and IL-12p70 respectively).  
 
2.2.11 Statistical analysis. 
All results were expressed as mean ±standard deviation (SD). Differences observed between 
groups were evaluated using the Wilcoxon / Mann-Whitney U test, a nonparametric test that 
does not assume normality of the measurements (it compares medians instead of means). Values 
of p<0.05 were considered statistically significant. All statistical analyses were performed with 
STATISTICA version 8.0.725.0 (Statsoft GmbH). 
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2.3. Influence of E/S products of E. multilocularis larvae on Foxp3+ Treg 
expansion. 
2.3.1 Ethics statement. 
All experiments were in compliance with European and German regulations on the protection of 
animals (Tierschutzgesetz). Ethical approval of the study was obtained from the local ethics 
committee of the government of Lower Franconia (Regierung von Unterfranken, 55.2-2531.01-
31/10). 
 
2.3.2 Parasite material. 
For in vivo assays, metacestodes were obtained from infected Mongolian jirds (Meriones 
unguiculatus). The recovered parasite homogenates were washed thrice in PBS (1X) then 
transferred to DMEM10redox for axenic maintenance with medium change twice per week for 
up to 10 days. The complete removal of host contaminants was assessed by PCR (section 2.2.4). 
The host-free parasite homogenates were then washed in PBS (1X), separated in aliquots of 5000 
acephalic cysts resuspended in a total volume of 500 µl PBS (1X) to be used for intraperitoneal 
injections. An equal volume (500 µl) of the carrier solution PBS (1X) was used in parallel for 
mock injections. Parasite preparations from 5 unrelated Jird infections were used so as to include 
any eventual parasite-related variation in the analysis.  For in vitro assays, E/S products collected 
from in vitro cultivated metacestode vesicles (section 2.2.6) were used in comparison to those of 
in vitro cultivated primary cells.  
 
2.3.3 Mice. 
All mice were bred and maintained at the Institute for Hygiene and Microbiology and the 
Institute of Virology and Immunobiology of the University of Würzburg according to the Local 
Ethics committee guidelines. C57BL/6 mice were purchased from Charles River. OT-II mice 
(TCR transgenic mice with TCR specific for I-Ab:OVA 323–339) were kindly provided by 
Francis Carbone, Melbourne, Australia. OT-II mice were crossed with RAG-1(-/-) mice (devoid 
of mature B and T cells), a generous gift from Thomas Winkler, Erlangen, Germany. C57BL/6 
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wild type mice were separated in groups of five (parasite injection, one animal for each parasite 
preparation) or fifteen (Mock injection, subdivided in sub-groups of three animals for each 
parasite preparation). 
 
2.3.4 Peritoneal lavage. 
At defined points within a time frame of 42 days post intraperitoneal injection, mice were 
sacrificed by CO2 asphyxiation. Ice cold PBS (1x) with 10% heat-inactivated filtered FBS 
Superior (Biochrom AG) was then used to wash the peritonea and retrieve the peritoneal 
exudates. In each of the five experimental replicates, i.e. the use of a different parasite biological 
replicate for i.p injection, the peritoneal cells were harvested from naïve (a pool of 3 mice) or 
infected (1 mouse) mice at each time point. The suspensions of peritoneal exudates were filtered 
through a 70µm nylon cell strainer (BD Biosciences). Red blood cells in the filtrates were lysed 
with 1.4% NH4Cl for 5 minutes at 37oC. The filtrates were then washed in R10 medium and the 
total numbers of recovered cells determined using the trypan blue (Biochrom) exclusion test on a 
bright-line Neubauer counting chamber prior to analysis. At the end of the infection follow up 
(42 days), the parasitic tissue was thoroughly excised from the peritonea of infected mice and the 
mass was determined. 
 
2.3.5 Flow cytometric analyses. 
2 x 105 peritoneal exudates were stained with fluorochrome-conjugated antibodies (anti-mouse) 
directed against the T-cell subset surface marker CD4 (Biotin, Miltenyi Biotec), the alpha chain 
of the IL-2 receptor CD25 (PE, eBioscience) present on activated T-cells and Foxp3 (APC, 
Miltenyi Biotec), the intracellular master transcription factor of regulatory T-cells. Biotinylated 
CD4 antibodies were detected by incubation with either FITC- or Pe-Cy5-conjugated 
streptavidin (BD Biosciences). As isotype control of activated/regulatory T-cells, Rat IgG1 K 
Isotype (PE, eBioscience) was used. The staining procedure was executed as per the 
manufacturer instructions (Treg Detection Kit, Miltenyi Biotec). The cells were resuspended in 
FACS buffer (1x PBS supplemented with 3% heat-inactivated and filtered FCS and 0.1%NaN3) 
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and acquired on a cytometer (FACSCaliburTM, Beckton Dickinson) equipped with CellQuest 
software. Results were further analyzed on FlowJo software (Tree Star, USA). 
 
2.3.6 In vitro regulatory T-cell suppression assay. 
From the spleen of a healthy mouse (section 2.2.8), and peritoneal exudates (section 2.3.4) of 
mice 7 days post infection (20 mice pooled), CD4+ cells were separately isolated using mouse 
CD4+ T-cell negative selection protocol (EasySep™ Mouse CD4+ T Cell Enrichment Kit, Stem 
Cell Technologies) to a purity of > 90% according to the manufacturer´s instructions. Purified 
CD4+ T-cells were stained with anti-CD4 (Biotin, Miltenyi Biotec) and anti-CD25 (PE, 
eBioscience) followed by incubation with Pe-Cy5-conjugated streptavidin (BD Biosciences). 
CD4+CD25- and CD4+CD25+ cells were then sorted on a MoFlo high-speed sorter 
(Cytomation). Sorted CD4+CD25- splenic cells (responders) were labeled with 2µM CFSE 
(CFDA SE, Molecular Probes/Invitrogen) at 37°C for 10 min and washed twice in R10 medium 
before use. For in vitro proliferation of the isolated responder cells, total splenocytes from a 
healthy mouse (section 2.2.8), were labeled with a cocktail of non-APC (antigen-presenting 
cells) binding antibodies directed against the murine T-cell lineage anti-Thy-1.2 (BD 
Pharmingen) , anti-CD4 (eBioscience) and anti-CD8 (eBioscience) on Ice for 30 minutes. The 
cells were then washed in 1x PBS supplemented with 3% heat-inactivated and filtered Fetal Calf 
Serum (FCS, PAA Laboratories) prior to antibody-mediated complement lysis (Rabbit 
complement, Cedarlane) at 1/10 dilution for 45 minutes under constant agitation at 37oC. Next, 
the suspension was filtered through a 70µm nylon cell strainer (BD Biosciences) and the filtrate, 
representing antigen presenting cells (APC), washed and resuspended in R10 medium (RPMI-
1640 from GIBCO BRL supplemented with 100U/ml Penicillin (Sigma), 100µg/ml Streptomycin 
(Sigma), 2mM L-glutamin (Sigma), 50µM ß-mercaptoethanol (Sigma) and 10% heat-inactivated 
filtered (0.22 µm, Millipore) fetal calf serum (FCS, PAA Laboratories). The purified antigen-
presenting cells were then irradiated on an X-ray unit (Faxitron, CellRad) with 20 Grays and 
counted using the trypan blue (Biochrom) exclusion test on a bright-line Neubauer counting 
chamber. A total of 2 X 105 irradiated APC were then cultured in anti-CD3 (1ug/ml, 
eBioscience) pre-coated 96-well round-bottom plates with 2 X 104 CFSE-labeled responders 
(Splenic CD4+CD25- cells) and 1-2 X 104 CD4+CD25+ cells for 5 days. The cells were then 
56 
 
harvested, resuspended in FACS buffer (1x PBS supplemented with 3% heat-inactivated and 
filtered FCS and 0.1%NaN3) prior to acquisition on a cytometer (FACSCaliburTM, Beckton 
Dickinson) equipped with CellQuest software. Results were further analyzed on FlowJo software 
(Tree Star, USA). 
 
2.3.7 In vitro regulatory T-cell conversion assay. 
Spleens and lymph nodes from 6-14 weeks old OT-II and OT-II×RAG-1(-/-) transgenic mice 
were isolated and cellular suspensions obtained as previously described (section 2.2.8). CD4+ T-
cells were isolated using a T-cell negative selection kit (Easy Sep mouse T-cell enrichment kit, 
Stem Cell Technologies) to a purity >90% as per the manufacturer´s instructions. Unlike OT-
II×RAG-1(-/-) mice which have no resting CD4+CD25+Foxp3+ T-cells [203], CD4+ T-cells 
from OT-II mice were further enriched for CD25- cells using Miltenyi Biotec´s LD columns with 
a suitable MACS separator achieving > 90% purity as per the manufacturer´s instructions. 
Murine bone marrow-derived DC at day 8 of cultivation (70-80% CD11c+, section 2.2.7) were 
incubated with 3-fold higher numbers of CD4+CD25- T-cells (OT-II or OT-II×RAG-1(-/-)) and 
200ng/ml OVA peptide (amino acid 323-339, grade V, Sigma) supplemented or not with parasite 
larvae E/S products (section 2.2.6). Recombinant human/porcine TGF-β1 (1, 2,10ng/ml; R&D 
Systems) were used as standards. In some experiments, the neutralizing multispecies anti-TGF-β 
antibody (1D11, R&D Systems) was added at 20µg/ml or 5µM of the TGF-β / Activin / Nodal 
subfamily - related ALKs (4,5 and 7) inhibitor, SB431245 (146; Sigma) was used. After 5 days 
of incubation, the cells were harvested and stained using the Treg detection kit (Miltenyi Biotec), 
resuspended in FACS buffer (1x PBS supplemented with 3% heat-inactivated and filtered FCS 
and 0.1%NaN3) prior to acquisition on a cytometer (FACSCaliburTM, Beckton Dickinson) 
equipped with CellQuest software. Results were further analyzed on FlowJo software (Tree Star, 
USA). 
 
2.3.8 In vitro IL-10 secretion assay. 
CD4+ T-cells were isolated from healthy C57BL/6 mice using a T-cell negative selection kit 
(Easy Sep CD4+ T cell enrichment kit, Stem Cell Technologies) to > 90% purity according to 
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the manufacturer´s instructions. The CD25- fraction was further enriched using Miltenyi Biotec´ 
LD columns with a suitable MACS separator achieving > 90% purity for CD4+CD25- T-cells. 
Next, 2 x 105 CD4+CD25- T-cells were seeded in a 24-well tissue culture plate (Flat bottom, 
SARSTEDT) that had been coated with anti-CD3 (0.1 µg/ml, eBioscience) overnight at 4oC in 
R10 medium. The cells suspension was supplemented with 5µg/ml anti-CD28 (eBioscience). 
Next, parasite E/S products (section 2.2.6) or unconditioned axenic culture medium 
(DMEM10redox, section 2.2.3.2.b) was added to the wells and supernatants were collected 72 
hours later. The amount of IL-10 in the culture supernatants was determined by ELISA as per the 
manufacturer´s instructions (BD OptEIA™ - Mouse IL-10 ELISA Set - BD Biosciences). 
 
2.3.9 Statistical analyses. 
All results were expressed as mean ±standard deviation (SD). Differences observed between 
groups were evaluated using the Wilcoxon / Mann-Whitney U test, a nonparametric test that 
does not assume normality of the measurements (it compares medians instead of means). Values 
of p<0.05 were considered statistically significant. Statistical analyses were performed with 
GraphPad Prism 6.00 for Windows (GraphPad Prism® Software). 
 
2.4. E. multilocularis larvae E/S products and Foxp3+ Tregs.  
2.4.1 Animals and Ethics statement. 
C57BL/6 and NMRI mice were purchased from Charles River and housed at the local animal 
facility of the institute for Hygiene and microbiology at least 1-2 weeks before experimentation 
as were Mongolian Jirds. All animals handling, care and subsequent experimentation were 
performed in compliance with European and German regulations on the protection of animals 
(Tierschutzgesetz). Ethical approval of the study was obtained from the local ethics committee of 
the government of Lower Franconia (Regierung von Unterfranken, 55.2-2531.01-31/10). 
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2.4.2 Parasite material. 
Echinococcus multilocularis larvae, i.e. primary cells, metacestodes and protoscoleces were 
isolated (section 2.2.3.3), freed from host contaminants as described elsewhere (section 2.2.4). 
The various larvae secretions were collected as previously detailed (section 2.2.6). The isolated 
parasite larvae and E/S products were then subsequently used as templates for RNA and protein 
assays. 
 
2.4.3 Echinococcus multilocularis Genome sequencing project. 
The nuclear genome of E. multilocularis has been produced by whole genome shotgun 
sequencing using a mixture of capillary sequencing, illumina sequencing and 454 
pyrosequencing [191,192]. A profiling of the different larvae transcriptome is currently 
underway. 
 
2.4.4 Identification of parasite factors, cloning and sequence analysis. 
2.4.4.1 Identification of a TGF-beta ligand from E. multilocularis. 
The full length of the TGF-β/Activin subfamily member, SmInACT (Schistosoma mansoni 
Inhibin/Activin, A4UAH0) was used as a query to search the E. multilocularis protein database 
([204], http://www.genedb.org/Homepage/Emultilocularis). A 2 step search was performed in 
order to identify a true TGF-β/Activin sub-family member.  Briefly, SmInACT was first used for 
a Blastp against Echinococcus multilocularis predicted protein database (http://www.genedb.org/ 
Homepage/Emultilocularis). The obtained hits were then used as queries for a Blastp against 
mammalian proteins to identify the true Inhibin/Activin orthologues from Echinococcus 
multilocularis.  
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2.4.4.2 Primer list. 
 
EmACT_Dw 5´- ATGACCATTACTACCCCCATGAAG-3´ 
EmACT_Up 5´- ACTACAACCGCACTCTAGGACAATG-3´ 
EmACT_DW 1 5´-GTCGTTCGACGAACACGGAG-3´ 
PBAD_Fwd 5´- ATGCCATAGCATTTTTATCC-3´ 
PBAD_Rev 5´- GATTTAATCTGTATCAGG-3´ 
tEcACT_Dw (Hind III)  5´- GTTGGAAGCTTACTCTTTAGACAGCCTGCAATAATG-3´ 
tEcACT_Up (Not I)  5´- GTGCGGCCGCCGAACAACCGCACTCTAGGAC-3´ 
T7_Dw 5´- TAATACGACTCACTATAGGG-3´ 
Psec_Rev 5´- TAGAAGGCACAGTCGAG-3´ 
EmACT 1 5´- TGAGCTCGAGAATTCAGTCGGCTTTTC-3´ 
EmACT 2 5´- GAGACCTTTGTGCCGAGTTGT-3´ 
EmACT 3 5´- GTACCGGAGTCAAAATTACGAC-3´ 
 
 
2.4.4.3 Amplification, Cloning and Sequence analysis of E. multilocularis TGF-beta 
ligand. 
RNA was isolated from in vitro cultivated metacestode vesicles using TRIzol® reagent 
(Invitrogen) as per the manufacturer´s instructions. Due to the fluid-containing structure of 
metacestode vesicles, the protocol was slightly modified. Briefly, a maximum of 5 cysts were 
ruptured using a sterile needle (23G, Neoject®, Dispomed Witt oHG). The released cyst fluid 
was removed upon centrifugation at 400g 3minutes at RT, and then the pellet was resuspended in 
1ml TRIzol® reagent and subsequently processed as per the manufacturer´s guidelines.  The 
isolated RNA was reverse-transcribed into complementary DNA (cDNA) using Omniscript RT 
Kit (Qiagen, Hilden, Germany) in a total volume of 20 µl as per the manufacturer´s 
prescriptions. For amplification of  the coding sequence, primers were made corresponding to the 
5´and 3´coding termini (EmACT_Dw and EmACT_Up for Emact).1µl of cDNA was used per 
20ul reaction as per the manufacturer´s guidelines (Phusion® High-Fidelity DNA Polymerase, 
New England Biolabs). 2µl of the amplicon were resolved on a 1.5% agarose gel and stained 
with Ethidium bromide prior to visualization under a UV transilluminator.                                   
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For cloning into PBAD/Thio-TOPO® (Invitrogen), A overhangs were added at the 3´ends of the 
amplified fragment. For this purpose, the PCR mix containing the fragment was purified over a 
silica gel column (NucleoSpin® Gel and PCR Clean-up, MACHEREY-NAGEL) as per the user 
manual. 150-1500ng of the amplicon was incubated at 72oC for 20minutes with 1U DNA 
polymerase (Taq DNA polymerase, NEB), 0.2mM dATP and 1X Buffer (Taq polymerase 
buffer). The 3´A-overhanged fragment was then ligated into pBAD/Thio_TOPO and chemically 
competent E. coli (One Shot® TOP10 Chemically Competent E. coli, Invitrogen) were 
transformed with the ligation product as per the pBAD/Thio-TOPO manual directives. Using a 
pair of primers (PBAD_Fwd and EmACT_Up), several transformed E.coli colonies growing on 
an ampicillin-supplemented solid medium were used as templates for PCR. Successful clones 
(yielding an amplicon) were sub-cultured overnight at 37oC in Luria Bertani medium 
supplemented with Ampicillin (50-100µg/ml) followed by plasmid isolation (Nucleospin 
Plasmid preparation, MACHEREY-NAGEL). 400ng of plasmid DNA as determined by 
spectrophotometry (NanoDrop® ND-1000, PEQLAB), were used for sequencing (3130 Genetic 
Analyzer, Applied Biosystems) with the primer pair (PBAD_Fwd and PBAD_Rev) and the 
sequencing readouts assembled into a single coding sequence using BIOEDIT  (Version 7.1.3).  
 
2.4.5 Recombinant expression, protein purification and antiserum generation. 
2.4.5.1 Bacterial expression of recombinant protein and generation of polyclonal 
antiserum. 
Upon identification of positive E.coli transformants, the arabinose-driven induction of Thio tag-
fused protein expression was conducted. The cloned full length factor was checked in sillico for 
antigenicity (tools.Immunoepitope.org) then recombinantly expressed. For the purpose, A single 
positive E.coli colony was grown overnight at 37oC in a 50ml inoculate of LB medium 
containing ampicillin (50-100ug/ml).The next day, the turbid LB medium was transferred to a 1 
Liter LB inoculum and kept on orbital shaker at 37oC until OD600nm =0.5. When the required 
OD600nm was achieved, a 1ml aliquot was taken and labeled as sample before induction. 2% 
Arabinose was then added to the broth culture and kept on orbital shaker at 37oC for an 
additional 4 hours. Another aliquot of 1ml was taken and labeled as sample after induction. The 
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remaining broth medium was centrifuged for 20 minutes at 6000g and the pellet processed for 
purification of the recombinant thio-tagged protein over a nickel-charged Sepharose®  resin, the 
ProBondTM resin (Invitrogen) as per the manufacturer instructions. The purified Thio-tagged 
protein was then diafiltered on Centrifugal Filter Units (Millipore) against sterile PBS (1X) 
before quantification using the BCA assay (ThermoScientific). An aliquot of the purified thio-
tagged protein was also collected and stored for subsequent gel analysis.  The stored aliquots 
were diluted 1:1 with 2 x STOPP mix ( 2ml 0.5M Tris-HCl pH 6.8, 1.6ml glycerol, 1.6ml 20% 
SDS, 1.4ml H2O, 0.4ml 0.05% (w/v) bromophenol blue, 7 µl ß-mercaptoethanol per 100 µl) and 
boiled for 10 min at 100oC. 10µl of each protein sample were separated by SDS-PAGE and 
transferred to a nitrocellulose membrane for Ponceau S staining (Sigma-Aldrich). After obtention 
of a clean pattern of the recombinant Thio-tagged protein on the gel, NMRI mice were 
immunized for generation of antiserum. NMRI mice were injected at two different locations with 
100µg of the recombinant Thio-tagged protein resuspended in 100µl Freund Incomplete adjuvant 
(Sigma). The double injections were repeated four weeks later to boost the mice immune 
response. Finally, ten days after the boost, the mice were bleeded from the heart and the serum 
collected and stored at -20oC until use. In parallel, naïve mice were also bleeded and the serum 
collected and stored as pre-immune serum or normal mouse serum.  
 
2.4.5.2 Recombinant expression in HEK cell line for functional assays. 
The identified TGF-β ligand was inserted in frame within the pSecTag2/Hygro expression 
system. In order to do so, the primer pair tEcACT_Dw and tEcACT_Up were used. The PCR 
program was designed as per the manufacturer instructions (Phusion High-Fidelity DNA 
Polymerase, New England Biolabs) generating a fragment flanked at the 5´end by a HindIII 
cutting site and at the 3´end by a NotI recognition site so as to mediate an in-frame insertion 
within the multiple cloning site of the vector. The PCR amplicon and the eukaryotic expression 
vector pSecTag2/Hygro were separately loaded on a 1.5 % agarose gel and the corresponding 
bands excised and the DNA cleaned up as per the kit directives (NucleoSpin® Gel and PCR 
Clean-up, MACHEREY-NAGEL). The purified vector and the amplicon were then digested 
simultaneously with HindIII and NotI as per the manufacturer´s instructions (New Englands 
Biolabs). The products of digestion were loaded on a 1.5% agarose gel, excised and cleaned 
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again as previously described (NucleoSpin® Gel and PCR Clean-up, MACHEREY-NAGEL). 
Using a well established vector-insert stochiometric ratio, the double digested amplicon and 
pSecTag2/Hygro were ligated using the T4 DNA ligase (New England Biolabs) as per the 
manufacturer´s instructions. Following ligation, the new plasmid construct was used to transform 
chemically competent E.coli as indicated by the supplier (One Shot® TOP10 Chemically 
Competent E. coli, Invitrogen). Using a pair of primers (T7_Fwd and PSec_Rev), several 
transformed E. coli colonies growing on an ampicillin-supplemented solid medium were used as 
templates for PCR. Successful clones (yielding an amplicon) were sub-cultured overnight at 
37oC in Luria Bertani medium supplemented with Ampicillin (50-100µg/ml) followed by 
plasmid isolation (Nucleospin Plasmid preparation, MACHEREY-NAGEL) and confirmation of 
the reading frame by sequencing. For this purpose, 400ng of plasmid DNA as determined by 
spectrophotometry (NanoDrop® ND-1000, PEQLAB), were used for sequencing (3130 Genetic 
Analyzer, Applied Biosystems) with the primer triplet (EmACT1, EmACT2 and EmACT3) and 
the sequencing readouts assembled  using BIOEDIT  (Version 7.1.3) to attest of the proper 
insertion of the TGF-β ligand within pSecTag2/Hygro.  Next, 293T Human Embryonic Kidney 
cells were used as the vessel for pSecTag2/Hygro-driven expression of the factor. More 
precisely, HEK 293T cells kept in DMEM10 medium (section 2.2.3.2.a) were grown to 50-70% 
confluency in a T75 flask (SARSTEDT) and harvested by trypsin treatment 
(Trypsin/Ethylenediamine tetraacetic acid, Biochrom, cat. L2143) at 37oC for 10 minutes. The 
cell concentration in the retrieved HEK culture suspension was determined (Trypan Blue, 
Neuebauer chamber) and 3 x 106 cells resuspended in 10 ml DMEM10 and seeded in a petri dish 
(92 x 16 mm [Ø x height], SARSTEDT) for 16 hours. The 293T human embryonic kidney cells 
were transfected with 10µg of either the empty expression vector pSecTag2/Hygro or the 
expression construct pSecTag2/Hygro-factor using linear polyethyleneimine (25kDa, Sigma). 
The supernatants were harvested upon 24 hours of incubation, filtered over a bottle top filter 
(Filtropur BT50, SARSTEDT), normalized for the total protein content (BCA Protein Assay Kit, 
ThermoScientific) and stored as aliquots at -80oC until use. 
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2.4.6 Assessment of factor secretion by in vitro cultivated metacestodes and 
transfected HEK cells.  
1ml of parasite or transfected HEK cell supernatants was resuspended in 9 volumes of 100% ice-
cold ethanol. The mixtures were kept at -80º C for at least 2 hours, then centrifuge for 30 min at 
14,000 rpm in a refrigerated centrifuge. The ethanolic supernatants were discarded and the 
pellets were dried thoroughly at 50oC and resuspended in 50µl of 2 x STOPP mix( 2ml 0.5M 
Tris-HCl pH 6.8, 1.6ml glycerol, 1.6ml 20% SDS, 1.4ml H2O, 0.4ml 0.05% (w/v) bromophenol 
blue, 7 µl ß-mercaptoethanol per 100 µl) and boiled for 10 min at 100oC. 10µl of each protein 
sample were separated by SDS-PAGE and transferred to a nitrocellulose membrane for 
immunodetection with the previously generated antiserum as compared to the pre-immune 
serum. 
 
2.4.7 Treatment of murine BMDC.  
Transiently transfected 293T HEK cell supernatants normalized for the total protein content were 
used throughout the stimulation process (see section 2.4.5.2 for collection and storage of 
supernatants). 8 days old cultures of in vitro generated BMDC from C57BL/6 mice (section 
2.2.7) were used at a concentration of 5 x 105 cells /ml of R10 medium and supplemented with 
either culture medium DMEM10 (see section 2.2.3.2.a), the supernatant of empty vector 
transfected HEK cells or that of the factor-containing vector transfected HEK cells. The DC were 
stimulated at 37oC under 5% CO2 for 24 hours before analysis. For restimulation assays, 24 
hours post initial treatment, DC were further stimulated with LPS (0.1µg/ml, E. coli 0127:B8) 
for an additional 24 hours. Upon completion, DC were stained for the lineage marker CD11c, the 
maturation markers MHCII and CD86 as previously described (section 2.2.10.4.a) and analyzed 
over a Flow cytometer (FACSCaliburTM, Beckton Dickinson) equipped with CellQuest software. 
Results were further processed on FlowJo software (Tree Star, USA). 
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2.4.8 Treg conversion assay. 
Spleens and lymph nodes from 6-14 weeks OT-II×RAG-1(-/-) transgenic mice were isolated and 
cellular suspensions obtained as previously described (section 2.2.8). CD4+ T-cells were isolated 
using a T-cell negative selection kit (Easy Sep mouse T-cell enrichment kit, Stem Cell 
Technologies) to a purity >90% as per the manufacturer´s instructions. OT-II mice derived 
CD4+ T-cells were further enriched for CD25- cells using Miltenyi Biotec´s LD columns with a 
suitable MACS separator achieving > 90% purity as per the manufacturer´s instructions. Murine 
BMDC at day 8 of cultivation (70-80% CD11c+, section 2.2.7) were incubated with 3-fold 
higher numbers of CD4+CD25- T cells (OT-II or OT-II×RAG-1(-/-)) and 200ng/ml OVA 
peptide (323-339, grade V, Sigma) supplemented or not with transfected 293T HEK cell 
supernatants (empty vector- and factor-transfected cells, see section 2.4.5.2) or unconditioned 
medium (DMEM10, section 2.2.3.2.a). Recombinant human/porcine TGF-β1 (1, 2,10ng/ml; 
R&D Systems) were used as standards or in conjunction with the various supernatants. After 5 
days of incubation, the cells were harvested and stained using the Treg detection kit (Miltenyi 
Biotec), resuspended in FACS buffer (1x PBS supplemented with 3% heat-inactivated and 
filtered FCS and 0.1%NaN3) prior to acquisition on a cytometer (FACSCaliburTM, Beckton 
Dickinson) equipped with CellQuest software. Results were further analyzed on FlowJo software 
(Tree Star, USA). 
 
2.4.9 IL-10 secretion assay.  
CD4+ T-cells were isolated from healthy C57BL/6 mice (6-8weeks old) using a T-cell negative 
selection kit (Easy Sep CD4+ T-cell enrichment kit, Stem Cell Technologies) to > 90% purity 
according to the manufacturer´s instructions. The CD25- fraction was further enriched using 
Miltenyi Biotec´ LD columns with a suitable MACS separator achieving > 90% purity for 
CD4+CD25- T cells. Next, 2 x 105 CD4+CD25- T-cells were seeded in a 24-well tissue culture 
plate (Flat bottom, SARSTEDT) that had been coated with anti-CD3 (0.1µg/ml, eBioscience) 
overnight at 4oC in R10 medium. The cells suspension was supplemented with 5µg/ml anti-
CD28 (eBioscience). Next, 50% of transfected 293T HEK cell supernatants (empty vector and 
factor-transfected cells, see section 2.4.5.2) or unconditioned culture medium (DMEM10, section 
2.2.3.2.a) was added to the wells and supernatants were collected 72 hours later for the amount 
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of IL-10 to be determined by ELISA as per the manufacturer´s instructions (BD OptEIA™ - 
Mouse IL-10 ELISA Set - BD Biosciences with a detection limit of 19pg/ml). 
 
2.4.10 Statistical analyses. 
All results were expressed as mean ±standard deviation (SD). Differences observed between 
groups were evaluated using the Wilcoxon / Mann-Whitney U test, a nonparametric test that 
does not assume normality of the measurements (it compares medians instead of means). Values 
of p<0.05 were considered statistically significant. Statistical analyses were performed with 
GraphPad Prism 6.00 for Windows (GraphPad Prism® Software). 
 
2.5 E. multilocularis larvae E/S products and Th1 immune responses. 
2.5.1 Animals and Ethics statement. 
See 2.4.1 
 
2.5.2 Parasite material. 
See 2.4.2 
 
2.5.3 Identification of parasite factors, cloning and sequence analysis. 
2.5.3.1 Identification of a T-cell immunomodulatory protein from E. multilocularis. 
A hit with significant similarity to Human T-cell Immunomodulatory protein [205] was identified 
within a previously established E. multilocularis trans-spliced cDNA library [206] and termed 
Emtip (Echinococcus multilocularis T-cell Immunomodulatory Protein).   
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2.5.3.2 Primer list. 
 
EmTIP_Dw 5´-CCTTGCAGTTTTGTATGAAAATG-3´ 
EmTIP_Up 5´-GATCATTCGACCTTCTACATTGC-3´ 
FG-GAP_Dw 5´-GAAACGTTGAAACAGATCG-3´ 
FG-GAP_Up 5´-GCTTATGTTTCCGAGCTTG-3´ 
AbTIP_Dw 5´-GCTGATTTGGCCGCTTTTG-3´ 
AbTIP_Up 5´-CTGAGATTCAACTCCAGGCAAAAG-3´ 
tEmTIP_Dw (EcoRV) 5´-GTTGGGATATCGGTGGCCATC-3´ 
tEmTIP_Up (NotI) 5´-GTGCGGCCGCCTACATTGCATC-3´ 
EmTIP1 5´-GAATGTAACCCGTTCTGTTG-3´ 
EmTIP2 5´-CATCATTGGACTCTCTTTAG-3´ 
EmTIP3 5´-GAAAATGTACCCGTTTCCGTTC-3´ 
 
2.5.3.3 Amplification, Cloning and Sequence analysis of Emtip. 
In order to verify the Emtip open reading frame, RNA was isolated from the parasite primary 
cells, metacestode vesicles and protoscoleces (section 2.4.4.3). More precisely, RNA was 
isolated using TRIzol® reagent (Invitrogen) as per the manufacturer´s instructions. Due to the 
fluid-containing structure of metacestode vesicles, the protocol was slightly modified for the 
latter. Briefly, a maximum of 5 cysts were ruptured using a sterile needle (23G, Neoject®, 
Dispomed Witt oHG). The released cyst fluid was removed upon centrifugation at 400g 
3minutes at RT, and then the pellet was resuspended in 1ml TRIzol® reagent and subsequently 
processed as per the manufacturer´s guidelines.  The isolated RNA was retro-transcribed into 
complementary DNA (cDNA) using Omniscript RT Kit (Qiagen, Hilden, Germany) in a total 
volume of 20 µl as per the manufacturer´s prescriptions. For amplification of Emtip coding 
sequence, primers (EmTIP_Dw and EmTIP_Up) were designed corresponding to the 5´and 
3´flanking regions of the corresponding nucleotide sequence as retrieved online and aligned to E. 
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multilocularis genomic DNA (147, http://www.genedb.org/Homepage/Emultilocularis).  1µl of 
cDNA was used per 20ul reaction as per the manufacturer´s guidelines (Phusion® High-Fidelity 
DNA Polymerase, New England Biolabs). 2µl of the amplicons were resolved on a 1.5% agarose 
gel and stained with Ethidium bromide prior to visualization under a UV transilluminator. 
EmTIP epitopes were predicted in sillico (tools.Immunoepitope.org). The antigenic N-terminal 
portion of the protein was chosen for immunization. A nested PCR was performed using as 
template 1µl of the full-length Emtip amplicon according to the enzyme manufacturer´s 
directives (Phusion® High-Fidelity DNA Polymerase, New England Biolabs) with the primers 
pair AbTIP_Dw / AbTIP_Up. Again, 2µl of the nested PCR amplicons , destined to insertion 
within the bacterial expression vector pBAD/Thio-TOPO® (Invitrogen) for sequence analysis 
and recombinant expression, were resolved on a 1.5% agarose gel and stained with Ethidium 
bromide prior to visualization under a UV transilluminator. A overhangs were then added at the 
3´ends of the amplified fragment. For this purpose, the nested PCR mix containing the fragment 
was purified over a silica gel column (NucleoSpin® Gel and PCR Clean-up, MACHEREY-
NAGEL) as per the user manual. 150-1500ng of the amplicon was incubated at 72oC for 
20minutes with 1U DNA polymerase (Taq DNA polymerase, NEB), 0.2mM dATP and 1X 
Buffer (Taq polymerase buffer). The 3´A-overhanged fragment was then ligated into 
pBAD/Thio_TOPO and chemically competent E. coli (One Shot® TOP10 Chemically 
Competent E. coli, Invitrogen) were transformed with the ligation product as per the 
pBAD/Thio-TOPO manual directives. Using a pair of primers (PBAD_Fwd and AbTIP_Up), 
several transformed E. coli colonies growing on an ampicillin-supplemented solid medium were 
used as templates for PCR. Successful clones (yielding an amplicon of expected size) were sub-
cultured overnight at 37oC in Luria Bertani medium supplemented with Ampicillin (50-
100µg/ml) followed by plasmid isolation (Nucleospin Plasmid preparation, MACHEREY-
NAGEL). 400ng of plasmid DNA as determined by spectrophotometry (NanoDrop® ND-1000, 
PEQLAB), were used for sequencing (3130 Genetic Analyzer, Applied Biosystems) with the 
primer pair (PBAD_Fwd and PBAD_Rev) and the sequencing readouts assembled into the 
corresponding thio tag-fused Emtip-coding fragment using BIOEDIT  (Version 7.1.3).  
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2.5.4 Recombinant expression of EmTIP and generation of antiserum. 
2.5.4.1 Bacterial expression of Thio tag-fused EmTIP and generation of polyclonal 
antiserum. 
Upon identification of Emtip-containing pBAD/Thio-TOPO positive E. coli transformants, the 
arabinose-driven induction of bacterial Thio-EmTIP expression was conducted. For the purpose, 
a single Thio-EmTIP expressing E. coli colony was grown overnight at 37oC in a 50ml inoculate 
of LB medium containing ampicillin (50-100ug/ml).The next day, the turbid LB medium was 
transferred to a 1 Liter LB inoculum and kept on orbital shaker at 37oC until OD600nm =0.5. 
When the required OD600nm was achieved, a 1ml aliquot was taken and labeled “Thio-EmTIP 
before induction”. 2% Arabinose was then added to the broth culture and kept on orbital shaker 
at 37oC for an additional 4 hours. Another aliquot of 1ml was taken and labeled “Thio-EmTIP 
after induction”. The remaining broth medium was centrifuged for 20 minutes at 6000g and the 
pellet processed for recombinant Thio-EmTIP purification over a nickel-charged Sepharose®  
resin, the ProBondTM resin (Invitrogen) as per the manufacturer instructions. The purified Thio-
EmTIP was then diafiltered on Centrifugal Filter Units (Millipore) against sterile PBS (1X) 
before quantification using the BCA assay (ThermoScientific). An aliquot of purified Thio-
EmTIP was also collected and stored for subsequent gel analysis.  The stored aliquots were 
diluted 1:1 with 2 x STOPP mix( 2ml 0.5M Tris-HCl pH 6.8, 1.6ml glycerol, 1.6ml 20% SDS, 
1.4ml H2O, 0.4ml 0.05% (w/v) bromophenol blue, 7 µl ß-mercaptoethanol per 100 µl) and 
boiled for 10 min at 100oC. 10µl of each protein sample were separated by SDS-PAGE and 
transferred to a nitrocellulose membrane for Ponceau S staining (Sigma-Aldrich).  
After obtention of a clean pattern for recombinant Thio-EmTIP on the gel (i.e. a single band 
visible), Inbred rabbits (1 year old) were intradermally immunized repetitively with the Thio-
EmTIP antigen suspensions in collaboration with the Biotechnology company ImmunoGlobe 
Antikörpertechnik GmbH (D-63762 Großostheim) generating 50 ml of  polyclonal antiserum. An 
aliquot of serum collected prior to the immunization scheme was termed pre-immune serum and 
used as specificity reference for the polyclonal antibodies generated. For affinity purification of 
the antiserum, 200-500µg of purified Thio-EmTIP antigen was run on SDS PAGE then blotted 
onto a nitrocellulose membrane. The band was visualized by ponceau S staining (Sigma-Aldrich) 
and excised prior to blocking in 5% skimmed milk in TBST (i.e. 5g of skimmed milk in 100ml 
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of 1 xTris Buffer Saline supplemented with 0.1% Tween 20) for 1 hour at room temperature on a 
rocking plate. The nitrocellulose stripe was then incubated overnight at 4oC with 500ul of anti-
Thio-EmTIP antiserum on a rotating wheel. Next, the stripe was sequentially washed in 0.15M 
NaCl, 1 X PBS then the bound antibodies eluted with 0.2M glycin solution supplemented with 
1mM EGTA at pH 2.5. The eluted anti-EmTIP antibody solution was neutralized to pH 7 with 
Tris solution (1M), then diafiltered on Centrifugal Filter Units (Millipore) against sterile PBS 
(1X) before quantification for the protein content using BCA assay (ThermoScientific) as per the 
manufacturer´s instructions then stored at -20oC until use. In parallel, whole IgG solution from 
naïve rabbit (Santa Cruz Biotechnology, inc.) was similarly eluted and diafiltered before storage 
at -20oC.    
 
2.5.4.2 Eukaryotic expression and collection of recombinant EmTIP. 
Metacestode cDNA was used as a template to amplify Emtip. The amplified amplicon was 
inserted in frame within the pSecTag2/Hygro expression system. In order to do so, the primer 
pair tEmTIP_Dw and tEmTIP_Up were used. The PCR program was designed as per the 
manufacturer instructions (Phusion High-Fidelity DNA Polymerase, New England Biolabs) 
generating an Emtip fragment flanked at the 5´end by a EcoRV cutting site and at the 3´end by a 
NotI recognition site so as to mediate the in-frame fragment insertion within the multiple cloning 
site of the vector. The PCR amplicon and the eukaryotic expression vector pSecTag2/Hygro 
were separately loaded on a 1.5 % agarose gel and the corresponding bands excised and the 
DNA cleaned up as per the kit directives (NucleoSpin® Gel and PCR Clean-up, MACHEREY-
NAGEL). The purified vector and Emtip amplicon were then digested simultaneously with 
EcoRV and NotI as per the manufacturer´s instructions (New Englands Biolabs). The products of 
digestion were loaded on a 1.5% agarose gel, excised and cleaned again as previously described 
(NucleoSpin® Gel and PCR Clean-up, MACHEREY-NAGEL). Using a well established vector-
insert stochiometric ratio, the double digested Emtip and pSecTag2/Hygro were ligated using the 
T4 DNA ligase (New England Biolabs) as per the manufacturer´s instructions. Following 
ligation, the Emtip-pSecTag2/Hygro plasmid was used to transform chemically competent E. 
coli as indicated by the supplier (One Shot® TOP10 Chemically Competent E. coli, Invitrogen). 
Using a pair of primers (T7_Fwd and PSec_Rev), several transformed E. coli colonies growing 
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on an ampicillin-supplemented solid medium were used as templates for PCR. Positive clones 
(yielding an amplicon) were sub-cultured overnight at 37oC in Luria Bertani medium 
supplemented with Ampicillin (50-100µg/ml) followed by plasmid isolation (Nucleospin 
Plasmid preparation, MACHEREY-NAGEL) and confirmation of the reading frame by 
sequencing. For this purpose, 400ng of plasmid DNA as determined by spectrophotometry 
(NanoDrop® ND-1000, PEQLAB), were used for sequencing (3130 Genetic Analyzer, Applied 
Biosystems) with the primer triplet (EmTIP1, EmTIP2 and EmTIP3) and the sequencing 
readouts assembled  using BIOEDIT  (Version 7.1.3) to attest of the proper insertion of Emtip 
within pSecTag2/Hygro.  Next, 293T Human Embryonic Kidney cells were transfected. More 
precisely, HEK 293T cells kept in DMEM10 medium (section 2.2.3.2.a) were grown to 50-70% 
confluency in a T75 flask (SARSTEDT) and harvested by trypsin treatment 
(Trypsin/Ethylenediamine tetraacetic acid, Biochrom, cat. L2143) at 37oC for 10 minutes. The 
cell concentration in the retrieved HEK culture suspension was determined (Trypan Blue, 
Neuebauer chamber) and 3 x 106 cells resuspended in 10 ml DMEM10 and seeded in a petri dish 
(92 x 16 mm [Ø x height], SARSTEDT) for 16 hours. The 293T human embryonic kidney cells 
were transfected with 10µg of either the empty expression vector pSecTag2/Hygro or the 
expression construct pSecTag2/Hygro-Emtip using linear polyethyleneimine (25kDa, Sigma). 
The supernatants were harvested upon 24 hours of incubation, filtered over a bottle top filter 
(Filtropur BT50, SARSTEDT), normalized for the total protein content (BCA Protein Assay Kit, 
ThermoScientific) and stored as aliquots at -80oC until use. 
 
2.5.5 Expression profile of EmTIP. 
The expression of EmTIP in larvae of E. multilocularis and as recombinantly expressed protein 
in 293T HEK cells was analyzed by RT-PCR, Immunoprecipitation and Immunodetection. First, 
1µl of the different parasite larvae cDNA were used for PCR amplification using the TAQ 
polymerase (NEB) with 5 pmoles of each primer (FG-GAP_Dw/FG-GAP_Up) and a protocol of 
30 cycles of 30 s at 94°C, 30 s at 53°C, and 30 s at 72°C. PCR-products were then separated on a 
1.5% agarose gel and stained with ethidium bromide for visualization. Next, E. multilocularis 
larvae at quantities previously defined (section 2.2.5) were passed through a pipette tip and 
washed in PBS (1X). The various homogenates were then treated with 50 µl of 2 X STOPP mix 
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(2ml 0.5M Tris-HCl pH 6.8, 1.6ml glycerol, 1.6ml 20% SDS, 1.4ml H2O, 0.4ml 0.05% (w/v) 
bromophenol blue, 7 µl ß-mercaptoethanol per 100 µl) and boiled for 10 min at 100oC. The 
larvae protein mixes were separated by SDS-PAGE and analyzed by Western blotting using 
polyclonal rabbit anti-EmTIP antibodies. Similarly,  the 293T human embryonic kidney cells that 
were transfected with 10µg of either the expression vector pSecTag2/Hygro or the expression 
construct pSectag2-Emtip (section 2.5.4.2) were harvested, washed thrice in 1 X PBS, treated 
with 50ul 2 x STOPP mix, resolved on a SDS gel, blotted then probed against anti-EmTIP 
antibodies.  
Finally, secretions of E. multilocularis larvae normalized as described elsewhere (section 2.2.6) 
as well as pSecTag2/Hygro- and pSecTag2/Hygro-Emtip-transfected 293T HEK cell 
supernatants (section 2.5.4.2) were immunoprecipitated and probed with anti-EmTIP antibody.  
More precisely, 20µg of anti-EmTIP antibody was captured on Protein G agarose as per the 
manufacturer´s guidelines (Protein G Agarose, Fast Flow, Upstate cell signaling solutions). The 
anti-EmTIP coated Protein G agarose beads were packed into a column and used to capture 
EmTIP from the above mentioned supernatants. The beads were then resuspended in 2 x STOPP 
mix (2ml 0.5M Tris-HCl pH 6.8, 1.6ml glycerol, 1.6ml 20% SDS, 1.4ml H2O, 0.4ml 0.05% 
(w/v) bromophenol blue, 7 µl ß-mercaptoethanol per 100 µl) and boiled for 10 min at 100oC. The 
protein mixes were separated by SDS-PAGE and analyzed by Western blotting using polyclonal 
rabbit anti-EmTIP antibodies. 
 
2.5.6 Immunohistochemical localization of EmTIP within Echinococcus 
multilocularis larvae. 
Samples of in vitro maintained parasite larvae (section 2.2.3.3), in vivo retrieved parasitic 
material within jird liver (2.2.3.1) and liver tissue of a non infected jird were fixed in 2% 
paraformaldehyde (in 1 x PBS) and washed at 4oC overnight in 1 x PBS containing 6.8% 
sucrose. The tissues were then dehydrated in 100% acetone for 1 hour at 4oC prior to embedding 
into Technovit 8100 as per the manufacturer´s instructions (Technovit® 8100, Heraeus Kulzer 
Technik). Next, using a rotary microtome, 4µm sections were prepared and stained sequentially 
with purified anti-EmTIP antibody then peroxydase-coupled anti-rabbit-IgG (Jackson 
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ImmunoResearch) against haematoxilin counterstain as recommended (Technovit® 8100, 
Heraeus Kulzer Technik). 
 
2.5.7 Neutralization of EmTIP during Echinococcus primary cells cultivation. 
The purified antibodies solutions (anti-EmTIP and IgG) prepared as described previously 
(section 2.5.4.1) were used for the following neutralization assays. 
 
2.5.7.1 Isolation of parasite primary cells and quantification. 
E. multilocularis metacestodes were maintained in DMEM10 with 106 rat hepatoma cells as 
feeder cells (Rat Reuber RH- hepatoma cells, ATCC no. CRL-1600) for 2-3 months with weekly 
medium and RH- cells replacement. When the cysts achieved a diameter > 5mm (2-3 months of 
culture), the latter were extensively washed with 1 X PBS and positively selected for integral 
laminated layer where the broken or compromised ones were gently aspired using a 10ml 
serological pipette (SARSTEDT) and discarded . 20ml of uncompromised cysts were then 
cultured in 50 ml of DMEM10redox for 96 hours without medium change under axenic 
conditions (i.e. under nitrogen phase, 130). Next, the cysts were washed thrice with 1 X PBS and 
the parasite germinal layer/primary/stem cells were isolated as extensively described elsewhere 
(130).The isolated cells were resuspended in 2 ml of DMEM10redox and the absorbance of a 
1:80 dilution of the suspension measured at 600nm.An OD600nm of 0.02/ml of the diluted 
suspension was taken as a reference unit for parasite cells quantification. 
 
2.5.7.2 Monitoring parasite primary cells proliferation in vitro 
7-10 units of isolated parasite germinal layer cells were seeded in a total volume of 100µl 
DMEM10redox supplemented or not with different concentrations of antibodies solution 
(purified rabbit IgG or anti-EmTIP) in flat-bottom 96 well plates (Nunc, Thermo Scientific). The 
plates were sealed in ziploc freezer bags filled with nitrogen before incubation in a CO2 
incubator at 37oC for 36 hours. Next, 10µM BrdU solution (BrdU Cell proliferation Elisa kit; 
Roche Applied Science) was added to the cultures and the cells were reincubated for 4 additional 
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hours. The cells were subsequently fixed and the amount of incorporated BrdU revealed after 
cell DNA denaturation, probing with a peroxydase conjugated anti-BrdU monoclonal antibody 
and finally colorimetric detection with tetra methyl-benzidine (peroxydase substrate) as per the 
BrdU Cell proliferation Elisa kit manufacturer´s directives (Roche Applied Science). In parallel, 
0.1 x 104 Rat hepatoma cells were seeded in a total volume of 100µl DMEM10 with similar 
stimuli (purified rabbit IgG or anti-EmTIP) and the proliferation rate also assessed by BrdU 
incorporation. 
 
2.5.7.3 Monitoring parasite primary cells differentiation into metacestode vesicles in 
vitro 
70 units of isolated parasite germinal layer cells were seeded in a total volume of 500µl 
DMEM10redox supplemented or not with a 30µg/ml of anti-EmTIP in flat-bottom 48 well plates 
(Nunc, Thermo Scientific). The plates were sealed in ziploc freezer bags filled with nitrogen 
before incubation in a CO2 incubator at 37oC. The medium was replaced with anti-EmTIP 
supplemented-DMEM10redox every 48 hours. At day 8, the DMEM10redox medium was 
completely aspired and fully replaced with A4 medium (see section 2.2.3.2.c) to fasten the 
regeneration process. The cultures were then further kept with frequent A4 medium change 
(twice per week). After 14 days, when cyst generation was distinctively noticeable, aggregates of 
parasitic primary cells were dissociated by gently pipetting up and down with a 1-mL pipette to 
loosen the aggregates and release newly formed cysts hitherto hidden. The total numbers of cysts 
per well were then determined by microscope-aided counting. 
 
2.5.8 In vitro stimulation of CD4+ T-cells. 
CD4+ T-cells were isolated from healthy C57BL/6 mice (6-8weeks old) using a T-cell negative 
selection kit (Easy Sep CD4+ T cell enrichment kit, Stem Cell Technologies) to > 90% purity 
according to the manufacturer´s instructions. The CD25- fraction was further enriched using 
Miltenyi Biotec´ LD columns with a suitable MACS separator achieving > 90% purity for 
CD4+CD25- T cells. Next, 2 X 105 CD4+CD25- T-cells were seeded in a 24-well tissue culture 
plate (Flat bottom, SARSTEDT) that had been coated with anti-CD3 (0.1µg/ml, eBioscience) 
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overnight at 4oC in R10 medium. The cells suspension was supplemented with 5µg/ml anti-
CD28 (eBioscience). Next, transfected 293T HEK cell supernatants (empty vector and Emtip-
construct transfected cells, see section 2.5.4.2), unconditioned culture medium (DMEM10, 
section 2.2.3.2.a) or parasite larvae E/S (section 2.2.6) was added to the wells and supernatants 
were collected 72 hours later for the amounts of IL-10 and IFN-γ to be determined by ELISA as 
per the manufacturer´s instructions (BD OptEIA™ - Mouse IL-10 ELISA Set; Mouse IFN-γ 
ELISA Set  - BD Biosciences with detection limits of 19pg/ml and 0.762pg/ml respectively). In 
another set of experiments, Brefeldin A (5µg/ml; Sigma) was added during the final 6h of CD4+ 
T-cell treatment and the cells were harvested for intracellular FACS analysis.  Briefly, the cells 
were stained for surface markers (CD4-PE, BD Biosciences) in ice-cold PBS supplemented with 
0.1% BSA and 0.1% sodium azide, followed by fixation in 2% formaldehyde and 
permeabilization in perm buffer (0.5% saponin in PBS) and then stained in perm buffer for 
intracellular IFN-γ (IFN-γ-FITC, BD Biosciences). Samples were measured at a FACScalibur 
flow cytometer (BD) and data were analyzed with FlowJo software (TreeStar).  
 
2.5.9 Statistical analyses. 
See 2.4.10 
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3. RESULTS 
3.1 Isolation and normalization of E. multilocularis larval material. 
In order to assess the influence of E/S products of E. multilocularis larvae on the host immune 
system, early (primary cells), mid- (metacestodes) and late (protoscoleces) E. multilocularis 
larval stages devoid of any host contaminants were isolated according to Spiliotis and Brehm 
[186]. Briefly, E. multilocularis material was excised from intraperitoneally infected jirds 2-3 
months post infection. After extensive washing, the material was axenically cultivated to remove 
host contaminants [186]. Host-free primary cells (Fig. 10A), metacestode vesicles (Fig. 10B) and 
protoscoleces (Fig. 10C) could thus be obtained as shown by polymerase chain amplification of a 
jird (host)-specific β-tubulin gene and the parasite specific elp gene (Fig. 11A). A series of 
experiments revealed that approximately one sixth of E. multilocularis primary cells isolated 
from 40 ml of metacestodes could regenerate into metacestode vesicles (Fig. 11B) within a time 
window similar to that reported for the in vivo transition of oncosphere into metacestode; i.e.  2-4 
weeks [207]. Since this amount of primary cells did display an aggregation of cells into cavities 
but failed to show any budding metacestode structure a week after in vitro cultivation, the latter 
was used as a reference for primary cell material for the following stimulation assays and thereby 
as the reference amount to be used for the normalization of E. multilocularis material (Fig. 11C). 
Hence, 4 metacestode vesicles (2 months of age) of a diameter of 5 mm and 2000 protoscoleces 
were used in comparison since the latter were shown to contain a similar amount of protein to 
that of the defined primary cells reference (Fig. 11C). E/S products could then be generated by 
incubation of an equivalent amount of each larvae material in serum-containing DMEM10redox 
medium (Fig. 10). The collected E/S products were further adjusted for the total protein content 
(Fig. 11D) prior to use in the subsequent stimulation assays.  
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Figure 10: Preparation of E. multilocularis larval material. Isolation, maintenance and collection of 
E/S products from E. multilocularis primary cells (A), metacestode vesicles (B) and protoscoleces (C). 
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Figure 11: Qualitative and quantitative assessment of E. multilocularis larval material. (A) 
Isolated and axenically maintained larvae of E. multilocularis are free of host contaminants. Genomic DNA was  
isolated from parasite larvae (PC: primary cells, MV: metacestode vesicles, Pro: protoscoleces) 1 week post-axenic 
maintenance, or liver tissue from M. unguiculatus (MuLT). Each DNA sample was used as PCR template for 
amplification of parasite (elp) and jird (beta-tubulin) specific genes. (B) Determination of a reference amount of 
parasite primary cells for stimulation assays in vitro. Series of experiments on different amounts of primary cells 
kept in axenic culture. Note the development of 1/6 of the total amount of primary cells isolated from 40 ml of 
metacestode vesicles in vitro herein defined as reference quantity for larvae isolation. No budding cysts could be 
observed after a week but regeneration into metacestode vesicles was achieved within 2-4 weeks as reported in vivo 
with oncospheres [207]. (C) Normalization of parasite material. Various quantities of E. multilocularis larvae free 
from host cells were probed for β-actin content and the blots analyzed by ImageJ (i). Based on the values obtained, 
as a mean of quantification of the β-actin content, the starting material of larvae were adjusted (ii) and the reliability 
of such system of inference tested on half of the normalized quantities obtained from each larval stage (iii). The 
reference value defined here (2PC) was obtained from 7-days-old-cultured primary cells (1/6 of total) obtained from 
40 ml of vesicles as previously defined. (D) Normalization of parasite excretory/secretory products. The total protein 
content of E/S products collected from E. multilocularis larvae were determined using BCA assay. The lowest value 
(highlighted) was used as a baseline for normalization by determining the amount necessary to give an equal final 
concentration in a total volume of 100ul. The solutions were topped to 100ul using double distilled sterile water as 
reported. 
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3.2 Excretory/secretory-products of Echinococcus multilocularis larvae 
induce apoptosis and tolerogenic properties in dendritic cells in vitro. 
3.2.1 E/S products of E. multilocularis primary cells and metacestodes but not 
those of protoscoleces kill DC in vitro.  
To compare the influence of E/S products from each of E. multilocularis larvae on DC, BMDC 
were exposed for 48 h to an equal biomass of each larvae through thin well inserts allowing 
uniquely fluid exchange but not cell-to-cell contact. BMDC viability appeared considerably 
reduced after exposure to primary cells and metacestode vesicles but largely unchanged with 
protoscoleces (Fig. 12A). Since metabolically active larvae could be depriving BMDC of 
nutrients thus inducing death by starvation, collected E/S products were used instead of live 
larvae. A similar reduction of BMDC viability was observed with primary cell secretions (Fig. 
12) indicating that E. multilocularis primary cells and metacestodes release a factor (or factors) 
capable of inducing BMDC death.  
 
Figure 12: E/S products of E. multilocularis larvae kill BMDC in vitro. BMDC were either 
exposed to live larvae, separated by tissue culture inserts (A), or to collected larvae E/S products (B). 48 hours later, 
cells were harvested and viability assessed by trypan blue. Viability is expressed as a percentage of the number of 
living cells harvested to the number of living cells seeded. The results represent the mean ± SD from 4 independent 
experiments. *:p<0.05.  
 
Since Echinococcus spp. hydatid fluid has been shown to lyse peritoneal macrophages, 
splenocytes, primary T-cells or T-cell lines [156-159], I reasonably hypothesized that the 
79 
 
cytotoxic factor (s) of Echinococcus hydatid fluid could be released in culture and thus mediate 
the observed BMDC death. To examine this hypothesis, mouse splenocytes were exposed to E. 
multilocularis metacestodes through transwells for up to 72 hours. Interestingly, metacestode 
secretions failed to affect mouse splenocyte viability in general (Fig. 13A) as well as splenic B-
cells and non B-cells in particular (Fig. 13B). Furthermore, I found that human red blood cells 
exposed to any of the parasite larvae E/S products were also not lysed (Fig. 13C) suggesting that 
the cytotoxic factor(s) released by E. multilocularis primary cells and metacestodes do(es) not 
mediate BMDC death by cell lysis and functionally differ(s) from those previously described 
within the hydatid fluid of Echinococcus spp. [208–211].  
 
 
Figure 13: E/S products of E. multilocularis metacestode vesicles larvae do not kill murine 
splenocytes and fail to lyse human red blood cells in vitro. (A) Splenocytes from female C57BL/6 
mice were exposed to metacestode vesicles (MV), separated through a transwell system, and viability was assessed 
using the Trypan Blue exclusion test after 48 h and 72 hours. (B) Within the splenic lymphocytes, as defined with 
respect to the forward and side scatter, CD19+ lymphocytes were stained and CD19− lymphocytes deduced by flow 
cytometry and the proportions of both cell populations (CD19− and CD19+) were monitored for changes upon 
exposure to metacestode vesicles. The scatter plots are representatives of the two experiments depicting similar 
results. (C) E/S products of E. multilocularis larvae fail to lyse human red blood cells. Human blood was collected 
from 2 healthy donors in heparinized tubes and for each donor, an equal volume of red blood cell suspension was 
seeded in parasite culture medium. Red blood cells were exposed to comparable amounts of primary cells, 
metacestode vesicles and protoscoleces through a transwell system and were maintained in culture. Culture medium 
(DMEM10redox) was used as negative control whereas an equal volume of water was used as positive control.  
After 48 hours, the transwells were removed, the plate centrifuged and the supernatant collected for measurement of 
hemoglobin content as a marker of red blood cell lysis. The percentage of hemolysis is expressed as a ratio of the 
sample absorbance over that of water (540nm) fixed as the 100% reference. (A, C)Bars are means ± SD from 2 
independent experiments. (C) Results shown are means +- SD obtained with 2 healthy donors. NS, not significant; *, 
p<0.05.  
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3.2.2   E/S products of E. multilocularis primary cells and metacestodes induce 
DC death via apoptosis    
A previous study has indicated that the expression of pro-apoptotic markers was significantly 
higher in lymphocytes following treatment with hydatid fluid from Echinococcus spp. [212]. I 
thus reasonably suggested that the death of BMDC following exposure to E/S products of E. 
multilocularis larvae could be mediated by apoptosis. To examine this, BMDC were exposed to 
the larvae E/S products for 48 h and the levels of Annexin V expression (a maker of apoptosis) 
and 7-AAD (a marker of necrosis for exclusion of necrotic events) expression were measured. 
My analyses revealed that BMDC considerably underwent apoptosis following exposure to E/S 
products of primary cells (early larva) and metacestode vesicles (mid-larva) where as those 
exposed to protoscolex E/S products did not. These findings indicate that E. multilocularis early 
and mid larval stages secrete (a) factor(s) that induce(s) BMDC death via apoptosis whereas 
protoscoleces failed to do so. 
 
 
 
Figure 14: E/S-products of E. multilocularis larvae induce DC death via apoptosis. DC were 
exposed to comparable amounts of E. multilocularis larvae (primary cell aggregates, PC; metacestode vesicles, MV; 
protoscoleces, Pro), separated by a transwell system, for 24 hours. DC were then analyzed by flow cytometry for the 
expression of Cd11c, AnnexinV and 7-AAD. The proportion of apoptotic DC (Cd11c+AnnexinV+7-AAD−) was 
then determined. UV-treatment of DC was used as positive control for apoptosis-inducing conditions. (A) 
Representative plots of the proportion of AnnexinV+ 7-AAD− cells, gated on CD11c+ cells. (B) Mean percentage ± 
SD of apoptotic DC (Apo-DC) of 4 independent experiments. *=p<0,05.  
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3.2.3   E/S products of E. multilocularis primay cells and metacestodes but not 
those of protoscoleces impair DC maturation and responsiveness in vitro. 
Crude extracts of E. multilocularis larvae have been shown not to mediate DC maturation in 
vitro [182]. To test whether the parasite E/S products influence the host DC, BMDC were treated 
in vitro with E/S products from each of the parasite larvae for 72 hours. Neither E/S products of 
primary cells nor those of metacestode vesicles could elicit BMDC maturation with respect to 
MHCII and CD86 expression after this time (Fig. 15A,B). DC exposed to E/S products of 
protoscoleces rather showed an intermediate maturation state when compared to fully matured 
LPS-pulsed DC (Fig. 15A,B). Furthermore, E. multilocularis-treated DC showed a differential 
cytokine secretion profile depending on the larval stage E/S products that were used (Fig. 15C). 
From an equal number of surviving E. multilocularis-treated DC, no detectable amount of IL-
12p70 was secreted in the culture supernatants upon treatment with E/S products of any of the 
parasite larvae (Fig. 15C). Of interest, E/S products of primary cells triggered the release of IL-
10 by DC. DC exposed to protoscolex E/S products only appeared to secrete IL-6 whereas 
metacestode vesicle E/S products could not elicit the release of detectable amounts of any of the 
cytokines (Fig. 15C). Collectively, these findings showed that the influence of E. multilocularis 
E/S products on DC is larva-specific. Whereas E/S products of primary cells render DC 
tolerogenic, protoscolex E/S products are rather immunogenic.  
To investigate whether E/S products of E. multilocularis larvae could impair DC activation as 
observed during experimental AE [213], BMDC first exposed to each of the E. multilocularis 
larvae E/S products for 24 hours were harvested and an equal number of surviving cells were 
restimulated with LPS (0.1ug/ml) for an additional 48 hours. Interestingly, DC exposed to E/S 
products of primary cells or metacestode vesicles had an impaired maturation in response to LPS 
(Fig. 16A,B). DC exposure to protoscolex E/S products failed to show such an effect (Fig. 
16A,B). Furthermore, DC treated with primary cell or metacestode vesicle E/S products showed 
a reduced level of IL-12p70 secretion in response to LPS (Fig.16C). Interestingly, LPS-driven 
release of IL-12p70 was completely abrogated in DC treated with protoscolex E/S products 
(Fig.16C). These data show that E/S products of early (primary cells) and mid (metacestode 
vesicles) but not late (protoscoleces) E. multilocularis larvae impair classical DC maturation and 
responsiveness in vitro. 
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Figure 15: E/S-products of E. multilocularis larvae differentially affect DC maturation and 
cytokine profile. DC were exposed to E. multilocularis larvae (primary cell aggregates, PC; metacestode 
vesicles, MV; protoscoleces, Pro), separated through a transwell system, for 72 hours and their maturation was 
assessed by flow cytometry after staining for surface markers CD11c, MHCII and CD86. (A) Representative scatter 
plots showing the proportion of matured DC (upper right quadrant) with respect to MHCII and CD86, gated on 
CD11c cells. t0 indicates maturation at the beginning of the experiment. (B) Mean fluorescence intensities of 
MHCII and CD86 on DC after 72 hours of treatment. (C) DC supernatants were collected and analyzed for the 
presence of IL-12p70, IL-10 and IL-6 by ELISA. Data shown are the mean ± SD of 4 independent experiments. # : 
below the ELISA kit detection limit. 
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Figure 16: E/S-products of E. multilocularis differentially alter DC responsiveness to 
LPS.DC were first exposed to E. multilocularis larvae (primary cell aggregates, PC; metacestode vesicles, MV; 
protoscoleces, Pro), separated through a transwell system, for 24 hours. DC were then harvested, counted and seeded 
at equal numbers of living cells in medium containing LPS for 48 h, prior to staining and flow cytometric detection 
for surface markers CD11c, MHCII and CD86. (A) Representative scatter plots showing the proportion of matured 
DC (upper right quadrant) with respect to MHCII and CD86, gated on CD11c cells. (B) Mean fluorescence 
intensities of MHCII and CD86 on DC. (C) DC supernatants were collected and analyzed for the presence of IL-
12p70, IL-10 and IL-6 by ELISA. Data shown are the mean ± SD of 4 independent experiments. *=p<0,05. # : 
below the ELISA kit detection limit  
 
Taken together, these findings indicated that E/S products of E. multilocularis larvae directly 
infecting the intermediate host (rodents, humans), i.e. primary cells and metacestodes, but not 
those of the larva released within the definitive carnivorous host (foxes, dogs), i.e. protoscoleces, 
induce apoptosis and tolerogenic properties in DC in vitro.  
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3.3 Expansion of regulatory T-cells (Treg) by E. multilocularis 
metacestodes  
3.3.1 E/S products of E. multilocularis metacestode vesicles promote Foxp3 
expression and the production of the anti-inflammatory cytokine IL-10 by 
CD4+ T-cells in vitro.  
Maturation-resistant DC have been defined as tolerogenic DC [214]. Those DC share common 
characteristics, such as moderate or high expression of surface MHC molecules, in association 
with a low ratio of costimulatory to inhibitory signal and an impaired ability to secrete Th1 cell-
driving cytokines, such as IL-12p70 [214]. Furthermore, tolerogenic DC constantly present 
antigens to T-cells in a fashion that promotes tolerance, at least in part, through the control of 
regulatory T-cells [215] of which Foxp3+ regulatory T-cells are by far the best  studied 
[216,217].  With regards to my previous observations, E/S products of E. multilocularis primary 
cells and metacestode vesicles evoked a tolerogenic profile in BMDC. It would therefore be 
reasonably expected that E/S products of primary cells and metacestode vesicles condition DC to 
expand regulatory T-cells as a result of their tolerogenic properties. To examine this hypothesis, 
OVA-loaded BMDC were co-cultured with OT-II CD4+CD25- T-cells for 5 days in the presence 
of E/S products of primary cells, metacestode vesicles or protoscoleces as compared to 
recombinant TGF-β (positive control since shown to induce Foxp3+ regulatory T-cell conversion 
[218]). CD4+ T-cells were then analyzed by flow cytometry for expression of IL-2 receptor alpha 
(CD25) and Foxp3 (Fig.17A,B). No expansion of CD4+CD25+Foxp3+ Tregs could be observed 
with primary cell or protoscolex E/S products (Fig.17A,B). Strikingly, metacestode vesicle E/S 
products induced a considerable expansion of Foxp3+ Tregs, up to 3 fold more than the untreated 
controls (Fig. 17A,B).  
Mechanistically, Foxp3+ Treg expansion in this experimental setting can either be due to the de 
novo conversion of Foxp3-CD4+ T-cells and/or the proliferation of already present 
(contaminating) Foxp3+CD4+ T-cells. In order to discriminate between these mechanisms, naïve 
CD4+ T-cells from OT-II×RAG-1(-/-) mice, devoid of contaminating Foxp3+CD4+ T-cells (Fig. 
17C), were used for the Treg conversion assays in place of naïve CD4+ T-cells from OT-II mice,  
to specifically monitor the rate of de novo Treg conversion from naïve T-cells. Interestingly, co-
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cultures of DC and OT-II×RAG-1(-/-) CD4+ T-cells exposed to E/S products of metacestode 
vesicles showed a higher rate of de novo Foxp3+ Treg conversion (Fig. 17D,E). These findings 
indicated that E/S products of E. multilocularis metacestode vesicles promote Foxp3+ Treg 
conversion in vitro.  
Foxp3+ Treg functions have been tightly linked to the anti-inflammatory cytokine IL-10 [219–
221]. Furthermore, infections with E. multilocularis larvae were reported to provoke a higher 
production of IL-10 by the host CD4+ T-cells [142,143,151,163,164]. Since E/S products of E. 
multilocularis metacestodes were able to expand Foxp3+ Tregs in vitro, their effect on IL-10 
release by CD4+ T-cells was investigated. Interestingly, IL-10 release by CD4+ T-cells was 
considerably triggered if the latter were activated in the presence of metacestode vesicle E/S 
products (Fig. 17F).  
Collectively, these findings indicate that E. multilocularis potentiate the regulatory arm of the 
host CD4+ T-cell response in vitro.   
 
3.3.2   E. multilocularis metacestodes expand bona fide Foxp3+ regulatory T-
cells in mice. 
Having shown that metacestodes of E. multilocularis excrete/secrete factor(s) that drive 
regulatory CD4+ T-cell expansion in vitro, I sought to determine whether these parasite larvae 
can expand such cells in the course of an infection. Since, the intraperitoneal injection of E. 
multilocularis larvae is an accepted experimental model for secondary echinococcosis [222],  
metacestodes were injected in the peritoneum of mice and the peritoneal exudates were analyzed 
over time for CD4+CD25+Foxp3+ Tregs (Fig. 18).   
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Figure 17: E/S-products of E. multilocularis metacestode vesicles induce de novo 
CD4+CD25+Foxp3+ T-cell conversion in vitro. Freshly generated DC (Day 8) were co-cultured with 
naïve CD4+CD25− OT2 T cells at a DC:T-cell ratio of 1:3 in R10 medium supplemented with OVA peptide 
(200ng/ml) in the presence of medium conditioned with primary cell aggregates (PCE/S ), metacestode vesicles 
(MVE/S ) or protoscoleces (ProE/S ). After 5 days of incubation, cells were harvested and stained for CD4, CD25 
and Foxp3 prior to flow cytometry analysis. As a positive control for CD4+CD25+Foxp3+ T cell conversion, 
recombinant Transforming Growth Factor-β was used (TGF-β). (A) Representative plots showing the proportion of 
CD4+CD25+Foxp3+ T-cells (upper right quadrant) of pooled duplicates from 2 independent experiments, 
summarized in (B). (C) Treg (CD4+ Foxp3+) staining of total spleen and lymph node cells from wild type C57BL/6 
or C57BL/6 OT2 Rag -/- mice over a C57BL/6 background. (D) Reperesentative plots of Treg conversion assay 
performed with  OT2 Rag -/- CD4+ T cells as in A and summarized in (E).  (F) E/S products of E. multilocularis 
metacestode vesicles prompt IL-10 release by CD4+ T cells. Freshly isolated CD4+CD25- T cells (2 X 105 /ml) 
were stimulated with α-CD3 (0.1µg/ml) and α-CD28 (5µg/ml) in the presence of fresh medium or supplemented at 
50% with  E.multilocularis larvae products (MVE/S or PCE/S as control). Three days later, the T-cell supernatants 
were collected and probed for IL-10 concentration by Elisa. (B,E,F) The bars represent the mean ± SD from two 
independent experiments.  
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Figure 18: Experimental set up for the follow up of mice intraperitoneally infected with E. 
multilocularis metacestodes. Parasite homogenate was excised from infected jirds and thoroughly washed. 
Host contaminants were removed by axenic cultivation (see material and methods) and the axenization procedure 
assessed using host versus parasite gene specific amplification. 5000 acephalic cysts (metacestode vesicles) 
resuspended in PBS or PBS alone was injected in the peritoneum of C57BL/6 mice. Peritoneal exudates were then 
recovered and analyzed by FACS over a 6 weeks period. Finally, the mass of parasite material recovered was 
determined at the end of the study period as a measure of disease progression. (i) Qualitative assessment of E. 
multilocularis cyst material. Chromosomal DNA was isolated from liver tissue of healthy Jirds and parasite 
metacestode tissue harvested from infected jirds and kept for 0, 7 or 10 days under axenic conditions. The presence 
of host contaminants was assessed by organism-specific PCR, namely the host-specific β-tubulin (Left) and the 
parasite-specific elp (Right) genes were amplified.  
88 
 
An increase of total peritoneal cell numbers was observed as early as day 3 post injection and 
gradually rose throughout the study time (42 days) following injection of metacestodes. In naïve 
mice, peritoneal cell numbers remain relatively constant during this study period. (Fig. 19A). 
CD4+ T-cells showed a similar kinetics over time, increasing steadily in infected mice but 
remaining constant in naïve mice (Fig. 19B). Interestingly, despite the central role of CD4+ T-
cells in restraining E. multilocularis metacestode proliferation [161], about 10 fold more parasite 
tissue was recovered from infected mice autopsied at the end of the study time (Fig. 19C). 
Altogether, these observations show that intraperitoneal injection of E. multilocularis 
metacestodes in mice results in parasite proliferation and the expansion/recruitment of CD4+ T-
cells (Fig. 19) within/to the peritoneum. 
 
 
Fig 19: Intraperitoneally injected E. multilocularis cysts proliferate in the face of 
accumulating peritoneal CD4+ cells. (A, B) Peritoneal exudates recovered from naive (PBS) or infected 
(live cysts) mice at different time points were counted and analyzed by flow cytometry for CD4 expression. 
Parasite-driven accumulation of total (A) or CD4+ cells (B) is shown for D3-42 post injection. (C) Masses of 
parasitic tissue injected and recovered after 42 days. Horizontal bars stand for mean levels. Data represent means ± 
SD from groups of five mice for each time point assayed individually (Infected). Naive mice were clustered in sub-
groups of 3 mice pooled as one per assay (15 mice for each time point).*, p < 0.05.  
 
To determine whether E. multilocularis metacestodes induce regulatory T-cell expansion in vivo, 
peritoneal CD4+ T-cells were analyzed by flow cytometry for expression of CD25 and Foxp3. 
Infected mice displayed a significantly higher number of CD4+CD25+Foxp3+ regulatory T-cells 
when compared to naïve mice at every time point during the study (Fig. 20A). Startlingly, a 
higher frequency of CD4+CD25+Foxp3+ regulatory T-cells could be observed 7 days post 
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injection in infected mice when compared to naïve mice (Fig. 20B). To substantiate this finding, 
the ratios of CD4+CD25+Foxp3+ regulatory T-cells to CD4+CD25+Foxp3- effector T-cells 
were determined (Fig. 20C). Supportively, at day 7 post injection, infected mice showed a higher 
ratio of regulatory T-cells per effector T-cells than naïve mice (Fig. 20D) indicating that E. 
multilocularis metacestodes expand Foxp3+ regulatory T-cells in vivo.  
 
 
 
Fig 20: Initial CD4+ T-cell responses to E. multilocularis cysts are biased towards Foxp3+ 
regulatory T-cells. Analysis of peritoneal cells harvested at days 3, 7, 14 and 42 postinfection respectively by 
flow cytometry over the Treg markers CD4, CD25 and Foxp3. (A,B) Kinetics of CD4+CD25+Foxp3+ Treg 
numbers and frequencies is displayed. (C) Representative cluster of CD4+CD25+ population into effector or 
regulatory T-cells with regards to the level of Foxp3 expression.  (D) kinetics of CD4+CD25+Foxp3+(Treg) / 
CD4+CD25+Foxp3- (Teff) ratio over time. Each ratio obtained for given infected mice was substracted of the 
corresponding naive mice ratio. Data represent means ± SD from groups of five mice for each time point assayed 
individually (Infected). Naive mice were clustered in sub-groups of 3 mice pooled as one per assay (15 mice for 
each time point).*, p < 0.05.  
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To investigate whether peritoneal CD4+CD25+T-cells expanded by E. multilocularis 
metacestodes are functional Tregs in terms of suppressive capacity, cells were purified from the 
peritoneal lavage of metacestode-infected mice 7 days post injection, and from naive spleens. 
These were then used in a suppression assay, with naive splenic CD4+CD25− cells that had been 
CFSE-labeled as responder cells, and were stimulated with irradiated APCs and anti-CD3. As 
can be seen in Fig. 21A, infected peritoneal lavage Tregs are as suppressive as naive splenic 
Tregs in this assay, with similar proportions of labeled cells in each division in the presence of 
CD4+CD25+ cells from either source (represented graphically in Fig. 21B).  
 
 
Fig 21: Intraperitoneal injection of E. multilocularis metacestodes promotes the expansion 
of CD4+CD25+ Tregs that are functionally suppressive in vitro. Peritoneal exudates from mice 
infected for 7 days with 5000 acephalic E. multilocularis cysts, and naive splenocytes from control mice, were 
prepared by CD4+T cell magnetic selection, then FACS-sorted into CD4+CD25+ and CD4+CD25- populations. 
Splenic naive CD4+CD25- cells (responders) were then polyclonally stimulated in the presence or absence of 
CD4+CD25+ cells from either control or E.multilocularis-infected mice. (A) Representative plots of CFSE-labeled 
responder cells proliferation with increasing amounts of regulatory T cells. (B) Proportions of labeled live CD4+ 
cells in each generation of assay conducted at 1:1 ratio, as gated by CFSE dilution. Similar results were obtained in 
an additional experiment.  
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3.3.3   E. multilocularis metacestodes expand regulatory T-cells through the 
host TGF-β signaling loop. 
Since Foxp3+ regulatory T-cell fate is tightly regulated by the TGF-β signaling loop 
[103,218,223], TGF-β signaling antagonists were used to unravel the role of this signaling cascade in the 
ability of E. multilocularis metacestode products to promote Foxp3+ regulatory T-cell conversion.  
Addition of anti-TGF-β neutralizing antibodies, which bind to all host isoforms [224], or  a TGF-
β type I receptor (ALK 5) inhibitor, SB431245 [225], abrogated the ability of metacestode E/S 
products to promote Treg conversion in vitro (Fig. 22). These results show that E/S products of 
E. multilocularis metacestodes promote in vitro Treg conversion through the TGF-β pathway and 
in a TGF-β-dependent manner.  
 
 
 
Fig 22: Blockade of the host TGF-β signaling loop prevents E. multilocularis cyst-driven 
Treg conversion in vitro. Freshly generated DC (day 8) were co-cultured with naive CD4+CD25- OT-II T 
cells at a DC:T cell ratio of 1:3 in medium supplemented with OVA peptide in the presence of medium conditioned 
with E.multilocularis cysts (MVE/S). In some instances blockade of soluble TGF-β (20ug/ml, pan-TGF-β antibody 
1D11) or of the TGF-β signaling (5uM, ALK4,5,7 inhibitor SB431542) was performed simultaneously with MVE/S 
addition. 5 days later, the cells were stained for CD4, CD25 and Foxp3 prior to flow cytometry. Recombinant 
porcine TGF-β1 was used as standard. (A) Representative plots showing the proportion of CD4+CD25+Foxp3+ T 
cells (Upper right quadrant) of 2 experiments, summarized in (B). Data presented include experiments conducted 
elsewhere (Fig. 17A).  
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3.4 An Activin-ortholog secreted by Echinococcus multilocularis 
metacestodes promotes regulatory T-cell conversion in vitro. 
3.4.1 EmACT is a TGF-β superfamily member secreted by in vitro cultivated 
E. multilocularis metacestodes. 
Having shown that E/S products of E. multilocularis metacestodes promote TGF-β-driven 
Foxp3+ Treg conversion, I sought to identify parasite factors mediating this effect. Since Freitas 
and collaborators identified a TGF-β ligand homologue, SmInact, in the genome of the related 
flatworm Schistosoma mansoni [226], a tblastn search of the Welcome Trust's Sanger Institute's 
E. multilocularis protein database using the C-terminal region of the S. mansoni Inhibin/Activin 
(SmInACT) sequence was performed. Three hits (two Bone Morphogenetic Proteins and one 
Inhibin beta A) were identified and further studied elsewhere [227]. In the present work, 
EmuJ_000178100, the Inhibin beta chain A homologue was characterized given the reported ability 
of mammalian inhibin beta A homodimers or activin A to promote TGF-β-induced regulatory T-
cell conversion [228,229]. In mammals, heterodimers of inhibin α and β chains are denominated 
‘Inhibin’ while homodimers of Inhibin β chains form ‘Activin’ [230]. Since there is only one β-
chain orthologue present in E. multilocularis and no α-chain ortholog, I named the respective 
factor EmACT (E. multilocularis activin) since only β-chain homodimers of EmACT can be 
formed.  
The 1.5-kb, full-length Emact transcript was amplified from cDNA of the parasite metacestodes 
(Fig. 23A) with a 506 residues long deduced amino acids sequence (Fig. 23B). The deduced 
amino acid sequence of EmACT contains a signal sequence and three putative N-linked 
glycosylation sites at position 133, 257 and 382 (Fig. 23B) indicative of its potential secretion by 
the parasite metacestodes either into hydatid fluid and/or to the extracystic environment. EmACT 
contains the molecular hallmarks for a TGF-β superfamily member, including a putative basic 
proteolytic cleavage site [231] located at position 374 (RTRR) where the bioactive, C-terminal 
domain (130 amino acids) is usually enzymatically separated from the N-terminal pro-domain 
(Fig. 23B). Within the bioactive domain, EmACT is 49% identical to SmInAct from Schistosoma 
mansoni, 34% identical to human Inhibin beta A (subunit of activin A), 25% identical to DAF-7 
from Caenorhabditis elegans, 26% identical to dActivin from D. melanogaster, and 28% 
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identical to human TGF-β1 (Fig. 23C). Nine invariant cysteine residues (Fig. 23B), essential for 
proper dimerization and tertiary structure formation of  TGF-β superfamily members [232,233], 
of which two cysteines (Fig 23. C) are characteristic of TGF-β/Activin subfamily members 
[232,233], are all present  in EmACT. Moreover, phylogenetic analysis of EmACT among other 
TGF-β superfamily members grouped this homolog with members of the TGF-β/Activin 
subfamily (Fig. 23D), and further clusters EmACT with TGF-β homologs from the parasitic 
flatworm Schistosoma mansoni (SmInAct), the free-living nematode C. elegans (DAF-7) and the 
parasitic nematodes Brugia malayi (Bm-TGH-2) and Strongyloides stercoralis (Ss-TGH-1).  
To determine the expression of Emact at the transcript level, reverse transcriptase–polymerase 
chain reaction (RT-PCR) was performed on cDNA from primary cells, metacestodes and 
protoscoleces. Emact appeared to be transcribed by all the parasite larvae [227]. Western 
analyses using mouse polyclonal antibodies raised against recombinant EmACT (as depicted in 
Fig. 24A,B,C) recognized four distinct bands (14 kDa, 18kDa, 25kDa and 28 kDa) in E. 
multilocularis metacestode secretions (Fig. 24D). 
 
3.4.2   EmACT promotes IL-10 production and expression of the master 
regulatory transcription factor Foxp3 in CD4+ T-cells in vitro.  
For functional characterization of the EmACT polypeptide, the protein-coding region spanning  
amino acid 30 to the stop codon (EmACT without signal peptide) was expressed in HEK 293T 
(Human Embryonic Kidney) cells fused at the N-terminal to the murine Ig kappa chain leader 
sequence for optimal protein secretion (pSecTag2/Hygro, Invitrogen) under the control of the 
human cytomegalovirus promoter (see section 2.4.5.2 for construct design). As shown by 
Western analysis of the supernatant of Emact-transfected HEK cells, recombinant EmACT 
(rEmACT) was secreted to the medium as 14-28 kDa polypeptides (Fig. 25A) similar to the 
previously observed secretion pattern of EmACT by in vitro cultivated E. multilocularis 
metacestodes (Fig. 24D).  
To assess the effect of EmACT on immune cells, BMDC were stimulated for 24 hours with 
normalized supernatants (Fig. 25B) from HEK cells transfected with either empty 
pSecTag2/Hygro vector or pSecTag2/Hygro-Emact construct (see section 2.4.5.2).   
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Figure 23: Emact, amplification and sequence features. (A) Full-length amplification of the Emact 
coding sequence using primers corresponding to the 5´and 3´coding termini (EmACT_Dw and EmACT_Up). 1µl of 
metacestode cDNA was used as template for PCR with a high fidelity DNA polymerase (Phusion® High-Fidelity 
DNA Polymerase, New England Biolabs). 2µl of the amplicon were resolved on a 1.5% agarose gel and stained with 
Ethidium bromide prior to visualization under a UV transilluminator. (B) Nucleotide and deduced amino acid 
sequence of the E.multilocularis Emact cDNA. The TGF-β superfamily homology region located at the C-terminus, 
is  shaded in grey. The potential proteolytic cleavage cleavage site is an open box. The potential glycosylation sites 
(NRT, NLT and NSS) are shown in solid boxes. Nine cysteine residues found in invariant positions in the active 
domain are displayed in red. The 5´signal sequence is underlined. (C) Alignment of the C-terminal amino acid 
sequences of EmACT and five other representatives  of the TGF-β/Activin subfamily of the TGF-β superfamily. 
Residues that are identical are displayed in black, similarities in grey. Gaps introduced to maximize the alignment 
are represented by tildes. Two conserved cysteines found only in TGF-β/Activin subfamily are shown with asterisks. 
Numbers at the start and finish of each line correspond to the amino acid numbers in each respective sequence. The 
percentages of identities (% Id) and similarities (%Sim) to EmACT are given for each sequence. Accession numbers 
for the sequences shown are as follows: Emact, HF912278; S. mansoni InAct, A4UAH0 ;Human Inhibin beta A, 
P08476 ; Human TGF-β1, P01137 ;D. melanogaster Activin, O61643; C. elegans DAF-7, P92172. (D) Phylogenetic 
representation of the sequence relationship between active domains of members of the TGF-β superfamily. Numbers 
represent bootstrap values. EmACT is displayed within an open box. Solid line represents the BMP subfamily, 
dashed line clusters the TGF-β/Activin subfamily.  
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Figure 24: Secretion of EmACT by metacestode vesicles of E. multilocularis in culture. (A) 
In sillico prediction of EmACT epitopes. An epitope prediction was conducted online with the full EmACT 
sequence (tools.Immunoepitope.org). The portion retained for immunization and recombinantly expressed as a 
fusion protein is encompassed within the dashed red lines. A representation of EmACT (SMART analysis) showing 
the N-terminal signal peptide (SP) and the TGF-β superfamily domain has been aligned to the epitopes prediction. 
The region corresponding to yellow peaks above the default threshold line (horizontal solid red line) are potential 
EmACT epitopes. (B) Expression and purification of thio-EmACT fusion protein. EmACT was cloned into the 
bacterial expression vector pBADThio/TOPO. Competent E. coli (Top 10) bacteria were transformed with the Thio-
EmACT plasmid and induced to express the fusion Thio-EmACT protein under arabinose control. A C-terminal 
histidine repeats fused to the expressed Thio-EmACT fusion protein by the pBADThio/TOPO expression vector was 
used as target tag for protein purification over Nickel-supplemented beads. Lysates of pBADThio/TOPO-EmACT 
transformed E. coli before and after arabinose-driven protein expression as well as purified Thio-EmACT were 
separated by SDS PAGE, blotted over a nitrocellulose membrane and the protein detected by Ponceau S staining. 
The arrow indicates the recombinant Thio-EmACT. (C) Profile of anti-Thio-EmACT antibodies. Western blot of a 
similar amount of Thio-EmACT containing bacterial lysates obtained after arabinose driven induction. 1:50 
dilutions of normal mouse (pre-immune) serum and crude/purified mouse anti-Thio-EmACT sera were used for 
detection followed by ECL detection and autoradiography. The positions of the molecular mass markers (in 
kilodaltons) are shown on the left. (D) EmACT is present in metacestode E/S products. Shown is a Western blotting 
of metacestode vesicle E/S products (MVE/S) probed with normal (pre-immune) mouse serum or mouse anti-Thio-
EmACT antibodies followed by ECL detection and autoradiography. The positions of the molecular mass markers 
(in kilodaltons) are shown on the left. The arrows indicate secreted EmACT variants.  
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rEmACT failed to induce DC maturation as judged by MHC II and CD86 expression (Fig. 25C). 
When treated with rEmACT, there was no significant impairment of DC maturation in response 
to subsequent LPS stimulation (Fig. 25D). These results show that EmACT fails to activate host 
DC in vitro.  
Human (mammalian) activin A has been shown to promote the TGF-β-induced differentiation of 
Foxp3+ regulatory T-cells [228,229]. To examine EmACT in this regard, OVA-loaded BMDC 
were co-cultured with OT-II×RAG-1(-/-) CD4+CD25- T-cells in the presence of normalized 
supernatants (Fig. 25B) from HEK cells transfected with either pSecTag2/Hygro vector or 
pSecTag2/Hygro-Emact vector (see material and methods). CD4+CD25+Foxp3+ Treg cells 
were analyzed 5 days later by flow cytometry.  Although rEmACT failed to induce de novo Treg 
cell conversion (Fig.26A), it significantly increased the rate of TGF-β-induced Treg conversion 
(Fig. 26B). This finding indicates that, similarly to E. multilocularis metacestode E/S products 
(Fig. 22), EmACT is able to expand Foxp3+Tregs but requires TGF-β to do so. 
Since activin A triggers IL-10 release by CD4+ T cells (200), EmACT was also investigated with 
respect to IL-10 production by CD4+ T cells.  CD4+CD25- T cells (C57BL/6) showed a higher 
propensity to secrete IL-10 when stimulated in the presence of rEmACT (Fig. 26C), an effect 
above-reported with E. multilocularis E/S products (Fig. 17F).  
Collectively, these data show that EmACT, a TGF-ß ligand secreted by E. multilocularis 
metacestodes, failed to activate host DC, promoted TGF-beta-driven Foxp3+ Treg conversion 
and triggered IL-10 release by CD4+ T-cells similarly to E. multilocularis metacestode 
secretions. This indicates that E. multilocularis metacestodes might elude DC recognition and 
expand regulatory T-cells by the release of evolutionary conserved cytokine like EmACT.  
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Figure 25: EmACT do not induce BMDC maturation. (A) Secretion of recombinant EmACT by 
pSecTag2/Hygro-Emact transfected HEK cells. Shown is a Western blot of the Ethanol-precipitated supernatant of 
pSecTag2/Hygro-Emact transfected HEK cells probed with either normal (pre-immune) mouse serum or mouse 
anti-Thio-EmACT antibodies followed by ECL detection and autoradiography. The positions of the molecular mass 
markers (in kilodaltons) are shown on the left. The bracket delimitates -the location of recombinant EmACT 
variants. (B) Normalization of pSecTag2/Hygro- and pSecTag2/Hygro-Emact-transfected HEK cell supernatants. 
The total protein contents of E/S collected from transfected HEK cells were determined using BCA assay. The 
lowest value (dashed red line) was used as a baseline for normalization by determining the amount necessary to give 
an equal final concentration in a total volume of 100ul. The solutions were accordingly topped to 100ul using double 
distilled sterile water. (C, D) Recombinant EmACT failed to induce or promote DC maturation. Flow cytometric 
analyses of BMDC surface maturation markers CD11c, MHCII and CD86 following treatment with recombinant 
EmACT. BMDC were treated with DMEM10 (medium), the supernatant of empty vector-transfected HEK cells 
(pSecTag2/Hygro) or the supernatant of full Emact-vector construct transfected HEK cells (pSecTag2/Hygro-
Emact) for 24 hours (C) then supplemented for an additional 24 hours with 0.1µg/ml LPS (D) for a total of 48 hours, 
prior to staining and flow cytometric detection. (C,D) Shown are detailed scatter plots of two independent 
experiments summarized as means ± SD.  
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Figure 26: EmACT promotes de novo TGF-β- mediated Foxp3+Treg conversion and 
triggers IL-10 release by CD4+ T-cells in vitro. Freshly generated DC (Day 8) were co-cultured with 
naïve (CD25-) OT-II×RAG-1(-/-) CD4+ T cells at a DC:T-cell ratio of 1:3 in R10 medium supplemented with OVA 
peptide (200ng/ml) in the presence of  DMEM10 (medium), the supernatant of empty vector-transfected HEK cells 
(pSecTag2/Hygro) or the supernatant of full Emact-vector construct-transfected HEK cells (pSecTag2/Hygro-
Emact) in the absence (A) or presence (B) of 1ng/ml of recombinant TGF-β1. After 5 days of incubation, cells were 
harvested and stained for CD4, CD25 and Foxp3 prior to flow cytometry analysis. (A,B) Shown are detailed plots of 
two independently performed Treg conversion assay summarized as means (bars) ± SD. (C) Recombinant EmACT 
prompts IL-10 release by CD4+ T cells. Freshly isolated CD4+CD25- T-cells (2 X 105 /ml) were stimulated with α-
CD3 (0.1µg/ml) and α-CD28 (5µg/ml) in the presence of DMEM10 (medium), the supernatant of empty vector-
transfected HEK cells (pSecTag2/Hygro) or the supernatant of full Emact-vector construct-transfected HEK cells 
(pSecTag2/Hygro-Emact). Three days later, the T-cell supernatants were collected and probed for IL-10 
concentration by Elisa. The results represent the mean ± SD from two independent experiments.  
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3.5 EmTIP, a T-cell immunomodulatory protein secreted by E. 
multilocularis is important for early larval development.  
3.5.1   Identification of EmTIP, a T-cell immunomodulatory protein 
homologue from E. multilocularis.   
 
 
 
Figure 27: EmTIP sequence features. (A) Full-length amplification of Emtip Coding sequence using 
primers corresponding to the 5´and 3´coding termini (EmTIP_Dw and EmTIP_Up). 1µl of Metacestode cDNA was 
used as template for PCR with a high fidelity DNA polymerase (Phusion® High-Fidelity DNA Polymerase, New 
England Biolabs). 2µl of the amplicon were resolved on a 1.5% agarose gel and stained with Ethidium bromide prior 
to visualization under a UV transilluminator. (B) Nucleotide and deduced amino acid sequence of the 
E.multilocularis Emtip cDNA. The 5´signal sequence is underlined. The FG-GAP repeats located at the N-terminal 
end of Integrin-alpha FG-GAP repeat-containing proteins family, are shaded in grey. The potential glycosylation 
sites (NVT and NFT) are shown in solid boxes. The transmembrane region is delimitated with dashed underlines.  
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In previous investigations on the mechanism of trans-splicing in E. multuilocularis Brehm et al 
[206] were able to isolate a cDNA clone that apparently encoded a protein with significant 
homology to human T-cell Immunomodulatory Protein (TIP) [205].  
 
 
 
Figure 28: Alignment of the amino acid sequences of EmTIP and eight other 
representatives of the T-cell Immunomodulatory Protein family. Residues that are identical are 
displayed in black, similarities in grey. Gaps introduced to maximize the alignment are represented by dashes. 
Numbers at the start and finish of each line correspond to the amino acid numbers in each respective sequence. The 
percentages of identities (% Id) , similarities (%Sim) and alignment coverage (%Cov) to EmTIP are given for each 
sequence. Accession numbers for the sequences shown are as follows: Emtip, HF912277; Human TIP, Q8TB96; 
Mouse TIP, Q99KW9; D. Melanogaster predicted TIP, NP648776; C. elegans predicted TIP, NP498963; B. Malayi 
predicted TIP, EDP36995; A. Darlingi predicted TIP, EFR24550; S. mansoni predicted TIP, G4VRP9; P. 
Falciparum predicted TIP, Q8I3H7.  
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Since  human TIP has been shown to influence cytokine production in T-cells [205], and 
considering T-cell immunomodulatory activities of E. multilocularis larvae 
[130,141,143,161,164,234,235], I further investigated the parasite factor and named it EmTIP 
(E. multilocularis T-cell Immunomodulatory Protein). The 1.76-kb, full-length Emtip transcript 
was amplified from cDNA of the parasite metacestode vesicles (Fig. 27A) with a 592 residues 
long deduced amino acids sequence (Fig. 27B). The deduced amino acid sequence of EmTIP 
contains a signal sequence and two putative N-linked glycosylation sites at position 128 and 175 
(Fig. 27B) indicative of the possible secretion of EmTIP by the parasite. As shown in Fig. 27B, 
EmTIP contains atypical FG-GAP repeats (position 92-130 and 314-359), molecular hallmarks 
of Integrin-alpha FG-GAP repeat-containing proteins [236]. EmTIP also includes a predicted 
transmembrane domain at its C-terminus (position 548-568).  
EmTIP is 35% identical to the predicted SmTIP from Schistosoma mansoni, 30% identical to 
Human TIP, 29% to Anopheles darlingi predicted TIP, 28% identical to both mouse and 
Drosphila melanogaster predicted TIP, 27% identical to Brugia malayi predicted TIP, 26% 
identical to Caenorhabditis elegans predicted TIP and 25% identical to Plasmodium falciparum 
predicted TIP (Fig. 28).  
 
 
 
Figure 29: Emtip is transcribed throughout E.multilocularis larval development. (A) RT-PCR 
strategy for unequivocal amplification of Emtip transcript. Shown is an intron (red line)-exon (black boxes) 
arrangement of the Emtip genomic locus. A 400bp product specific for Emtip transcript was amplified using the 
primers FG-GAP_Dw and FG-GAP_Up spanning from exons 6-9. (B) Each E. multilocularis larvae (PC, MV and 
Pro) were separately used for qualitative assessment of Emtip transcription. 1µl of each larvae cDNA was used as 
template for PCR with a high fidelity DNA polymerase (Phusion® High-Fidelity DNA Polymerase, New England 
Biolabs). 2µl of each PCR amplicon were resolved on a 1.5% agarose gel and stained with Ethidium bromide prior 
to visualization under a UV transilluminator. gDNA: genomic DNA. 
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3.5.2   Expression and localization of EmTIP during larval development.   
To study the transcription of Emtip by E. multilocularis larvae, a RT-PCR of an intron flanking 
portion of the gene (Fig. 29A) was conducted on cDNA from primary cells, metacestode vesicles 
and protoscoleces. As seen in Figure 29B, Emtip is transcribed by all E. multilocularis larval 
stages. 
Next, to assess the expression of EmTIP by E. multilocularis larvae, Western analyses using 
rabbit polyclonal antibodies raised against a recombinantly expressed portion of EmTIP (Fig. 30, 
see section 2.5.4.2 for procedure) were used to investigate the production profile of EmTIP by E. 
multilocularis larvae. 
 
 
Figure 30: Recombinant expression and purification of a Thio tag-fused EmTIP for 
immunization.  (A) In sillico prediction and amplification of EmTIP epitopes.  An epitope prediction was 
conducted online with the full EmTIP sequence (tools.Immunoepitope.org). The N-terminal portion retained for 
immunization (a) is encompassed within the dashed red lines (amino acid 37 to 373). The signal sequence is 
depicted as a red box, the grey boxes represent the FG-GAP repeats and the blue box shows the transmembrane 
domain. (B) Amplification of the Emtip coding sequence portion to be used for immunization (a). 1µl of full-length 
Emtip amplicon was used as template for a nested PCR with a high fidelity DNA polymerase (Phusion® High-
Fidelity DNA Polymerase, New England Biolabs) using the primers AbTIP_Dw and AbTIP_Up. 2µl of the new 
amplicon Emtip (a) were resolved on a 1.5% agarose gel and stained with Ethidium bromide prior to visualization 
under a UV transilluminator. (C) Recombinant expression and purification of Thio-tagged truncated EmTIP for 
antibody production. The truncated Emtip (a) was cloned into the bacterial expression vector pBADThio/TOPO. 
Competent E. coli (Top 10) bacteria were transformed with the Thio-Emtip (a) plasmid and prompted to express the 
fusion Thio-EmTIP protein under the arabinose-driven induction of bacterial expression. The C-terminal histidine 
repeats conferred to the expressed fusion protein by the pBADThio/TOPO expression vector were used as target tag 
to column-purify the Thio-EmTIP fusion protein over Nickel-supplemented beads. Lysates of pBADThio/TOPO-
Emtip-transformed E. coli before and after arabinose driven protein expression as well as purified Thio-EmTIP were 
separated by SDS PAGE, blotted over a nitrocellulose membrane and the protein detected by Ponceau S staining. 
The arrow indicates the recombinant Thio-EmTIP fragment migration close to 58 kDa.  
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E. multilocularis larvae lysates (Fig. 11C) and E/S products (Fig. 11D), normalized for the 
protein content, were probed with rabbit polyclonal antibodies against EmTIP (Fig. 31). The 
anti-EmTIP antibodies specifically recognized a 58kDa protein in all lysates tested (Fig. 31A). 
Interestingly, a 58kDa band could only be detected in the E/S products of primary cells and 
protoscoleces whereas metacestode vesicle secretions did not show any reactivity to anti-EmTIP 
antibodies (Fig. 31B). Additionally, protoscolex secretions revealed a higher molecular weight 
band  (~125kDa, Fig. 31B) when probed with anti-EmTIP antibodies.  
 
  
 
Figure 31: Differential expression of EmTIP protein by E.multilocularis larvae. Western blots 
of E. multilocularis larvae lysates (A) or E/S products (B) probed with pre-immune rabbit (pre-TIP) serum and/or 
rabbit anti-thio-EmTIP (α-TIP) antibodies followed by ECL detection and autoradiography. (A) Whole larvae 
lysates were probed with Normal rabbit (pre-TIP) serum and/or rabbit anti-thio-EmTIP (α-TIP) antibodies followed 
by ECL detection and autoradiography. (B) Western blot of E/S products of E. multilocularis larvae first 
immunoprecipitated and later on probed with rabbit anti-thio-EmTIP (α-TIP) antibodies followed by ECL detection 
and autoradiography. The arrows indicate EmTIP position.  
 
In order to localize EmTIP within the parasite larvae, anti-EmTIP antibodies were affinity-
purified (see material and methods for procedure) and checked for eventual cross-reactivity (Fig. 
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32). Although crude anti-EmTIP antibodies non-specifically detected additional bands in 
Western blots of tag-purified recombinant EmTIP (Fig. 32A) and AE-infected Jird liver tissue 
(Fig. 32B), affinity purified anti-EmTIP antibodies recognized in a highly specific manner a 
single EmTIP band (Fig. 32) as required for unambiguous immunolocalization of EmTIP within 
the parasite larvae tissue. 
 
Figure 32: Profile of purified anti-Thio-EmTIP antibodies. Western blot of a similar amount of 
purified Thio-EmTIP (A) or parasite-containing liver tissue from infected jirds (B). 1:500 dilutions of normal rabbit 
(pre-immune) serum or that of crude/purified rabbit anti-Thio-EmTIP sera were used for detection followed by ECL 
detection and autoradiography. The positions of the molecular mass markers (in kilodaltons) are shown on the left. 
The arrow indicates the size of natural EmTIP in parasite lysates between 50-60 kDa.  
 
Affinity-purified anti-EmTIP antibodies also failed to show a signal on liver tissue from a 
healthy jird as judged by immunohistochemistry (Fig. 33A). Further immunohistochemical 
analyzes localized EmTIP to the inter-cellular space and the surface of cells within all E. 
multilocularis larvae. (Fig. 33B,C,D,E).  
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Figure 33: Immunohistochemical localization of EmTIP within E. multilocularis larvae. 
Dual staining (anti-EmTIP/peroxydase-coupled anti-rabbit-IgG (Jackson ImmunoResearch) against haematoxilin 
counterstain) of representative tissue sections of healthy Jird ´s liver (A), infected Jird´s liver (B) and in vitro 
maintained E. multilocularis larvae (section 2.2.3.3) namely primary cells (C), Metacestode vesicles (D) and 
protoscoleces (E). Scale bars: 40 μm.  
 
3.5.3 EmTIP triggers IFN-γ secretion by CD4+ T cells. 
Since human TIP has been shown to induce IFN-γ, IL-10 and TNF release by T-cells, resulting 
in a protective effect in graft versus host disease model [205], the influence of EmTIP on CD4+ 
T-cells was investigated. The supernatant of rEmTIP-expressing HEK cells (see section 2.5.4.2 
for recombinant expression, Fig. 34A,B,C) was added to CD4+CD25- T-cells in the presence of 
anti-CD3 / anti-CD28 activating antibodies. After 3 days in culture, CD4+ T-cell culture 
supernatants were tested by ELISA for IFN-γ and IL-10 release. When compared to the controls, 
EmTIP induced a higher release of IFN-γ but failed to trigger IL-10 secretion in CD4+ T-cell 
cultures (Fig. 34D). Further analyses at a single cell level by intracellular FACS analysis 
revealed that CD4+ T-cells and not contaminating CD4- cells (< 5%), like NK cells, were  the 
true source of the elevated IFN- γ production in those cultures (Fig. 35). Interestingly, primary 
cell E/S products evoked a stronger IFN- γ release by CD4+ T-cells than those observed with E/S 
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products of metacestode vesicles or protoscoleces indicating that E. multilocularis primary cells 
secrete EmTIP which promote IFN- γ release by CD4+ T-cells in vitro.   
 
Figure 34: EmTIP augments IFN-γ release by CD4+ T cells.  (A) Western blots of pSecTag2/Hygro 
vs. pSecTag2/Hygro-Emtip transfected 293T HEK cells lysates probed with purified rabbit anti-EmTIP antibodies 
followed by ECL detection and autoradiography. (B) Western blot of normalized supernatants of pSecTag2/Hygro- 
and pSecTag2/Hygro-Emtip-transfected 293T HEK cells first immunoprecipitated and later on probed with purified 
rabbit anti-EmTIP antibodies followed by ECL detection and autoradiography. The arrows indicate recombinant 
EmTIP position on the blots. (C) Normalization scheme for collected supernatants of pSecTag2/Hygro- and 
pSecTag2/Hygro-Emtip-transfected 293T HEK cells. The red dashed line represents the reference for protein 
content normalization. (D) Freshly isolated CD4+CD25- T cells (2 X 105 /ml) were stimulated with α-CD3 
(0.1µg/ml) and α-CD28 (5µg/ml) in the presence of DMEM10 (medium), the supernatant of empty vector-
transfected HEK cells (pSecTag2/Hygro) or the  supernatant of full Emtip-vector construct-transfected HEK cells 
(pSecTag2/Hygro-Emtip) or alternatively (E) supplemented with conditioned medium of primary cells (PCE/S), 
metacestode vesicles (MVE/S) or protoscoleces (ProE/S). Three days later, the T-cell supernatants were collected 
and probed for IL-10 concentration by Elisa. The results represent the mean ± SD from two independent 
experiments.  
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Figure 35: CD4+ T-cells are the true producers of EmTIP-driven IFN-γ. (A) Freshly isolated 
CD4+CD25- T cells (2 X 105 /ml) were stimulated with α-CD3 (0.1µg/ml) and α-CD28 (5µg/ml) in medium 
supplemented with normalized supernatants of parasite larvae (PCE/S or MVE/S) or transfected HEK cells 
(pSecTag or pSecTag-EmTIP). At day 3 of culture, 5µg/ml Brefeldin A was added for 6 additional hours then the 
cells were harvested and intracellular IFN-γ levels were determined by flow cytometry. Numbers in upper gates 
indicate the percentage of IFN-γ+ CD4+ cells whereas the lower gate shows the percentage of IFN-γ+ CD4- cells. 
One representative experiment of 2 conducted with similar results is shown. (B) Percentages of IFN-γ+ CD4+ cells 
are summarized by bar graphs with values of each experimental repeat normalized to the “medium” samples and 
displayed as mean ± SD from the two independent experiments.  
 
3.5.4   Anti-EmTIP antibodies block E. multilocularis primary cell 
proliferation and the generation of metacestode vesicles.  
EmTIP, as secreted by E. multilocularis primary cells, associates with a higher release of IFN-γ 
by CD4+ T-cell. Since IFN-γ-driven immune effector functions have been shown to be 
detrimental for E. multilocularis larvae [133,136,137,237], I hypothesized that the release of 
EmTIP by the parasite might be important for development. To examine this hypothesis, anti-
EmTIP antibodies were added to E. multilocularis primary cell cultures.  
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Figure 36: Anti-EmTIP antibody inhibits E. multilocularis primary cell proliferation and 
regeneration into metacestode vesicles. (A) Dose-response curve of the antiproliferative effect of purified 
rabbit anti-EmTIP on E.multilocularis primary cells. (B) 60ug/ml of purified rabbit anti-EmTIP antibodies but not 
pre-immune total rabbit IgG limit E. multilocularis primary cells proliferation. (C) Effect of purified rabbit anti-
EmTIP antibodies (60ug/ml) on Rat hepatoma cell line proliferation. (D) Representation of regenerated metacestode 
vesicle following in vitro primary cells cultivation. (E) Effect of purified rabbit anti-EmTIP antibodies on E. 
multilocularis metacestode vesicles formation from primary cells. (A,B,C) Bars represent mean ± SD for 4-6 
replicates of two independent experiments. (E) Horizontal bars stand for mean levels. Data represent four biological 
primary cells isolates assayed individually. #, statistical trend p<0.1; *, statistical significance p<0.05; NS, not 
significant.  
 
A considerable inhibition of primary cell proliferation was observed with anti-EmTIP antibodies 
(Fig. 36A) but not total rabbit IgG (Fig. 36B) as judged by BrdU incorporation. Of note, rat 
hepatoma cells treated with anti-EmTIP antibodies did not show such an impaired proliferation 
(Fig. 36C) ruling out general cytotoxicity as mediating the negative effect of anti-EmTIP 
antibodies on E. multilocularis primary cell proliferation.   
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In vitro cultivation of E. multilocularis primary cells enables the de novo generation of 
metacestode vesicles ([190], Fig36D), a unique system to study the post-oncospheral transition 
into metacestodes as it occurs in vivo [191]. To further assess the role of EmTIP in parasite 
biology, primary cell cultures supplemented with anti-EmTIP antibodies were microscopically 
monitored over time for metacestode formation.  Interestingly, incubation of primary cell 
cultures with anti-EmTIP antibody led to diminished vesicle formation (Fig. 36E).  
Taken together, these findings showed that E. multilocularis primary cells secrete a T-cell 
immunomodulatory protein, EmTIP, that is important for parasite development and also evoke a 
parasiticidal IFN-γ-rich response from the host CD4+ T-cell.  
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4. DISCUSSION 
4.1 Modulation of the host immune system by E. multilocularis larvae 
E/S products: larvae-specific effects on host immune cells.  
The present study demonstrates a larva-specific influence of E. multilocularis on host immune 
effector cells. Notably, taking advantage of an in vitro cultivation system for axenic maintenance 
of larvae from the early (primary cells), mid (metacestode vesicles) and late (protoscoleces) 
phases of the fox-tapeworm E. multilocularis-driven infections [186] and collection of their E/S 
products, I show that, (i) E/S products of primary cells and metacestode vesicles, but not 
protoscoleces, induce apoptosis in murine BMDC in vitro; (ii) E/S products of primary cells and 
metacestode vesicles, but not protoscoleces, restrain the ability of BMDC to mature even in the 
presence of the TLR ligand LPS; and (iii) all E. multilocularis larvae E/S products limit the 
production of the Th1- associated cytokine IL-12 by BMDC, with a unique cytokine profile 
elicited by each larvae E/S products, where primary cell E/S products induce IL-10 but not IL-6 
release, metacestode vesicle E/S products fail to induce any of these  cytokines, and protoscolex 
E/S products only triggering  IL-6 release by BMDC.  
One problem of previous studies on the influece of parasite tissue on host immune cells 
[150,213] was the presence of contaminating host products, which could not be entirtely removed 
through (even extensive) washing [186]. In the present work, I used the method described by 
Spiliotis et al. for the production of parasite material [186]. In this system, contaminating host 
cells are effectively removed through the application of reducing conditions (axenization), thus 
allowing investigations under  conditions that are (largely) free of host contaminants [186]. This 
was verified by RT-PCR analyses on the cultured material, demonstrating that cells of the 
laboratory host are no longer present in these cultures after one week of incubation.    
E. multilocularis larvae are morphologically highly distinct. Primary cells in in vitro cultivation 
are of few µm of diameter and form aggregates that represent the post-oncospheral, or early 
Echinococcus larval stage in the infection of the intermediate host [186,190,191]. These 
aggregates are meshes of intermingled cells within a diffused inter-cellular matrix [190]. After in 
vitro maintenance for several weeks, the aggregates will form central cavities and progressively 
release buds of nascent vesicles: the metacestode vesicles [190]. Metacestodes, used at 2-5 mm 
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of diameter, do have a cystic appearance in vitro, are fluid-filled with an inner cellular or 
germinal layer and an outer accelular, carbohydrate-rich layer (or laminated layer) [186]. The 
inner germinal layer will internally give rise to brood capsules that will later form the head 
region of the adult worm, the protoscoleces. Protoscoleces are covered by a tegument,  have an 
average 100µm of diameter with a pair of suckers and hooks [11]. The approach used in this 
work to compare an equivalent amount of each of these larvae, based on the normalization of 
their biomasses with respect to the total protein content or the level of expression the 
housekeeping ß-actin gene [238], minimizes the bias introduced by the distinct morphology of 
the parasite larval stages. As a result, an equal biomass of each parasite larval stages was used 
throughout the transwell stimulation assays. The differential effects observed with each of the 
larvae could therefore be interpretated in terms of a qualitative difference between one larval 
stage and the other considering that a similar quantity of each of the latters was used. 
In this work, E/S products used were from normalized and biologically relevant amounts of E. 
multilocularis larvae. Indeed, the amount of parasite used throughout were normalized to the 
protein content in primary cells capable of regenerating into metacestode vesicles in 2-4 weeks, 
as reported in vivo for the oncosphere-metacestode transition [207,239,240]. This approach is 
more representative of the in vivo situation than the common use of excessively concentrated 
parasite E/S products to achieve significant effects [241–244].  
When exposed to E. multilocularis larvae, E/S products of primary cells and those of 
metacestode vesicles induce DC death whereas protoscolex E/S products largely failed to show 
this effect. The interference of Echinococcus spp. with immune cell proliferation/viability has 
been suggested in early studies using parasitic cyst fluid [211,245]. It is interesting to note the 
inability of E/S products of the protoscoleces to mediate DC killing indicating that the factor (s) 
responsible (s) for this effect is / are poorly, if at all, released by this larval stage. This finding 
suggests that E. multilocularis protoscoleces behave differently from primary cells and 
metacestode vesicles. Therefore when considering previous studies on the interactions between 
E. multilocularis and its intermediate hosts where protoscoleces, although not in direct contact 
with the host immune system, were used in place of the tissue-dwelling metacestodes to infer for 
events governing the chronic phase of the disease [183–185,246–249], our present observation of 
their dissimilar secretome challenges the pertinence of the latter studies [183–185,246–249].   
112 
 
One of the most important findings of this study was the ability of larval E/S products to induce 
apoptosis in host DC. A similar activity has previously been reported for E/S products from the 
parasitic nematode Brugia malayi on human DC [250], where they acted through the TNFR 
pathway [251].  In this respect, it is noteworthy that I have identified a homologue to mammalian 
TNFR within the E. multilocularis genome (Suppl. Fig. 1), indicating that the parasite might also 
express/secrete a cognate ligand that possibly acts on host TNF receptors. Although in silico 
analyses to identify a gene encoding a respective TNF ligand on the E. multilocularis genome 
were unsuccessful, this does not necessarily mean that they are fully absent since TNF ligands of 
different organisms are usually highly diverse  [252]. Among other TNFR superfamily members 
that could be involved in  BMDC apoptosis driven by E. multilocularis larvae is the Fas death 
receptor [253–255] which is likely to mediate apoptosis in immature DC when exposed to TNF 
ligands [255]. Corticosteroids have also been shown to be involved in DC apoptosis [256–258]. 
Interestingly, the tapeworm Taenia crassiceps has been shown to produce sex steroids [259,260]  
and it is reasonably likely that E. multilocularis is doing it as well. Whether these hormones are 
really produced by the parasite has to be shown. Neverthles, the depletion of DC by primary cells 
and metacestodes would be beneficial to the parasite establishment and persistence in the course 
of an infection, unveiling here a so far unknown mechanism likely to mediate the subversion of 
the host immune system during Alveolar echinococcosis.  
E. multilocularis larvae secretions also affect the function of surviving DC, modifying their 
ability to mature and altering their cytokine profile. In this respect, IL-12 is a highly potent 
inflammatory cytokine released by host immune cells upon encountering invading agents like 
bacteria. This cytokine is important for the onset of Th1 immune responses which properly 
control some tissue-dwelling pathogens  [133]. Parasitic helminths and their products generally 
fail to promote the release of this cytokine by cells like DC [250,261–264]. Accordingly, E/S 
products from larvae of the early, mid- or late phases of E. multilocularis-driven infections did 
not elicit the release of detectable amounts of IL-12 by DC in vitro. Additionally, IL-10, a 
cytokine shown to set a tolerogenic environment around host immune cells l [265] was released 
by DC in response to primary cell E/S products. This would clearly promote a more permissive 
environment for the parasite. However, E/S products of E. multilocularis metacestodes did not 
show such an effect although this larval stage still needs to impair the host immune responses. 
The presence of a protective carbohydrate-rich laminated layer surrounding the germinal layer of 
113 
 
the parasite metacestode suggests that this larval stage is probably less vulnerable to the host 
immune attacks when compared to primary cells thus the absence of IL-10 production by DC 
exposed to metacestode products. It stands therefore to reason to propose that the induction of 
IL-10 secretion in DC by E. multilocularis primary cells is a parasite early mechanism to help 
temper the host response to the vulnerable post-oncospheral stage and thereby facilitates the host 
colonization. This observation brings more support to the immunoregulatory role of IL-10 during 
AE, a role already suggested by murine and human studies where an anticytotoxic role was 
proposed [152,153]. Again, the induction of IL-10 release by DC is no novelty for helminth 
parasites in general. DC exposed to antigens from the cestodes Echinococcus granulosus 
[266,267] and Taenia crassiceps [263] or the nematode Trichuris muris [268] had shown an 
enhanced production of IL-10.  “What role would these IL-10-secreting DC play if elicited in 
vivo during AE?” and “which factor(s) within primary cell E/S products prompt IL-10 release by 
DC?”  are questions yet to be answered. Such answers would provide more understanding of the 
molecular means of host colonization by E. multilocularis. As potential factors in nematode 
infections,  filarial cystatins have been associated with IL-10 secretion in APC, including 
immature DC [269]. Interestingly, ongoing analyses on the E. multilocularis genome 
(http://www.sanger.ac.uk/resources/down-loads/helminths/echinococcus-multilocularis.html) 
indicate that related molecules are also encoded by the cestode (Suppl. Fig. 2). Further 
experimentation is therefore needed to assess the possible secretion of these molecules by 
primary cells and whether they can exert immunomodulatory activities comparable to those of 
filarial cystatins. Another possible explanation for the observed IL-10 secretion by surviving DC 
after exposure to primary cell E/S products is the likely uptake of apoptotic DC by the surviving 
DC. It is indeed conceivable that the uptake of apoptotic bodies by DC would trigger  the release 
of IL-10, as previously reported in the case of  apoptotic macrophages [270]. However, DC 
exposed to metacestode E/S products, of which a fraction also died by apoptosis, failed to release 
IL-10, therefore challenging this line of interpretation. The likeliest scenario would therefore be 
that of a differential, yet overlapping, composition of the E/S products from E. multilocularis 
primary cells and metacestodes. While the E/S products of both contain factors that induce 
apoptosis in DC, only those of primary cells contain an IL-10 inducing compound.  
DC exposed to metacestode E/S products as well as primary cell E/S products failed to 
upregulate DC activation markers with no detectable release of proinflammatory cytokines (IL-6 
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or IL-12) whereas protoscolex E/S products elicited DC maturation and IL-6 release. This 
observation further supports the sketched scenario of an overlapping composition of primary cell 
and metacestode E/S products and strengthens the idea of a different profile for protoscolex E/S 
products. The absence of DC maturation following exposure to primary cell or metacestode E/S 
products is consistent with a previous study reporting the inability of E. multilocularis 
metacestode extracts to induce classical DC activation or any apparent sign of activation for that 
matter [182]. This is a rather common feature of helminth-derived products [63,65,271]. Given 
the central role of DC activation in the onset of host immune responses [54], I reasonably 
hypothesize that E. multilocularis primary cells and metacestodes, by failing to alert host DC, 
would most efficiently elude the host immune responses in the course of an infection. In contrast, 
protoscolex E/S products as potent activators of DC therefore point at a reduced ability of this 
larval stage to avoid immune recognition by the host DC. This corroborates the previous 
observation that E. multilocularis primary cells and metacestodes could more efficiently 
establish secondary alveolar AE upon intravenous injection in rodents whereas protoscoleces 
displayed no infectivity [272].  
When further investigating the influence of the parasite E/S products on DC, I found that BMDC 
pretreated with either primary cell or metacestode E/S products appeared diminished in their 
ability to respond to subsequent LPS challenge as judged by the lack of surface markers 
upregulation and the reduction of IL-12p70 release. This indicates that the previously reported, 
impaired secretion of IL-12 by LPS-pulsed PBMC from AE patients [169], could be a direct 
consequence of the influence of the parasite E/S products on the host immune cells. TGF-β, a 
cytokine associated with the impaired responsiveness of a wide range of immune cells [273–
275], has been detected in DC of E. multilocularis-infected hosts [213]. Accordingly, several 
studies suggested an important role for the TGF-β pathway during host colonization by E. 
multilocularis [213,235]. It is therefore reasonable to assume that E. multilocularis primary cell 
and metacestode E/S products would not only fail to activate DC but might additionally restrain 
their ability to respond to any bystander inflammatory stimuli. This does not simply indicate that 
E. multilocularis would avoid a parasiticidal host inflammatory response in the eventuality of 
bystander immune stimulation but might additionaly limit the host response to unrelated 
antigens. Indeed, this hypothesis is supported by the recent observations that E. multilocularis-
infected animals enable a prolonged survival of transplanted organs as a result of a suppressed 
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immune-mediated rejection [276,277]. It therefore stands to reason to look at E. multilocularis 
products as a novel source of immunomodulatory factors with potential application as 
immunotherapeutics against host deleterious inflammatory responses [278]. This reconciles with 
the regulatory component of the hygiene hypothesis which proposes a key role for pathogens to 
keep host deleterious immune responses in check [279]. Consistent with E. multilocularis, 
several helminths have also been reported to release products with  the ability to impair DC 
responsiveness [63]. The glycoprotein ES-62 of Acanthocheilonema viteae [280,281], the E/S 
products of the rodent nematode Heligmosomoides polygyrus [262,282], the egg antigens of the 
trematode Schistosoma mansoni [283,284] or the E/S products from the cestode Teania 
crassiceps [263]  have all failed to promote a classical DC maturation and could each block 
subsequent PAMP-driven pro-inflammatory cytokine secretion by these DC. In this study, the 
identification of the factor (s) and mechanisms used by E. multilocularis primary cells and 
metacestodes to mediate DC impairment has not been achieved but would clearly provide a 
valuable wealth of informations to understand the basis of the host immunomodulation by E. 
multilocularis. In silico analyses have identified a TGF-β/Activin subfamily member within E. 
multilocularis genome. With respect to circumstancial evidences on the likelihood of true TGF-ß 
ligands in parasitic helminths [285,286], this factor represents a potential mediator of the DC 
impairment caused by E. multilocularis E/S products. Future experimentation in this regards are 
currently underway. As a possible mechanism, Echinococcus multilocularis larvae E/S-products 
might negatively regulate the TLR signaling through interaction with non-TLR pattern 
recognitions receptors such as C-type lectin receptor MGL [263] DC-SIGN and /or Dectin family 
members [63] as reported for E/S products of the closely related tapeworm Taenia crassiceps 
[263]. Equally likely is the induction of apoptosis by E. multilocularis larvae secretions which 
would explain the limited responsiveness of the surviving DC. In fact, since DC loaded with 
apoptotic bodies are known to display such an impaired responsiveness to subsequent TLR 
stimulation [270,287,288], it is reasonable to believe that apoptotic DC bodies induced by E. 
multilocularis larvae products if and when taken up by the surviving DC would most likely lead 
to the onset in these cells of a tolerogenic program.  
E/S products of the pro-adult stage, the protoscoleces failed to inhibit DC responses but rather 
promoted an intermediate maturation of the latter associated with the sole release of the 
inflammatory cytokine IL-6. Such a profile resembles that of DC exposed to hydatid fluid or 
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antigen B of the closely related tapeworm Echinococcus granulosus [266,267] but does not fully 
match it.  This discrepancy could simply be due to a differential spectrum of factors between the 
hydatid fluid content and the secretions of protoscoleces. This differential composition of the 
parasite preparations is further illustrated by the rate of AgB secretion which is only weakly 
expressed by protoscoleces [289,290] but considerably produced within the hydatid cyst fluid 
[291]. Interestingly, the phenotype and cytokine profile of DC exposed to protoscoleces in this 
study is also similar to those of Trypanosoma- treated DC [68] which have been closely related to 
the induction of Th2 response in vitro and in vivo [68]. Furthermore, the complete abrogation of 
LPS-pulsed IL-12 release in protoscolex-treated DC in spite of their ability to still mature in 
response to LPS, provides yet another supportive evidence for the Th2-inducing profile of these 
DC given that such a profile has previously been associated with Th2-inducing DC [292–294]. 
Again, this observation highlights the inability of protoscolex E/S products in impairing the 
activation of the intermediate host’s immune system as reported for primary cell and 
metacestode products. Moreover, Th2-dominated immune responses might not be entirely 
relying on protoscoleces since such an immune profile can also be observed in chronic AE under 
conditions in which no protoscoleces are produced [18]. However, since intestinal luminal 
infections by adult cestodes are associated with Th2 immune responses [2], the phenotype I 
observed in this study for DC treated with E/S products of E. multilocularis protoscoleces could 
rather be associated with events that are relevant for an infection of the definitive host [2]. It 
should therefore be recalled that the interpretation of results obtained when investigating the 
immune response to E. multilocularis larvae during an infection of the intermediate host by 
exposing host cells to Echinococcus protoscoleces [183–185,246–249] or by employing the 
mouse model of peritoneal, protoscolex-induced secondary alveolar echinococcosis for short-
term infections [179], with regards to the evidences herein provided, is highly subjective and 
probably biologically impertinent.  
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4.2  Utilizing evolutionarily conserved cytokines to subvert the host 
immune response:  EmACT, an Echinococcus multilocularis activin that 
expands host regulatory T-cells.  
Following the observation that E. multilocularis primary cell and metacestode E/S products 
induce tolerogenic DC, which might reasonably expand regulatory T-cells [214], I demonstrated 
that Echinococcus multilocularis metacestode vesicle E/S products induce de novo Foxp3+ Treg 
conversion from naïve CD4+ T-cells in a DC-based regulatory T-cell conversion assay in vitro. 
This indicates a major role for E/S products of the parasite metacestodes in host 
immunomodulation. Furthermore this finding  implies that the regulatory T-cell expansion in E. 
multilocularis -infected hosts is  a parasite-driven process, rather than just a mere homeostatic 
mechanism of any chronically infected host in order to limit the disease pathology, as previously 
reported for other diseases [295,296]. In vivo analyses carried out in this work further supported 
the idea of parasite-driven Treg expansion in AE. Indeed, the recruitment of Foxp3+ Treg took 
place at a time point where the experimentally infected hosts were not chronically infected (day 
7). This is in contrast with a past study where Foxp3+ Treg expansion was first reported in 
heavily-infected hosts (> day 42) [235]. The latter study, although informative, was equivocal 
with respect to the basis of Treg expansion. It was not possible to differentiate between a 
parasite-driven process and a homeostatic response of the chronically infected host as the cause 
of the observed Treg expansion. My present observation of an early recruitment of Treg in E. 
multilocularis-infected mice therefore ascertains the ability of the parasite metacestodes to 
actively drive host Treg expansion in vivo. However, with respect to the early (day 7 post 
injection) expansion of Treg in mice following metacestode injection in this study, the data also 
suggest the possibility of a mitogenic effect of the parasite on natural/pre-existing Tregs. Future 
studies using differential markers for natural vs. induced Tregs like Neuropilin 1 [297] should be 
conducted to distinguish between the proliferation of natural Tregs (neuropilin 1high) and/or the 
conversion of inducible Tregs (neuropilin1low) by E. multilocularis metacestodes in vivo. All the 
same, expanding natural [298,299] and/or inducible Foxp3+ Tregs [300] has already been 
reported for parasitic helminths with large implication for disease establishment and/or 
progression [286,298,301]. Taking advantage of the recently developed bacterial artificial 
chromosome–transgenic mice termed “depletion of regulatory T-cell” or DEREG mice 
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[302,303], the question whether a similar role for Tregs (as a whole) in disease establishment 
and/or progression applies during AE can  now be addressed. The induction of Treg by helminth 
E/S products has already been described. Grainger et al., [286] have elegantly demonstrated a 
similar potency of E/S products of the parasitic nematode H. polygyrus via the host TGF-β 
pathway [286]. Similarly, the blockade of the host TGF-β pathway abrogated the ability of 
metacestode E/S products to drive Foxp3 expansion in T-cells suggesting that this pathway is 
instrumental for the Treg-converting ability of metacestode E/S products. Furthermore, this 
metacestode Treg-converting potency was equally lost when TGF-ß was neutralized with 
antibodies pointing out that metacestode products require the host TGF-β to expand regulatory 
T-cells, as previously reported for a major egg antigen of the related parasitic flatworm S. 
mansoni [304].  
As a candidate factor mediating host Treg expansion, a TGF-β/Activin subfamily member with 
highest homology to mammalian inhibin beta A subunit could be identified in silico within E. 
multilocularis genome. In mammals, heterodimers of inhibin α and inhibin beta A / beta B are 
denominated inhibin A and B, respectively, while homodimers of either inhibin beta A or inhibin 
beta B are called activin A and activin B [230]. Since further in silico searches within the E. 
multilocularis genome failed to identify any other inhibin homologue, I termed the inhibin beta 
A subunit homologue E. multilocularis activin or EmACT, given that most probably only 
homodimer chains of the inhibin beta A orthologue can be formed by the parasite. Interestingly, 
EmACT appeared to be secreted by the parasite metacestodes suggestive of a role at the host-
parasite interface. Indeed, subsequent results indicated that recombinant EmACT (rEmACT) was 
able to promote TGF-β-driven Foxp3+ Treg conversion in a manner similar to what has been 
shown for mammalian activin A [228], thus suggesting a possible role of this factor in the Treg 
converting potency of E. multilocularis metacestode E/S products.  
Of note, primary cells and protoscolex secretions failed to promote Foxp3+ Treg conversion but 
could also secrete EmACT in vitro (Suppl. Fig. 5). Strikingly, EmACT appeared to be 
differentially processed in these stages (Suppl. Fig. 5) illustrating the complexity of post-
translational modifications in TGF-β superfamily members and the ensuing effect on their 
activities. It is therefore likely that posttranslational modifications, like N-glycosylations, that 
have commonly been reported to affect TGF-β superfamily members’ activity [305–307], could 
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regulate the activity of EmACT in E. multilocularis E/S products. On the other hand, two 
follistatin homologues (Suppl. Fig. 6) could be identified within E. multilocularis genome with 
one flanked at its N-terminus by a signal sequence suggesting secretion. Since follistatins are 
specific inhibitors of activins [308,309], it is reasonable to hypothesize that the parasite, similarly 
to its mammalian host, is using this regulatory loop to control EmACT activity throughout 
development. Whether the post translational modifications of EmACT and/or the differential 
expression of parasite follistatins govern the dissimilarities observed with E. multilocularis 
larvae E/S products with respect to Foxp3+ Treg conversion clearly requires further 
investigations.     
The data of this study also indicated that EmACT failed to induce DC maturation. Additionally, 
rEmACT also failed to impair DC responsiveness to subsequent LPS challenge, unlike what was 
previously observed with metacestode E/S products and reported for activin A [229,310] . 
Interestingly, rEmACT did not promote Foxp3+ Treg conversion in the absence of TGF-β, as 
was observed for metacestode E/S products. Although the latter observation is in agreement with 
previous studies where CD4+ T-cells failed to upregulate Foxp3 expression in response to 
activin A alone [229], unless co-stimulated with TGF-β [228],  limitations in the present 
experimental settings can not be ruled out. Using supernatant of transiently transfected 
mammalian cell lines is a common approach for the preliminary assessment of novel factors 
[205,311] but still hold the drawback of yielding a limited and uncontrolled amount of the factor 
[205]. In fact, since in another study, purified activin A could singly elicit host Treg conversion 
in a dose-dependent manner in the absence of TGF-β [228], a reasonable step to take from here 
would therefore be the dose-dependent assessment of purified rEmACT alone in the DC 
stimulation assay and the Treg conversion assay. However, the TGF-ß-dependent Treg 
converting capacity of rEmACT corroborates with the mode of action of E. multilocularis 
metacestode E/S products. Indeed, the neutralization of TGF-β abrogated the rate of Foxp3+ 
Treg conversion with metacestode E/S products. This stands as indirect evidence for EmACT as 
the Treg promoting factor secreted by the parasite metacestodes. Other possible parasite factor 
(s) that could support TGF-β-driven Treg conversion through the TGF-β pathway are bone 
morphogenetic proteins (BMPs). Indeed, BMP-2 and BMP-4 have been shown to act in synergy 
with TGF-β to promote Foxp3+ Treg induction [312]. Two BMPs homologues (Suppl. Fig. 3) 
have been identified by in silico search within the E. multilocularis genome and although not 
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studied in this work, these factors are awaiting an in-depth characterization. I also can not 
dismiss the implication of T2 ribonucleases which, with respect to Schistosoma mansoni 
hepatotoxic T2 ribonuclease omega-1 [304], could be able to drive a TGF-β-dependent Foxp3+ 
Treg expansion and DC modulation. Of note, an in silico search lead to the identification of an 
omega-1 homologue (EmOMG) within the parasite genome which clearly warrants further 
analysis in this respect (Suppl. Fig. 4). However, the role of EmACT in the metacestode-driven 
host T-cell modulation gained more support with the observation that, similarly to metacestode 
E/S products and as reported for activin A [229], rEmACT triggered IL-10 secretion by CD4+ T-
cells in vitro. Of interest, IL-10 as an anti-inflammatory cytokine [265], has been extensively 
reported to peak during murine and human infection with E. multilocularis larvae 
[130,142,143,145,151,163,164,170,313,314] and is therefore suggested to play a crucial role in 
the maintenance of tolerance and partial inhibition of cytotoxic mechanisms [152,153]. 
Interestingly, the mechanisms governing Foxp3 expression and IL-10 secretion by activin A-
treated CD4+ T-cells involve both the TGF-β and p38 map kinase pathways [315]. Whether 
EmACT utilizes both the host TGF-β pathway and the p38 MAPK cascade to mediate the 
aforementioned effects would therefore be interesting to test. 
Collectively, these findings demonstrate the long suspected but unproven harnessing of one 
evolutionary conserved TGF-β superfamily cytokines by larvae of the fox tapeworm E. 
multilocularis in particular and helminths in general, to subvert host immune cell functions. 
EmACT, an activin orthologue secreted by E. multilocularis metacestode E/S products, 
promoted regulatory functions within T-cell populations in a manner similar to metacestode 
secretions.  Not only could these data prove to be valuable for novel anti-AE strategies but, 
beyond the level of parasitology, provide a lead factor for the control of detrimental immune 
responses and their associated pathologies in humans such as autoimmune diseases and allergies. 
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4.3 An IFN-gamma-inducing protein secreted by Echinococcus 
multilocularis larvae is important for parasite development.  
IFN-γ and its associated effects dominate the very early post-oncospheral phases of infection 
with E. multilocularis [129,154,155] and have been shown to be potentially deleterious to the 
parasite larvae [133,136,137,170,237]. The resulting Th1 immune response is progressively 
suppressed as the metacestodes are formed and disseminate within the host [234]. The 
mechanisms mediating the early onset of host protective Th1 responses against E. multilocularis 
larvae are still not known. I herein characterized a factor homologous to human T-cell 
immunomodulatory protein (TIP). Since human TIP is known to trigger the release of IFN-γ, 
TNF and IL-10 by T-cells [205], I characterized and functionally assessed the parasite TIP 
homologue, renamed EmTIP, with regard to an eventual ability to trigger the release of these 
cytokines by CD4+ T-cells.    
This gene renamed Emtip codes for an atypical FG-GAP repeat containing protein EmTIP (E. 
multilocularis T-cell immunomodulatory protein). I showed that EmTIP is expressed by all 
larval stages of the parasites and released in soluble forms by primary cells and protoscoleces but 
not metacestodes. I also showed that EmTIP localized to the inter-cellular space of the parasite 
larvae and that antibodies directed against EmTIP limited the proliferation of the parasite cells 
and restrained them in their ability to regenerate into metacestode vesicles in vitro. Finally, I 
found that EmTIP instructed murine CD4+T cells to release IFN-γ but not IL-10 in vitro. Taken 
together, these findings suggest that EmTIP is an antigen important for the early phases of 
Echinococcus multilocularis larvae development and at the same time capable of eliciting IFN-γ 
release by CD4+ T-cells.  
Even though the precise function of the T-cell immunomodulatory protein family is largely 
unknown and has so far only been associated with a protective effect in a graft-versus-host 
model amid a complex cytokine profile (IFN-γ, IL-10 and TNF) [205], they are widely conserved  
throughout the animal kingdom. A structural feature of all TIP proteins is the presence of FG-
GAP repeats, which are present in 2 atypical copies in EmTIP as opposed to one copy in human 
and mouse TIP. In mammals, FG-GAP repeat-containing proteins have principally been 
associated with cell-cell/ECM (extracellular matrix) interactions [316,317]. Alpha-Integrins 
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constitute a group of such proteins harboring up to 7 copies of the FG-GAP repeat at their N-
terminus through which they mediate ligand binding and cell-cell/ECM interactions [318–321].  
Similar to cell-cell/ECM interaction-mediating integrins alpha [316,317], a signal sequence and a 
transmembrane domain are found within EmTIP and thus suggest a membrane-
bound/extracellular localization. Indeed, the observation that EmTIP could be detected in the 
parasite lysates and as a soluble form in the secretions of early and late parasite larvae 
corroborates this point. EmTIP secretion, in spite of its transmembrane domain, is congruent 
with the secretion of TIP by mammalian cells [205]. Moreover, EmTIP localization to the inter-
cellular space within all the parasite larvae provide yet additional support to its role in the cell-
cell/ECM interactome as described for FG-GAP repeat-conatining proteins [317].  
Interestingly, antibodies directed against the putative interacting domain of the FG-GAP repeat-
containing protein EmTIP i.e. the FG-GAP repeat-containing portion [236,321–323] could limit 
E. multilocularis primary/stem cell proliferation. Since cell-cell/ECM interactions are necessary 
for stem cell proliferation in various organisms [324–326], this observation suggests that EmTIP 
antibody-mediated binding could affect the parasite cell-cell/ECM interactions. Therefore 
EmTIP would probably be an important component of the parasite cell-cell/ECM interactome. 
Although the mechanism through which anti-EmTIP antibodies inhibit E. multilocularis cell 
proliferation remains unknown, it is likely that these antibodies sequester soluble EmTIP or 
cover membrane-associated EmTIP, and thus interfere with any eventual ligand binding and/or 
transduce an inhibitory signal. Assessing whether these proposed mechanisms would separately 
or altogether account for the impairment of E. multilocularis cell proliferation would clearly 
provide valuable information on the biology of E. multilocularis.  
Furthermore, I showed that anti-EmTIP antibodies inhibited the formation of mature metacestode 
vesicles from primary cells  in vitro. Given the suggested importance of this process as a model 
for the early transformation from oncosphere into metacestode [190,191] and the process of 
metastasis formation [190,191,272,327], this finding suggests that EmTIP might play a role 
during the onset of AE and most probably for the metastatic growth of the parasite larvae in vivo. 
Indeed, E. multilocularis primary cells have been suggested to mediate the early expansion of the 
parasite metacestode tissue and to drive the parasite dissemination within the host [14].  
Therefore, the in vitro impairment of E. multilocularis primary cell culture transition into 
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metacestodes as a result of EmTIP blockade/binding suggests that this approach holds 
considerable promise for the control of AE onset and progression. First, assessing the role of the 
antibody-mediated EmTIP blockade in vivo during Echinococcus infection is needed.  Given the 
prospect of additional parasiticidal mechanisms like ADCC (antibody-dependent cell 
cytotoxicity), likely to follow EmTIP recognition by host antibodies in vivo, it would also be 
desirable to see the potency of EmTIP antigen as a candidate vaccine.  
Rather encouraging for this potential host-protective role of EmTIP is the observation that 
EmTIP triggered the release of IFN-γ by CD4+ T-cells in vitro, a cytokine shown to promote 
anti-parasitic events in E. multilocularis-infected hosts [133,136,137,170,237]. It therefore 
appears that EmTIP homologies with TIP enabled the parasite factor to instruct a similar pro-
IFN-γ response in T-cells. Which receptor(s) on these cells is/are recruited by T-cell 
immunomodulatory proteins and which signaling pathway(s) is/are of importance are yet to be 
determined. But again, this effect of EmTIP is unprecedented and provides the first possible 
explanation for the early Th1 response reported during AE [129,152–154]. Clearly, if released in 
vivo as observed in vitro during the immunoprecipitation assays, EmTIP would interact with the 
host CD4+ T-cell. This interaction might lead to IFN-γ release, which would support T-cell 
polarization towards Th1.   
The present in vitro stimulation system, although failing to show IL-10 release in response to 
EmTIP-containing supernatants, does not establish that the purified protein would similarly fail 
in this regard.  Indeed, the supernatant of TIP-transfected cells used in a previous study [205] 
could uniquely trigger IFN-γ release by T-cells. When purified, TIP could in addition to IFN-γ 
secretion prompt the release of IL-10 and TNF by the stimulated T-cells [205]. An affinity 
purification of EmTIP is therefore needed to pursue the T-cell stimulation assays. In this respect, 
I already generated an EmTIP-expressing cell line which would facilitate the obtention of large 
amounts of EmTIP-containing supernatants.  
TIP has up to 12 N-glycosylation sites and is secreted as highly glycosylated form [205], EmTIP 
only has 2 potential N-glycosylation sites and only appears secreted at a higher molecular weight 
by protoscoleces. Interstingly, neither primary cells nor Emtip-transfected mammalian cells 
could release this higher molecular weight form. This could explain the differences observed 
with regards to the induction of IFN-γ release by CD4+ T-cells following exposure to these 
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supernatants. Whereas primary cell E/S products and recombinant EmTIP could clearly trigger 
IFN-γ release on the one side, protoscolex E/S products failed to show this ability. Thus, the 
presence of this additional band of higher molecular weight in protoscolex E/S products could be 
explained here as a posttranslational variant associated with feedback regulation/inhibition, 
whereas the lower molecular weight (58kDa) EmTIP variant, as secreted by primary cells and 
transfected HEK cells, would be associated with the induction of IFN-γ release by T-cells.  
Fractionation studies on protoscolex E/S products in order to separately assess the IFN-γ 
inducing potency of these 2 variants in T-cells could provide more insights towards this issue. 
Additionally, the differential secretome of E. multilocularis larval stage as previously suggested 
in this work could clearly account for an anti-IFN-γ potency of protoscolex released metabolites 
which would be absent from primary cell E/S products. In any case, the present data indicate that 
EmTIP as expressed by the parasite primary cells strongly evokes IFN-γ production by CD4+ T-
cells. Whether EmTIP is secreted (or cleaved off) by the primary cell to affect the host T-cells is 
rather unlikely since the metacestode failed to release EmTIP, probably as a result of their 
morphology (i.e. fluid-filled cyst, surrounded by a laminated layer). Indeed at this stage EmTIP 
is most probably retained completely within the intracystic compartment as observed in the 
immunohistochemical experiments. Therefore, EmTIP would rather appear to be released in an 
attempt to fulfill developmental functions, accumulating within the cellular matrices and defining 
a suitable niche for the parasite cell proliferation and differentiation.  
In conclusion, given the implication of EmTIP in Echinococcus multilocularis stem cell 
proliferation and cyst formation and the essential role of this phenomenon in disease 
establishment and metastasis formation and in keeping with the ability of this factor to promote 
IFN-γ release by CD4+ T-cells, I strongly recommend the assessment of EmTIP as a candidate 
vaccine. Moreover, I propose the investigation of the latter with regard to the identification of 
lead target for anti-echinococcal prophylaxis on asymptomatic seropositive patients as well as in 
post-operative instances as an attempt to limit relapses. 
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4.4 A model for the immunomodulation of hosts by Echinococcus 
multilocularis.  
Understanding the events and associated molecular bases of the host immunomodulation by 
parasitic helminths in the course of an infection is of clear benefits for the development of more 
efficient deworming strategies. Additionally, beyond the level of parasitology, unraveling and 
utilizing the molecular stratagems used by long-lasting parasitic helminths like E. multilocularis 
to persist within immunocompetent hosts could clearly provide new tools to counterpose 
detrimental immune responses and the ensuing human pathologies like autoimmune diseases, 
allergies or acute graft rejection during transplantation. In the light of such multiple applications 
of the understanding of host immune response to parasitic helminths in general and to our model 
the fox-tapeworm E. multilocularis in particular, I will herein draw a possible picture of the 
immunological events governing hosts colonization by our model the fox-tapeworm E. 
multilocularis (Fig. 37) using previous investigations and evidences provided by the present 
work.  
In susceptible murine hosts, upon uptake, E. multilocularis eggs / oncospheres fail to trigger an 
augmentation of total IgG, IgA or IgM within the intestine [128]. However, the local amount of 
anti-echinococcocal immunoglobulins is enhanced by the parasite eggs entry. The eggs / 
oncospheres trigger a strong local production of anti-echinococcocal IgG and IgA [128]. 
Additionally, lymphocytes then gradually infiltrate the lamina propria of the intestine. The 
intestinal mucosa permeability is significantly increased allowing the transit of the parasite 
oncospheres [128]. At the systemic level, the humoral response appears non-specifically 
suppressed with a reduced amount of total IgG, IgA and IgM [128]. Slowly, the intestinal 
response vanishes with the oncospheres now extraintestinal. The intestinal mucosa permeability 
also returns to normal [128]. At this level, little is known on the profile of host-protective 
responses. It would be interesting to assess the role of the local and systemic anti-echinococcal 
immunoglobulins on the containment of the parasite oncospheres within the gut and short upon 
gaining access to the host interior milieu. Given the widely approved central role of IgA in 
mucosal immunity [328], recent lines of research are underway to identify IgA-inducing antigens 
from the parasites as vaccination approaches [329,330].  
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Figure 37: Alterations of the immune system in response to E. multilocularis larvae: a 
model. 
 
An interesting point here is the early and non-specific impairment of the systemic host humoral 
response by E. multilocularis oncospheres [128]. This reconciles with the present consensus of a 
dominating cellular Th1 response following passage of the oncospheres through the intestinal 
barrier [129,152–155]. It is enviseageable that following the oncosphere drainage and in the 
process of metamorphosis, its population of undifferentiated cells release factors like EmTIP that 
are important for cellular proliferation and cyst formation. In the process, however, EmTIP 
triggers the release of IFN-γ by host CD4+ T-cells. Given, the deleterious effect of IFN-γ-driven 
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immune cell activation on the parasite larvae [136,137], the completion of the oncosphere 
metarmophosis and the formation of metacestode are likely to be severely compromised. This is 
consistent with the frequent observation of abortive cases of the disease in patients confirmed 
seropositive for E. multilocularis antigens [331–334]. However, the parasite cells can eventually 
reprogram the host immune sentinels like DC that are encountered during their migration from 
the intestinal entry site to the liver. Aided by their released products, the oncospheres induce 
apoptosis and evoke IL-10 production in DC. Moreover, to presumably counter the inflammation 
resulting from the intestinal epithelia damage as a result of the oncosphere passage, the 
oncosphere secretions render these DC hyporesponsive to bystander inflammatory stimuli. This 
immunosuppressive environment most probably helps alleviate the deleterious effects of IFN-γ-
activated macrophages and cytotoxic cells that result from EmTIP release. This altogether most 
probably enables a certain degree of survival for the parasite cells in the face of a dominated Th1 
immune response and, with the help of factors like EmTIP, drives the metamorphosis of the early 
oncospheres into metacestodes  
The development of E. multilocularis metacestode coincides with the decline of parasiticidal Th1 
responses [170,237]. As the potential Th1 driving factor, EmTIP is no longer secreted by the 
parasite at this stage and given the ability of the parasite somatic and secretory factors to drive T-
independent responses [175], a dominating Th2 response gradually arises [134,142,163]. 
Shedded carbohydrate rich components of the laminated layer [174] might also instruct the 
recruited phagocytes to preferentially direct Th2 polarization. Moreover, Th2-driving factors like 
the parasite omega-1 homologue EmOMG could account for a Th1- to TH2 switch. A role has, 
however, still to be demonstrated for this factor in the course of an infection. Furthermore, the 
metacestode might support the commitment of T-cell to a Th2 profile by promoting IL-4 release 
by basophils [176]. The metacestode also targets the host DC. In keeping with the pivotal role of 
DC in T-cell polarization [54,181,335], metacestodes alter DC away from a classical Th1-
inducing profile. To continue minimizing the host protective responses, the metacestodes sustain 
host DC killing by apoptosis via its released products. Interestingly, presumably due to 
protection by a thick accelular membrane, the metacestode stops inducing IL-10 production in 
DC, as opposed to the early oncospheres. This could additionally occur as a result of the fact that 
the infection has now progressed over the initial immune recognition phase where innate 
immune functions were predominantly actives. Now that the host might have recruited cells from 
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the adaptive immune response, metacestodes would accordingly redirect some of their 
immunomodulatory tools against the host adaptive immune response, probably as a result of a 
long evolutionary process of adaptation to parasitism. Again, the metacestode efficiently limits 
the chemotaxis of inflammatory cells [150,171] to possibly achieve a more permissive 
environment and thus quietly thrive. To further counter the host immunity in general, the 
metacestodes now release factors like EmACT which induce regulatory properties in the host T-
cells. As a result, the gradually establishing Th2 response is also negatively affected, therefore 
allowing a silent and lengthy dwelling of the metacestode until a chronic stage is attained. A 
particularly critical aspect of this model is the presumption that regulator T-cells are important 
for the parasite persistence. Further investigation is urgently needed in order to attest or refute 
such a role for these cells. Whatever the case, the switch from a larvicidal Th1 to a Th2 response 
that is supposedly supported by the induction of an immunoregulatory network both at the level 
of the host innate and adaptive immune responses, is clearly a result of the metacestode driven 
fine-tuning of the host immune system. In this setting, the metacestode proliferates, metastasizes 
and, in the case of highly susceptible rodents, produces protoscoleces. The heavily infected 
rodent hosts are now easy preys for the definitive carnivorous host as a result of their slowness of 
gate. 
In the gut of the definitive host, E. multilocularis protoscoleces excyst and closely adhere to the 
definitive intestinal submucosa [165]. The protoscoleces and its secretions evoke mucosal 
immune responses triggering the chemotaxis and activation of IgA-producing cells at the local 
level [165]. Supposedly, mucosal DC are also altered by the parasite secretions and mature into 
Th2-inducing DC that would most probably foster the production of anti-echinococcocal 
antibodies. The higher the anti-echinococcal titer of these hosts the more protected they are thus 
the more impaired is the protoscoleces development of gravid proglottids [165,336]. The 
protoscoleces also trigger a systemic response in their carnivorous hosts given their tight 
anchorage to the intestinal sub-mucosa [165]. The systemic response appears finely 
downregulated in the vicinity of the scolex, limited in both cytotoxic and and effector cell 
activity [165]. A central role for the protosoclex E/S products is highly likely mediating these 
effects. Neverthless, serum IgG and IgA titers become elevated in response to the protoscoleces 
and tightly correlates with the protection against the partasite [165].  
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In conclusion, the present model proposes novel, appealing clues for the modulation of the hosts 
immune responses by E. multilocularis larvae. An important role is demonstrated for the parasite 
secretions of which two evolutionarily conserved parasite factors EmTIP and EmACT shed more 
light to the mechanisms of the early host Th1 response and the mitigation of potentially host-
protective immune responses, respectively. An in-depth investigation of the scope of the present 
factors at the molecular level with regards to the control of AE and inflammatory diseases should 
therefore be performed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
130 
 
5. BIBLIOGRAPHY 
 
 1.  Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J (2008) Helminth infections: the great 
neglected tropical diseases. J Clin Invest 118: 1311-1321. 10.1172/JCI34261 [doi]. 
 2.  McKay DM, Webb RA (2005) Cestode Infection: Immunological Considerations from Host and Tapeworm 
Perspectives. In: Maule AG, Marks NJ, editors. Parasitic flatworms: Molecular biology, 
Biochemistry, Immunology and Physiology. Wallingford, United Kingdom: CABI publishing. pp. 
193-206. 
 3.  Vuitton DA (2004) Echinococcosis and allergy. Clin Rev Allergy Immunol 26: 93-104. CRIAI:26:2:093 
[pii];10.1007/s12016-004-0004-2 [doi]. 
 4.  Eckert J, P.M.Schantz, R.B.Gasser, P.R.Torgerson, A.S.Bessonov, et al. (2001) Geographic distribution 
and prevalence. In: Eckert J, Gemmel MA, Meslin FX, Pawlowski ZS, editors. WHO/OIE Manual 
on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern. Paris: 
World Organisation for Animal Health. pp. 100-134. 
 5.  Zitouna MM, Boubaker S, Dellagi K, Ben SZ, Hadj SH, Robbana M, Ben Rachid MS (1985) [Alveolar 
echinococcosis in Tunisia. Apropos of 2 cases]. Bull Soc Pathol Exot Filiales 78: 723-728. 
 6.  Jenkins DJ, Romig T, Thompson RC (2005) Emergence/re-emergence of Echinococcus spp.--a global 
update. Int J Parasitol 35: 1205-1219. S0020-7519(05)00277-8 [pii];10.1016/j.ijpara.2005.07.014 
[doi]. 
 7.  Deplazes P, Hegglin D, Gloor S, Romig T (2004) Wilderness in the city: the urbanization of Echinococcus 
multilocularis. Trends Parasitol 20: 77-84. S1471492203003234 [pii]. 
 8.  Torgerson PR, Keller K, Magnotta M, Ragland N (2010) The global burden of alveolar echinococcosis. 
PLoS Negl Trop Dis 4: e722. 10.1371/journal.pntd.0000722 [doi]. 
 9.  Jorgensen P, an der HM, Kern P, Schoneberg I, Krause G, Alpers K (2008) Underreporting of human 
alveolar echinococcosis, Germany. Emerg Infect Dis 14: 935-937. 10.3201/eid1406.071173 [doi]. 
 10.  Romig T, Dinkel A, Mackenstedt U (2006) The present situation of echinococcosis in Europe. Parasitol Int 
55 Suppl: S187-S191. S1383-5769(05)00133-9 [pii];10.1016/j.parint.2005.11.028 [doi]. 
 11.  Thompson RCA, McManus DP (2001) Aetiology: parasites and life-cycles. In: Eckert J, Gemmel MA, 
Meslin FX, Pawlowski ZS, editors. WHO/OIE Manual on Echinococcosis in Humans and Animals: 
A Public Health Problem of Global Concern. Paris: World Organisation for Animal Health. pp. 1-
17. 
 12.  Eckert J, Deplazes P (2004) Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis 
of increasing concern. Clin Microbiol Rev 17: 107-135. 
 13.  Kern P, Ammon A, Kron M, Sinn G, Sander S, Petersen LR, Gaus W, Kern P (2004) Risk factors for 
alveolar echinococcosis in humans. Emerg Infect Dis 10: 2088-2093. 10.3201/eid1012.030773 
[doi]. 
 14.  Mehlhorn H, Eckert J, Thompson RC (1983) Proliferation and metastases formation of larval Echinococcus 
multilocularis. II. Ultrastructural investigations. Z Parasitenkd 69: 749-763. 
131 
 
 15.  Virchow R (1855) Die multiloculäre, ulcerirende Echinokokkengeschwulst der Leber. Verhandlungen der 
Physicalisch-Medicinischen Gesellschaft 84-95. 
 16.  Pawlowski ZS, Eckert J, Vuitton DA, Ammann RW, Kern P, et al. (2001) Echinococcosis in humans: 
clinical aspects, diagnosis and treatment. In: Eckert J, Gemmel MA, Meslin FX, Pawlowski ZS, 
editors. WHO/OIE Manual on Echinococcosis in Humans and Animals: A Public Health Problem of 
Global Concern. Paris: World Organisation for Animal Health. pp. 20-69. 
 17.  Kern P (2010) Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis 23: 505-
512. 10.1097/QCO.0b013e32833d7516 [doi]. 
 18.  Matsumoto J, Kouguchi H, Oku Y, Yagi K (2010) Primary alveolar echinococcosis: course of larval 
development and antibody responses in intermediate host rodents with different genetic 
backgrounds after oral infection with eggs of Echinococcus multilocularis. Parasitol Int 59: 435-
444. S1383-5769(10)00100-5 [pii];10.1016/j.parint.2010.06.003 [doi]. 
 19.  Brunetti E, Kern P, Vuitton DA (2010) Expert consensus for the diagnosis and treatment of cystic and 
alveolar echinococcosis in humans. Acta Trop 114: 1-16. S0001-706X(09)00358-1 
[pii];10.1016/j.actatropica.2009.11.001 [doi]. 
 20.  Wilson JF, Rausch RL, Wilson FR (1995) Alveolar hydatid disease. Review of the surgical experience in 
42 cases of active disease among Alaskan Eskimos. Ann Surg 221: 315-323. 
 21.  Ammann RW (1991) Improvement of liver resectional therapy by adjuvant chemotherapy in alveolar 
hydatid disease. Swiss Echinococcosis Study Group (SESG). Parasitol Res 77: 290-293. 
 22.  1996) Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working 
Group on Echinococcosis. Bull World Health Organ 74: 231-242. 
 23.  Saimot AG, Meulemans A, Cremieux AC, Giovanangeli MD, Hay JM, Delaitre B, Coulaud JP (1983) 
Albendazole as a potential treatment for human hydatidosis. Lancet 2: 652-656. S0140-
6736(83)92533-3 [pii]. 
 24.  Davis A, Pawlowski ZS, Dixon H (1986) Multicentre clinical trials of benzimidazolecarbamates in human 
echinococcosis. Bull World Health Organ 64: 383-388. 
 25.  Teggi A, Lastilla MG, De RF (1993) Therapy of human hydatid disease with mebendazole and 
albendazole. Antimicrob Agents Chemother 37: 1679-1684. 
 26.  Lacey E (1990) Mode of action of benzimidazoles. Parasitol Today 6: 112-115. 0169-4758(90)90227-U 
[pii]. 
 27.  Elsheikha HM, McOrist S, Geary TG (2011) Antiparasitic Drugs: Mechanisms of Action and Resistance. 
In: Elsheikha HM, Khan NA, editors. Essentials of Veterinary Parasitology. Norfolk, UK: Caister 
Academic Press. pp. 191. 
 28.  Wilson JF, Rausch RL, McMahon BJ, Schantz PM (1992) Parasiticidal effect of chemotherapy in alveolar 
hydatid disease: review of experience with mebendazole and albendazole in Alaskan Eskimos. 
Clin Infect Dis 15: 234-249. 
 29.  Kern P (2010) Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis 23: 505-
512. 10.1097/QCO.0b013e32833d7516 [doi]. 
 
132 
 
 30.  Seiler JP (1975) Toxicology and genetic effects of benzimidazole compounds. Mutat Res 32: 151-168. 
 31.  McKellar QA, Scott EW (1990) The benzimidazole anthelmintic agents--a review. J Vet Pharmacol Ther 
13: 223-247. 
 32.  Cook GC (1995) Adverse effects of chemotherapeutic agents used in tropical medicine. Drug Saf 13: 31-
45. 
 33.  Morris DL, Smith PG (1987) Albendazole in hydatid disease--hepatocellular toxicity. Trans R Soc Trop 
Med Hyg 81: 343-344. 
 34.  Taylor DH, Morris DL, Reffin D, Richards KS (1989) Comparison of albendazole, mebendazole and 
praziquantel chemotherapy of Echinococcus multilocularis in a gerbil model. Gut 30: 1401-1405. 
 35.  Taylor DH, Morris DL, Richards KS, Reffin D (1988) Echinococcus multilocularis: in vivo results of 
therapy with albendazole and praziquantel. Trans R Soc Trop Med Hyg 82: 611-615. 
 36.  Andersen FL, Crellin JR, Cox DD (1981) Efficacy of praziquantel against immature Echinococcus 
multilocularis in dogs and cats. Am J Vet Res 42: 1978-1979. 
 37.  Schelling U, Frank W, Will R, Romig T, Lucius R (1997) Chemotherapy with praziquantel has the 
potential to reduce the prevalence of Echinococcus multilocularis in wild foxes (Vulpes vulpes). 
Ann Trop Med Parasitol 91: 179-186. 
 38.  Taylor DH, Morris DL (1988) In vitro culture of Echinococcus multilocularis: protoscolicidal action of 
praziquantel and albendazole sulphoxide. Trans R Soc Trop Med Hyg 82: 265-267. 
 39.  Hegglin D, Deplazes P (2008) Control strategy for Echinococcus multilocularis. Emerg Infect Dis 14: 
1626-1628. 10.3201/eid1410.080522 [doi]. 
 40.  Hegglin D, Ward PI, Deplazes P (2003) Anthelmintic baiting of foxes against urban contamination with 
Echinococcus multilocularis. Emerg Infect Dis 9: 1266-1272. 10.3201/eid0910.030138 [doi]. 
 41.  Ito A (1997) Basic and applied immunology in cestode infections: from Hymenolepis to Taenia and 
Echinococcus. Int J Parasitol 27: 1203-1211. S0020-7519(97)00118-5 [pii]. 
 42.  Lightowlers MW (1990) Cestode infections in animals: immunological diagnosis and vaccination. Rev Sci 
Tech 9: 463-487. 
 43.  Heath DD, Holcman B (1997) Vaccination against echinococcus in perspective. Acta Trop 67: 37-41. 
 44.  Osborn PJ, Heath DD (1982) Immunisation of lambs against Echinococcus granulosus using antigens 
obtained by incubation of oncospheres in vitro. Res Vet Sci 33: 132-133. 
 45.  Osborn PJ, Heath DD, Parmeter SN (1981) Immunisation of lambs against infection with Taenia ovis using 
an extract of Taenia ovis eggs. Res Vet Sci 31: 90-92. 
 46.  Rickard MD, Bell KJ (1971) Induction of immunity of lambs to a larval cestode by diffusible antigens. 
Nature 232: 120. 232120a0 [pii];10.1038/232120a0 [doi]. 
 47.  Lightowlers MW, Lawrence SB, Gauci CG, Young J, Ralston MJ, Maas D, Health DD (1996) Vaccination 
against hydatidosis using a defined recombinant antigen. Parasite Immunol 18: 457-462. 
133 
 
 48.  Gauci C, Merli M, Muller V, Chow C, Yagi K, Mackenstedt U, Lightowlers MW (2002) Molecular cloning 
of a vaccine antigen against infection with the larval stage of Echinococcus multilocularis. Infect 
Immun 70: 3969-3972. 
 49.  Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J 
Med 347: 911-920. 10.1056/NEJMra020100 [doi];347/12/911 [pii]. 
 50.  Abbas AK, Lichtman AH, Pillav S (2010) Properties and Overview of Immune Responses. In: Abbas AK, 
Lichtman AH, Pillav S, editors. Cellular and Molecular Immunology. Philadelphia: 
Saunders/Elsevier. pp. 3-17. 
 51.  Abbas AK, Lichtman AH, Pillav S (2010) Innate Immunity. In: Abbas AK, Lichtman AH, Pillav S, editors. 
Cellular and Molecular Immunology. Philadelphia: Saunders/Elsevier. pp. 19-46. 
 52.  Abbas AK, Lichtman AH, Pillav S (2010) Antigen Processing and Presentation to T lymphocytes. In: 
Abbas AK, Lichtman AH, Pillav S, editors. Cellular and Molecular Immunology. Philadelphia: 
Saunders/Elsevier. pp. 113-136. 
 53.  Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12: 991-1045. 
10.1146/annurev.iy.12.040194.005015 [doi]. 
 54.  Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245-252. 
10.1038/32588 [doi]. 
 55.  Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML (1999) T-cell priming by type-1 and type-2 
polarized dendritic cells: the concept of a third signal. Immunol Today 20: 561-567. S0167-
5699(99)01547-9 [pii]. 
 56.  Abbas AK, Lichtman AH, Pillav S (2010) Antigen Receptors and Accessory Molecules of T Lymphocytes. 
In: Abbas AK, Lichtman AH, Pillav S, editors. Cellular and Molecular Immunology. Philadelphia: 
Saunders/Elsevier. pp. 137-149. 
 57.  Abbas AK, Lichtman AH, Pillav S (2010) Activation of T Lymphocytes. In: Abbas AK, Lichtman AH, 
Pillav S, editors. Cellular and Molecular Immunology. Philadelphia: Saunders/Elsevier. pp. 189-
214. 
 58.  Abbas AK, Lichtman AH, Pillav S (2010) Immunological Tolerance. In: Abbas AK, Lichtman AH, Pillav 
S, editors. Cellular and Molecular Immunology. Philadelphia: Saunders/Elsevier. pp. 243-263. 
 59.  Schwartz RH (2003) T cell anergy. Annu Rev Immunol 21: 305-334. 
10.1146/annurev.immunol.21.120601.141110 [doi];120601.141110 [pii]. 
 60.  Fathman CG, Lineberry NB (2007) Molecular mechanisms of CD4+ T-cell anergy. Nat Rev Immunol 7: 
599-609. nri2131 [pii];10.1038/nri2131 [doi]. 
 61.  Abbas AK, Lichtman AH, Pillav S (2010) Effector Mechanisms of Cell-mediated Immunity. In: Abbas 
AK, Lichtman AH, Pillav S, editors. Cellular and Molecular Immunology. Philadelphia: 
Saunders/Elsevier. pp. 303-348. 
 62.  Abbas AK, Lichtman AH, Pillav S (2010) Cytokines. In: Abbas AK, Lichtman AH, Pillav S, editors. 
Cellular and Molecular Immunology. Philadelphia: Saunders/Elsevier. pp. 267-301. 
 63.  Everts B, Smits HH, Hokke CH, Yazdanbakhsh M (2010) Helminths and dendritic cells: sensing and 
regulating via pattern recognition receptors, Th2 and Treg responses. Eur J Immunol 40: 1525-
1537. 10.1002/eji.200940109 [doi]. 
134 
 
 64.  Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA (1997) Interleukin (IL)-6 directs the 
differentiation of IL-4-producing CD4+ T cells. J Exp Med 185: 461-469. 
 65.  Diehl S, Chow CW, Weiss L, Palmetshofer A, Twardzik T, Rounds L, Serfling E, Davis RJ, Anguita J, 
Rincon M (2002) Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 
differentiation. J Exp Med 196: 39-49. 
 66.  Voll RE, Jimi E, Phillips RJ, Barber DF, Rincon M, Hayday AC, Flavell RA, Ghosh S (2000) NF-kappa B 
activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte 
development. Immunity 13: 677-689. S1074-7613(00)00067-4 [pii]. 
 67.  Diehl S, Rincon M (2002) The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39: 531-536. 
S0161589002002109 [pii]. 
 68.  Pletinckx K, Stijlemans B, Pavlovic V, Laube R, Brandl C, Kneitz S, Beschin A, De BP, Lutz MB (2011) 
Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens 
instruct default Th2-cell responses. Eur J Immunol 41: 3479-3494. 10.1002/eji.201141631 [doi]. 
 69.  Abbas AK, Lichtman AH, Pillav S (2010) Immunity to Microbes. In: Abbas AK, Lichtman AH, Pillav S, 
editors. Cellular and Molecular Immunology. Philadelphia: Saunders/Elsevier. pp. 351-373. 
 70.  Abbas AK, Lichtman AH, Pillav S (2010) Effector Mechanisms of Humoral Immunity. In: Abbas AK, 
Lichtman AH, Pillav S, editors. Cellular and Molecular Immunology. Philadelphia: 
Saunders/Elsevier. pp. 321-348. 
 71.  Leech MD, Barr TA, Turner DG, Brown S, O'Connor RA, Gray D, Mellanby RJ, Anderton SM (2013) 
Cutting edge: IL-6-dependent autoimmune disease: dendritic cells as a sufficient, but transient, 
source. J Immunol 190: 881-885. jimmunol.1202925 [pii];10.4049/jimmunol.1202925 [doi]. 
 72.  Li MO, Wan YY, Flavell RA (2007) T cell-produced transforming growth factor-beta1 controls T cell 
tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26: 579-591. S1074-
7613(07)00246-4 [pii];10.1016/j.immuni.2007.03.014 [doi]. 
 73.  Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, Ramos HL, Wei L, Davidson 
TS, Bouladoux N, Grainger JR, Chen Q, Kanno Y, Watford WT, Sun HW, Eberl G, Shevach EM, 
Belkaid Y, Cua DJ, Chen W, O'Shea JJ (2010) Generation of pathogenic T(H)17 cells in the 
absence of TGF-beta signalling. Nature 467: 967-971. nature09447 [pii];10.1038/nature09447 
[doi]. 
 74.  Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA (2006) 
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression 
of antimicrobial peptides. J Exp Med 203: 2271-2279. jem.20061308 [pii];10.1084/jem.20061308 
[doi]. 
 75.  Zhang Z, Zhong W, Spencer D, Chen H, Lu H, Kawaguchi T, Rosenbaum JT (2009) Interleukin-17 causes 
neutrophil mediated inflammation in ovalbumin-induced uveitis in DO11.10 mice. Cytokine 46: 
79-91. S1043-4666(09)00030-1 [pii];10.1016/j.cyto.2008.12.019 [doi]. 
 76.  Dardalhon V, Korn T, Kuchroo VK, Anderson AC (2008) Role of Th1 and Th17 cells in organ-specific 
autoimmunity. J Autoimmun 31: 252-256. S0896-8411(08)00050-4 
[pii];10.1016/j.jaut.2008.04.017 [doi]. 
 77.  Abbas AK, Lichtman AH, Pillav S (2010) Diseases caused by Immune Responses: Hypersensitivity and 
Autoimmunity. In: Abbas AK, Lichtman AH, Pillav S, editors. Cellular and Molecular 
Immunology. Philadelphia: Saunders/Elsevier. pp. 419-439. 
135 
 
 78.  Garrod KR, Moreau HD, Garcia Z, Lemaitre F, Bouvier I, Albert ML, Bousso P (2012) Dissecting T cell 
contraction in vivo using a genetically encoded reporter of apoptosis. Cell Rep 2: 1438-1447. 
S2211-1247(12)00370-1 [pii];10.1016/j.celrep.2012.10.015 [doi]. 
 79.  Schmidt N, Khanolkar A, Harty J (2008) Multigenic mechanisms ensure T cell contraction and prevent 
mortality during persistent infections. FASEB J 22. 
 80.  Henao-Mejia J, Elinav E, Strowig T, Flavell RA (2012) Inflammasomes: far beyond inflammation. Nat 
Immunol 13: 321-324. ni.2257 [pii];10.1038/ni.2257 [doi]. 
 81.  Bohgaki T, Mozo J, Salmena L, Matysiak-Zablocki E, Bohgaki M, Sanchez O, Strasser A, Hakem A, 
Hakem R (2011) Caspase-8 inactivation in T cells increases necroptosis and suppresses 
autoimmunity in Bim-/- mice. J Cell Biol 195: 277-291. jcb.201103053 
[pii];10.1083/jcb.201103053 [doi]. 
 82.  Panneerselvam P, Singh LP, Selvarajan V, Chng WJ, Ng SB, Tan NS, Ho B, Chen J, Ding JL (2013) T-cell 
death following immune activation is mediated by mitochondria-localized SARM. Cell Death 
Differ 20: 478-489. cdd2012144 [pii];10.1038/cdd.2012.144 [doi]. 
 83.  Krammer PH, Arnold R, Lavrik IN (2007) Life and death in peripheral T cells. Nat Rev Immunol 7: 532-
542. nri2115 [pii];10.1038/nri2115 [doi]. 
 84.  Arnold R, Brenner D, Becker M, Frey CR, Krammer PH (2006) How T lymphocytes switch between life 
and death. Eur J Immunol 36: 1654-1658. 10.1002/eji.200636197 [doi]. 
 85.  Brenner D, Krammer PH, Arnold R (2008) Concepts of activated T cell death. Crit Rev Oncol Hematol 66: 
52-64. S1040-8428(08)00013-9 [pii];10.1016/j.critrevonc.2008.01.002 [doi]. 
 86.  Chen M, Wang J (2010) Programmed cell death of dendritic cells in immune regulation. Immunol Rev 236: 
11-27. IMR916 [pii];10.1111/j.1600-065X.2010.00916.x [doi]. 
 87.  Steinman RM (2012) Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 30: 1-
22. 10.1146/annurev-immunol-100311-102839 [doi]. 
 88.  Kushwah R, Oliver JR, Zhang J, Siminovitch KA, Hu J (2009) Apoptotic dendritic cells induce tolerance in 
mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory 
T cells. J Immunol 183: 7104-7118. jimmunol.0900824 [pii];10.4049/jimmunol.0900824 [doi]. 
 89.  Kushwah R, Wu J, Oliver JR, Jiang G, Zhang J, Siminovitch KA, Hu J (2010) Uptake of apoptotic DC 
converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur J 
Immunol 40: 1022-1035. 10.1002/eji.200939782 [doi]. 
 90.  da Costa TB, Sardinha LR, Larocca R, Peron JP, Rizzo LV (2011) Allogeneic apoptotic thymocyte-
stimulated dendritic cells expand functional regulatory T cells. Immunology 133: 123-132. 
10.1111/j.1365-2567.2011.03420.x [doi]. 
 91.  Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, Fioretti MC, Puccetti P (2002) T cell 
apoptosis by tryptophan catabolism. Cell Death Differ 9: 1069-1077. 10.1038/sj.cdd.4401073 
[doi]. 
 92.  Ravishankar B, Liu H, Shinde R, Chandler P, Baban B, Tanaka M, Munn DH, Mellor AL, Karlsson MC, 
McGaha TL (2012) Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase. 
Proc Natl Acad Sci U S A 109: 3909-3914. 1117736109 [pii];10.1073/pnas.1117736109 [doi]. 
136 
 
 93.  Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8: 523-
532. nri2343 [pii];10.1038/nri2343 [doi]. 
 94.  Jonuleit H, Schmitt E (2003) The regulatory T cell family: distinct subsets and their interrelations. J 
Immunol 171: 6323-6327. 
 95.  Mills KH (2004) Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4: 841-855. 
nri1485 [pii];10.1038/nri1485 [doi]. 
 96.  Ramsdell F (2003) Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 19: 165-168. 
S1074761303002073 [pii]. 
 97.  Kushwah R, Hu J (2011) Role of dendritic cells in the induction of regulatory T cells. Cell Biosci 1: 20. 
2045-3701-1-20 [pii];10.1186/2045-3701-1-20 [doi]. 
 98.  Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, 
Hawrylowicz CM, O'Garra A (2002) In vitro generation of interleukin 10-producing regulatory 
CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- 
and Th2-inducing cytokines. J Exp Med 195: 603-616. 
 99.  Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997) A CD4+ T-
cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742. 
10.1038/39614 [doi]. 
 100.  Weiner HL (2001) Induction and mechanism of action of transforming growth factor-beta-secreting Th3 
regulatory cells. Immunol Rev 182: 207-214. 1820117 [pii]. 
 101.  Weiner HL (2001) Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting 
regulatory cells. Microbes Infect 3: 947-954. S1286-4579(01)01456-3 [pii]. 
 102.  Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van LM, Buckner JH, Ziegler SF (2003) Induction of 
FoxP3 and acquisition of T regulatory activity by stimulated human CD4+. J Clin Invest 112: 
1437-1443. 10.1172/JCI19441 [doi];112/9/1437 [pii]. 
 103.  Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM (2003) Conversion of 
peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of 
transcription factor Foxp3. J Exp Med 198: 1875-1886. 10.1084/jem.20030152 
[doi];jem.20030152 [pii]. 
 104.  Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF (2004) Cutting edge: TGF-beta 
induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-
regulation of Smad7. J Immunol 172: 5149-5153. 
 105.  Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, Maeda M, Onodera M, Uchiyama T, 
Fujii S, Sakaguchi S (2004) Crucial role of FOXP3 in the development and function of human 
CD25+CD4+ regulatory T cells. Int Immunol 16: 1643-1656. dxh165 
[pii];10.1093/intimm/dxh165 [doi]. 
 106.  Semple K, Nguyen A, Yu Y, Wang H, Anasetti C, Yu XZ (2011) Strong CD28 costimulation suppresses 
induction of regulatory T cells from naive precursors through Lck signaling. Blood 117: 3096-
3103. blood-2010-08-301275 [pii];10.1182/blood-2010-08-301275 [doi]. 
 107.  Oliveira VG, Caridade M, Paiva RS, Demengeot J, Graca L (2011) Sub-optimal CD4+ T-cell activation 
triggers autonomous TGF-beta-dependent conversion to Foxp3+ regulatory T cells. Eur J 
Immunol 41: 1249-1255. 10.1002/eji.201040896 [doi]. 
137 
 
 108.  Long SA, Rieck M, Tatum M, Bollyky PL, Wu RP, Muller I, Ho JC, Shilling HG, Buckner JH (2011) Low-
dose antigen promotes induction of FOXP3 in human CD4+ T cells. J Immunol 187: 3511-3520. 
jimmunol.1003880 [pii];10.4049/jimmunol.1003880 [doi]. 
 109.  Huber S, Schramm C, Lehr HA, Mann A, Schmitt S, Becker C, Protschka M, Galle PR, Neurath MF, 
Blessing M (2004) Cutting edge: TGF-beta signaling is required for the in vivo expansion and 
immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 173: 6526-6531. 
173/11/6526 [pii]. 
 110.  Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA (2007) IL-2 is essential for TGF-beta to convert naive 
CD4+. J Immunol 178: 2018-2027. 178/4/2018 [pii]. 
 111.  D'Cruz LM, Klein L (2005) Development and function of agonist-induced CD25+Foxp3+ regulatory T 
cells in the absence of interleukin 2 signaling. Nat Immunol 6: 1152-1159. ni1264 
[pii];10.1038/ni1264 [doi]. 
 112.  Bilate AM, Lafaille JJ (2012) Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu Rev 
Immunol 30: 733-758. 10.1146/annurev-immunol-020711-075043 [doi]. 
 113.  Xu L, Kitani A, Strober W (2010) Molecular mechanisms regulating TGF-beta-induced Foxp3 expression. 
Mucosal Immunol 3: 230-238. mi20107 [pii];10.1038/mi.2010.7 [doi]. 
 114.  Kim HJ, Verbinnen B, Tang X, Lu L, Cantor H (2010) Inhibition of follicular T-helper cells by CD8(+) 
regulatory T cells is essential for self tolerance. Nature 467: 328-332. nature09370 
[pii];10.1038/nature09370 [doi]. 
 115.  Singh RP, La CA, Wong M, Ebling F, Hahn BH (2007) CD8+ T cell-mediated suppression of 
autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 
expression. J Immunol 178: 7649-7657. 178/12/7649 [pii]. 
 116.  Leavy O (2010) Regulatory T cells: CD8+ TReg cells join the fold. Nat Rev Immunol 10: 680. 
10.1038/nri2862 [doi]. 
 117.  Bouaziz JD, Le BH, Saussine A, Bensussan A, Bagot M (2012) IL-10 producing regulatory B cells in mice 
and humans: state of the art. Curr Mol Med 12: 519-527. CMM-EPUB-20120127-012 [pii]. 
 118.  Mauri C, Bosma A (2012) Immune regulatory function of B cells. Annu Rev Immunol 30: 221-241. 
10.1146/annurev-immunol-020711-074934 [doi]. 
 119.  Lund FE, Randall TD (2010) Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat 
Rev Immunol 10: 236-247. nri2729 [pii];10.1038/nri2729 [doi]. 
 120.  Peterson RA (2012) Regulatory T-cells: diverse phenotypes integral to immune homeostasis and 
suppression. Toxicol Pathol 40: 186-204. 0192623311430693 [pii];10.1177/0192623311430693 
[doi]. 
 121.  Okuno Y, Murakoshi A, Negita M, Akane K, Kojima S, Suzuki H (2013) CD8(+) CD122(+) regulatory T 
cells contain clonally expanded cells with identical CDR3 sequences of the T cell receptor beta 
chain. Immunology . 10.1111/imm.12067 [doi]. 
 122.  Pletinckx K, Dohler A, Pavlovic V, Lutz MB (2011) Role of dendritic cell maturity/costimulation for 
generation, homeostasis, and suppressive activity of regulatory T cells. Front Immunol 2: 39. 
10.3389/fimmu.2011.00039 [doi]. 
138 
 
 123.  Schmidt SV, Nino-Castro AC, Schultze JL (2012) Regulatory dendritic cells: there is more than just 
immune activation. Front Immunol 3: 274. 10.3389/fimmu.2012.00274 [doi]. 
 124.  Mukhopadhyay S, Pluddemann A, Gordon S (2009) Macrophage pattern recognition receptors in 
immunity, homeostasis and self tolerance. Adv Exp Med Biol 653: 1-14. 
 125.  Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. 
Nat Rev Immunol 9: 162-174. nri2506 [pii];10.1038/nri2506 [doi]. 
 126.  Gourley TS, Wherry EJ, Masopust D, Ahmed R (2004) Generation and maintenance of immunological 
memory. Semin Immunol 16: 323-333. S1044-5323(04)00046-6 [pii];10.1016/j.smim.2004.08.013 
[doi]. 
 127.  Ahmed R, Cyster J, Gray D, Jankovic D, Lamm M, et al. (2008) Dynamics of Adaptive Immunity. In: 
Murphy K, Travers P, Walport M, editors. Janeway´s Immunobiology. New York and London: 
Garland Science, Taylor and Francis Group. pp. 421-458. 
 128.  Pater C, Muller V, Harraga S, Liance M, Godot V, Carbillet JP, Meillet D, Romig T, Vuitton DA (1998) 
Intestinal and systemic humoral immunological events in the susceptible Balb/C mouse strain after 
oral administration of Echinococcus multilocularis eggs. Parasite Immunol 20: 623-629. 
 129.  Gottstein B, Wittwer M, Schild M, Merli M, Leib SL, Muller N, Muller J, Jaggi R (2010) Hepatic gene 
expression profile in mice perorally infected with Echinococcus multilocularis eggs. PLoS One 5: 
e9779. 10.1371/journal.pone.0009779 [doi]. 
 130.  Emery I, Liance M, Deriaud E, Vuitton DA, Houin R, Leclerc C (1996) Characterization of T-cell immune 
responses of Echinococcus multilocularis-infected C57BL/6J mice. Parasite Immunol 18: 463-
472. 
 131.  Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383: 787-
793. 10.1038/383787a0 [doi]. 
 132.  Dražilová S, Kincekova J, Bena M, Zachar M, Svajdler M, Königova A, Janicko M, Jarcuska P (2012) 
Regression of alveolar echinococcosis after chronic viral hepatitis C treatment with pegylated 
interferon alpha-2a. Helminthologia 49: 134-138. 
 133.  Emery I, Leclerc C, Sengphommachanh K, Vuitton DA, Liance M (1998) In vivo treatment with 
recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite 
Immunol 20: 81-91. 
 134.  Godot V, Harraga S, Podoprigora G, Liance M, Bardonnet K, Vuitton DA (2003) IFN alpha-2a protects 
mice against a helminth infection of the liver and modulates immune responses. Gastroenterology 
124: 1441-1450. S0016508503002737 [pii]. 
 135.  Amiot F, Vuong P, Defontaines M, Pater C, Dautry F, Liance M (1999) Secondary alveolar echinococcosis 
in lymphotoxin-alpha and tumour necrosis factor-alpha deficient mice: exacerbation of 
Echinococcus multilocularis larval growth is associated with cellular changes in the periparasitic 
granuloma. Parasite Immunol 21: 475-483. pim245 [pii]. 
 136.  Jenne L, Kilwinski J, Radloff P, Flick W, Kern P (1998) Clinical efficacy of and immunologic alterations 
caused by interferon gamma therapy for alveolar echinococcosis. Clin Infect Dis 26: 492-494. 
 137.  Liance M, Ricard-Blum S, Emery I, Houin R, Vuitton DA (1998) Echinococcus multilocularis infection in 
mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver 
fibrogenesis. Parasite 5: 231-237. 
139 
 
 138.  Rau ME, Tanner CE (1975) BCG suppresses growth and metastasis of hydatid infections. Nature 256: 318-
319. 
 139.  Reuben JM, Tanner CE, Portelance V (1979) Protection of cotton rats against experimental Echinococcus 
multilocularis infections with BCG cell walls. Infect Immun 23: 582-586. 
 140.  Reuben JM, Tanner CE, Rau ME (1978) Immunoprophylaxis with BCG of experimental Echinococcus 
multilocularis infections. Infect Immun 21: 135-139. 
 141.  Harraga S, Godot V, Bresson-Hadni S, Pater C, Beurton I, Bartholomot B, Vuitton DA (1999) Clinical 
efficacy of and switch from T helper 2 to T helper 1 cytokine profile after interferon alpha2a 
monotherapy for human echinococcosis. Clin Infect Dis 29: 205-206. 10.1086/520157 [doi]. 
 142.  Sturm D, Menzel J, Gottstein B, Kern P (1995) Interleukin-5 is the predominant cytokine produced by 
peripheral blood mononuclear cells in alveolar echinococcosis. Infect Immun 63: 1688-1697. 
 143.  Jenne L, Kilwinski J, Scheffold W, Kern P (1997) IL-5 expressed by CD4+ lymphocytes from 
Echinococcus multilocularis-infected patients. Clin Exp Immunol 109: 90-97. 
 144.  Emery I, Liance M, Deriaud E, Vuitton DA, Houin R, Leclerc C (1996) Characterization of T-cell immune 
responses of Echinococcus multilocularis-infected C57BL/6J mice. Parasite Immunol 18: 463-
472. 
 145.  Wei XL, Ding JB, Xu Y, Wen H, Lin RY (2004) [Change of cytokines in mice with Echinococcus 
multilocularis infection]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 22: 
361-364. 
 146.  Vuitton DA, Bresson-Hadni S, Lenys D, Flausse F, Liance M, Wattre P, Miguet JP, Capron A (1988) IgE-
dependent humoral immune response in Echinococcus multilocularis infection: circulating and 
basophil-bound specific IgE against Echinococcus antigens in patients with alveolar 
echinococcosis. Clin Exp Immunol 71: 247-252. 
 147.  Ito K, Horiuchi Y, Kumagai M, Ueda M, Nakamura R, Kawanishi N, Kasai Y (1977) Evaluation of RAST 
as an immunological method for diagnosis of multilocular echinococcosis. Clin Exp Immunol 28: 
407-412. 
 148.  Dessaint JP, Bout D, Wattre P, Capron A (1975) Quantitative determination of specific IgE antibodies to 
Echinococcus granulosus and IgE levels in sera from patients with hydatid disease. Immunology 
29: 813-823. 
 149.  Vuitton DA, Lassegue A, Miguet JP, Herve P, Barale T, Seilles E, Capron A (1984) Humoral and cellular 
immunity in patients with hepatic alveolar echinococcosis. A 2 year follow-up with and without 
flubendazole treatment. Parasite Immunol 6: 329-340. 
 150.  Mejri N, Gottstein B (2009) Echinococcus multilocularis metacestode metabolites contain a cysteine 
protease that digests eotaxin, a CC pro-inflammatory chemokine. Parasitol Res 105: 1253-1260. 
10.1007/s00436-009-1549-z [doi]. 
 151.  Wellinghausen N, Gebert P, Kern P (1999) Interleukin (IL)-4, IL-10 and IL-12 profile in serum of patients 
with alveolar echinococcosis. Acta Trop 73: 165-174. S0001-706X(99)00027-3 [pii]. 
 152.  Mejri N, Hemphill A, Gottstein B (2010) Triggering and modulation of the host-parasite interplay by 
Echinococcus multilocularis: a review. Parasitology 137: 557-568. S0031182009991533 
[pii];10.1017/S0031182009991533 [doi]. 
140 
 
 153.  Vuitton DA, Gottstein B (2010) Echinococcus multilocularis and its intermediate host: a model of parasite-
host interplay. J Biomed Biotechnol 2010: 923193. 10.1155/2010/923193 [doi]. 
 154.  Yang Y, Ellis MK, McManus DP (2012) Immunogenetics of human echinococcosis. Trends Parasitol 28: 
447-454. S1471-4922(12)00141-9 [pii];10.1016/j.pt.2012.08.001 [doi]. 
 155.  Zhang W, Ross AG, McManus DP (2008) Mechanisms of immunity in hydatid disease: implications for 
vaccine development. J Immunol 181: 6679-6685. 181/10/6679 [pii]. 
 156.  Bresson-Hadni S, Liance M, Meyer JP, Houin R, Bresson JL, Vuitton DA (1990) Cellular immunity in 
experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic 
study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin Exp Immunol 82: 
378-383. 
 157.  Kamiya H, Kamiya M, Ohbayashi, Nomura T (1980) Studies on the host resistance to infection with 
Echinococcus multilocularis. I. Difference of susceptibility of various rodents, especially of 
congenitally athymic nude mice. Japanese Journal of Parasitology 29: 87-100. 
 158.  Playford MC, Ooi HK, Oku Y, Kamiya M (1992) Secondary Echinococcus multilocularis infection in 
severe combined immunodeficient (scid) mice: biphasic growth of the larval cyst mass. Int J 
Parasitol 22: 975-982. 
 159.  Zingg W, Renner-Schneiter EC, Pauli-Magnus C, Renner EL, van OJ, Schlapfer E, Weber M, Weber R, 
Opravil M, Gottstein B, Speck RF (2004) Alveolar echinococcosis of the liver in an adult with 
human immunodeficiency virus type-1 infection. Infection 32: 299-302. 
 160.  Sailer M, Soelder B, Allerberger F, Zaknun D, Feichtinger H, Gottstein B (1997) Alveolar echinococcosis 
of the liver in a six-year-old girl with acquired immunodeficiency syndrome. J Pediatr 130: 320-
323. S0022-3476(97)70364-0 [pii]. 
 161.  Dai WJ, Waldvogel A, Siles-Lucas M, Gottstein B (2004) Echinococcus multilocularis proliferation in 
mice and respective parasite 14-3-3 gene expression is mainly controlled by an alphabeta CD4 T-
cell-mediated immune response. Immunology 112: 481-488. 10.1111/j.1365-2567.2004.01885.x 
[doi];IMM1885 [pii]. 
 162.  Vuitton DA, Bresson-Hadni S, Laroche L, Kaiserlian D, Guerret-Stocker S, Bresson JL, Gillet M (1989) 
Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer 
cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients 
with alveolar echinococcosis. Clin Exp Immunol 78: 67-74. 
 163.  Godot V, Harraga S, Deschaseaux M, Bresson-Hadni S, Gottstein B, Emilie D, Vuitton DA (1997) 
Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human 
alveolar echinococcosis. Eur Cytokine Netw 8: 401-408. 
 164.  Kilwinski J, Jenne L, Jellen-Ritter A, Radloff P, Flick W, Kern P (1999) T lymphocyte cytokine profile at a 
single cell level in alveolar Echinococcosis. Cytokine 11: 373-381. S1043-4666(98)90432-X 
[pii];10.1006/cyto.1998.0432 [doi]. 
 165.  Heath DD (1995) Immunology of Echinococcus infections. In: Thompson RCA, Lymbery AJ, editors. The 
biology of Echinococcus and hydatid disease. Wallingford: CAB International. pp. 183-232. 
 166.  Yamamoto M, Vancott JL, Okahashi N, Marinaro M, Kiyono H, Fujihashi K, Jackson RJ, Chatfield SN, 
Bluethmann H, McGhee JR (1996) The role of Th1 and Th2 cells for mucosal IgA responses. Ann 
N Y Acad Sci 778: 64-71. 
141 
 
 167.  Turner JD, Faulkner H, Kamgno J, Cormont F, Van SJ, Else KJ, Grencis RK, Behnke JM, Boussinesq M, 
Bradley JE (2003) Th2 cytokines are associated with reduced worm burdens in a human intestinal 
helminth infection. J Infect Dis 188: 1768-1775. JID30296 [pii];10.1086/379370 [doi]. 
 168.  Zhang S, Hue S, Sene D, Penfornis A, Bresson-Hadni S, Kantelip B, Caillat-Zucman S, Vuitton DA (2008) 
Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and 
transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in 
the tolerance to parasites? J Infect Dis 197: 1341-1349. 10.1086/586709 [doi]. 
 169.  Hubner MP, Manfras BJ, Margos MC, Eiffler D, Hoffmann WH, Schulz-Key H, Kern P, Soboslay PT 
(2006) Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine 
release by peripheral blood mononuclear cells in alveolar echinococcosis patients. Clin Exp 
Immunol 145: 243-251. CEI3142 [pii];10.1111/j.1365-2249.2006.03142.x [doi]. 
 170.  Godot V, Harraga S, Beurton I, Deschaseaux M, Sarciron E, Gottstein B, Vuitton DA (2000) 
Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. 
I. Comparison of patients with progressive and abortive lesions. Clin Exp Immunol 121: 484-490. 
cei1308 [pii]. 
 171.  Alkarmi T, Behbehani K (1989) Echinococcus multilocularis: inhibition of murine neutrophil and 
macrophage chemotaxis. Exp Parasitol 69: 16-22. 0014-4894(89)90166-5 [pii]. 
 172.  Mejri N, Gottstein B (2006) Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects 
CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell 
activation. Parasite Immunol 28: 373-385. PIM836 [pii];10.1111/j.1365-3024.2006.00836.x [doi]. 
 173.  Andrade MA, Siles-Lucas M, Espinoza E, Perez Arellano JL, Gottstein B, Muro A (2004) Echinococcus 
multilocularis laminated-layer components and the E14t 14-3-3 recombinant protein decrease NO 
production by activated rat macrophages in vitro. Nitric Oxide 10: 150-155. 
10.1016/j.niox.2004.03.002 [doi];S1089860304000527 [pii]. 
 174.  Diaz A, Casaravilla C, Allen JE, Sim RB, Ferreira AM (2011) Understanding the laminated layer of larval 
Echinococcus II: immunology. Trends Parasitol 27: 264-273. S1471-4922(11)00021-3 
[pii];10.1016/j.pt.2011.01.008 [doi]. 
 175.  Dai WJ, Hemphill A, Waldvogel A, Ingold K, Deplazes P, Mossmann H, Gottstein B (2001) Major 
carbohydrate antigen of Echinococcus multilocularis induces an immunoglobulin G response 
independent of alphabeta+ CD4+ T cells. Infect Immun 69: 6074-6083. 10.1128/IAI.69.10.6074-
6083.2001 [doi]. 
 176.  Aumuller E, Schramm G, Gronow A, Brehm K, Gibbs BF, Doenhoff MJ, Haas H (2004) Echinococcus 
multilocularis metacestode extract triggers human basophils to release interleukin-4. Parasite 
Immunol 26: 387-395. PIM724 [pii];10.1111/j.0141-9838.2004.00724.x [doi]. 
 177.  Gottstein B, Mesarina B, Tanner I, Ammann RW, Wilson JF, Eckert J, Lanier A (1991) Specific cellular 
and humoral immune responses in patients with different long-term courses of alveolar 
echinococcosis (infection with Echinococcus multilocularis). Am J Trop Med Hyg 45: 734-742. 
 178.  Wen H, Bresson-Hadni S, Vuitton DA, Lenys D, Yang BM, Ding ZX, Craig PS (1995) Analysis of 
immunoglobulin G subclass in the serum antibody responses of alveolar echinococcosis patients 
after surgical treatment and chemotherapy as an aid to assessing the outcome. Trans R Soc Trop 
Med Hyg 89: 692-697. 
142 
 
 179.  Dvoroznakova E, Porubcova J, Sevcikova Z (2009) Immune response of mice with alveolar echinococcosis 
to therapy with transfer factor, alone and in combination with albendazole. Parasitol Res 105: 
1067-1076. 10.1007/s00436-009-1520-z [doi]. 
 180.  McArthur J, Medina E, Mueller A, Chin J, Currie BJ, Sriprakash KS, Talay SR, Chhatwal GS, Walker MJ 
(2004) Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent 
growth and dissemination of Streptococcus pyogenes in a murine skin infection model. Infect 
Immun 72: 7342-7345. 72/12/7342 [pii];10.1128/IAI.72.12.7342-7345.2004 [doi]. 
 181.  Steinman RM (2007) Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the 
immune system. Nat Med 13: 1155-1159. nm1643 [pii];10.1038/nm1643 [doi]. 
 182.  Jenne L, Arrighi JF, Sauter B, Kern P (2001) Dendritic cells pulsed with unfractionated helminthic proteins 
to generate antiparasitic cytotoxic T lymphocyte. Parasite Immunol 23: 195-201. pim374 [pii]. 
 183.  Kizaki T, Kobayashi S, Ogasawara K, Day NK, Good RA, Onoe K (1991) Immune suppression induced by 
protoscoleces of Echinococcus multilocularis in mice. Evidence for the presence of CD8dull 
suppressor cells in spleens of mice intraperitoneally infected with E. multilocularis. J Immunol 
147: 1659-1666. 
 184.  Kizaki T, Ishige M, Bingyan W, Kumagai M, Day NK, Good RA, Onoe K (1993) Interleukin-1-dependent 
mitogenic responses induced by protoscoleces of Echinococcus multilocularis in murine 
lymphocytes. J Leukoc Biol 53: 233-239. 
 185.  Walbaum S, al NS, Gabrion C, Mesnil M, Petavy AF (1994) Echinococcus multilocularis: in vitro 
interactions between protoscolices and Kupffer cells. Parasitol Res 80: 381-387. 
 186.  Spiliotis M, Brehm K (2009) Axenic in vitro cultivation of Echinococcus multilocularis metacestode 
vesicles and the generation of primary cell cultures. Methods Mol Biol 470: 245-262. 
10.1007/978-1-59745-204-5_17 [doi]. 
 187.  Hemphill A, Gottstein B (1995) Immunology and morphology studies on the proliferation of in vitro 
cultivated Echinococcus multilocularis metacestodes. Parasitol Res 81: 605-614. 
 188.  Jura H, Bader A, Hartmann M, Maschek H, Frosch M (1996) Hepatic tissue culture model for study of 
host-parasite interactions in alveolar echinococcosis. Infect Immun 64: 3484-3490. 
 189.  Spiliotis M, Tappe D, Sesterhenn L, Brehm K (2004) Long-term in vitro cultivation of Echinococcus 
multilocularis metacestodes under axenic conditions. Parasitol Res 92: 430-432. 10.1007/s00436-
003-1046-8 [doi]. 
 190.  Spiliotis M, Lechner S, Tappe D, Scheller C, Krohne G, Brehm K (2008) Transient transfection of 
Echinococcus multilocularis primary cells and complete in vitro regeneration of metacestode 
vesicles. Int J Parasitol 38: 1025-1039. S0020-7519(07)00393-1 [pii];10.1016/j.ijpara.2007.11.002 
[doi]. 
 191.  Olson PD, Zarowiecki M, Kiss F, Brehm K (2012) Cestode genomics - progress and prospects for 
advancing basic and applied aspects of flatworm biology. Parasite Immunol 34: 130-150. 
10.1111/j.1365-3024.2011.01319.x [doi]. 
 
 
143 
 
 192.  Tsai IJ, Zarowieski M, Holroyd N, Garciarrubio A, Sanchez-Flores A, Brooks KL, Tracey A, Bobes RJ, 
Fragoso G, Sciutto E, Aslett M, Beasley H, Cai X, Camicia F, Clark R, MC, Desilva N, Day TA, 
Deplazes P, Estrada K, Fernandez C, Holland PWH, Hou J, Hu S, Huckvale T, Hung SS, 
Kamenetzky L, Keane JA, Kiss F, Koziol U, Lambert O, Liu K, Luo X, Macchiaroli N, Nichol S, 
Paps J, Parkinson JN, Pouchkina-Stantcheva N, Riddiford N, Rosenzvit M, Salinas G, Wasmuth 
JD, Zamanian M, Zheng Y, The Taenia solium Genome Consortium, Cai J, Soberon X, Olson PD, 
Laclette JP, Brehm K, Berriman M (2013) The genomes of four tapeworm species reveal 
adaptations to parasitism. Nature . 
 193.  Barnden MJ, Allison J, Heath WR, Carbone FR (1998) Defective TCR expression in transgenic mice 
constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous 
regulatory elements. Immunol Cell Biol 76: 34-40. 10.1046/j.1440-1711.1998.00709.x [doi]. 
 194.  Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE (1992) RAG-1-deficient 
mice have no mature B and T lymphocytes. Cell 68: 869-877. 0092-8674(92)90030-G [pii]. 
 195.  NORMAN L, KAGAN IG (1961) The maintenance of Echinococcus multilocularis in gerbils (Meriones 
unguiculatus) by intraperitoneal inoculation. J Parasitol 47: 870-874. 
 196.  Brehm K, Wolf M, Beland H, Kroner A, Frosch M (2003) Analysis of differential gene expression in 
Echinococcus multilocularis larval stages by means of spliced leader differential display. Int J 
Parasitol 33: 1145-1159. S0020751903001693 [pii]. 
 197.  Hubert K, Cordero E, Frosch M, Solomon F (1999) Activities of the EM10 protein from Echinococcus 
multilocularis in cultured mammalian cells demonstrate functional relationships to ERM family 
members. Cell Motil Cytoskeleton 42: 178-188. 10.1002/(SICI)1097-0169(1999)42:3<178::AID-
CM2>3.0.CO;2-3 [pii];10.1002/(SICI)1097-0169(1999)42:3<178::AID-CM2>3.0.CO;2-3 [doi]. 
 198.  Konrad C, Kroner A, Spiliotis M, Zavala-Gongora R, Brehm K (2003) Identification and molecular 
characterisation of a gene encoding a member of the insulin receptor family in Echinococcus 
multilocularis. Int J Parasitol 33: 301-312. S0020751902002655 [pii]. 
 199.  Abramoff MD, Magalhaes PJ, Ram SJ (2004) Image processing with ImageJ. Biophotonics international 
11: 36-42. 
 200.  Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G (1999) An advanced culture 
method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J 
Immunol Methods 223: 77-92. S0022-1759(98)00204-X [pii]. 
 201.  Zal T, Volkmann A, Stockinger B (1994) Mechanisms of tolerance induction in major histocompatibility 
complex class II-restricted T cells specific for a blood-borne self-antigen. J Exp Med 180: 2089-
2099. 
 202.  Valdez RH, Tonin LT, Ueda-Nakamura T, Dias Filho BP, Morgado-Diaz JA, Sarragiotto MH, Nakamura 
CV (2009) Biological activity of 1,2,3,4-tetrahydro-beta-carboline-3-carboxamides against 
Trypanosoma cruzi. Acta Trop 110: 7-14. S0001-706X(08)00324-0 
[pii];10.1016/j.actatropica.2008.11.008 [doi]. 
 203.  Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE (1992) RAG-1-deficient 
mice have no mature B and T lymphocytes. Cell 68: 869-877. 0092-8674(92)90030-G [pii]. 
 
 
144 
 
 204.  Logan-Klumpler FJ, De SN, Boehme U, Rogers MB, Velarde G, McQuillan JA, Carver T, Aslett M, Olsen 
C, Subramanian S, Phan I, Farris C, Mitra S, Ramasamy G, Wang H, Tivey A, Jackson A, 
Houston R, Parkhill J, Holden M, Harb OS, Brunk BP, Myler PJ, Roos D, Carrington M, Smith 
DF, Hertz-Fowler C, Berriman M (2012) GeneDB--an annotation database for pathogens. Nucleic 
Acids Res 40: D98-108. gkr1032 [pii];10.1093/nar/gkr1032 [doi]. 
 205.  Fiscella M, Perry JW, Teng B, Bloom M, Zhang C, Leung K, Pukac L, Florence K, Concepcion A, Liu B, 
Meng Y, Chen C, Elgin EC, Kanakaraj P, Kaufmann TE, Porter J, Cibotti R, Mei Y, Zhou J, Chen 
G, Roschke V, Komatsoulis G, Mansfield B, Ruben S, Sanyal I, Migone TS (2003) TIP, a T-cell 
factor identified using high-throughput screening increases survival in a graft-versus-host disease 
model. Nat Biotechnol 21: 302-307. 10.1038/nbt797 [doi];nbt797 [pii]. 
 206.  Brehm K, Jensen K, Frosch M (2000) mRNA trans-splicing in the human parasitic cestode Echinococcus 
multilocularis. J Biol Chem 275: 38311-38318. 10.1074/jbc.M006091200 [doi];M006091200 
[pii]. 
 207.  Zhang W, Li J, McManus DP (2003) Concepts in immunology and diagnosis of hydatid disease. Clin 
Microbiol Rev 16: 18-36. 
 208.  Janssen D, de Rycke PH, Osuna A (1993) Dose-dependent effects of hydatid fluid toxins from 
Echinococcus granulosus on mouse peritoneal macrophages. Folia Parasitol (Praha) 40: 109-113. 
 209.  de Rycke PH, Janssen D, Osuna A, Lazuen J (1991) The immunohomeostatic role of hydatid cyst toxins 
(Echinococcus granulosus). Parassitologia 33: 55-60. 
 210.  Annen JM, Kohler P, Eckert J (1981) Cytotoxicity of Echinococcus granulosus cyst fluid in vitro. Z 
Parasitenkd 65: 79-88. 
 211.  Janssen D, Osuna A, Lazuen J, de Rycke PH (1992) Comparative cytotoxicity of secondary hydatid cysts, 
protoscoleces, and in vitro developed microcysts of Echinococcus granulosus. J Helminthol 66: 
124-131. 
 212.  Spotin A, Majdi MM, Sankian M, Varasteh A (2012) The study of apoptotic bifunctional effects in 
relationship between host and parasite in cystic echinococcosis: a new approach to suppression 
and survival of hydatid cyst. Parasitol Res 110: 1979-1984. 10.1007/s00436-011-2726-4 [doi]. 
 213.  Mejri N, Muller J, Gottstein B (2011) Intraperitoneal murine Echinococcus multilocularis infection induces 
differentiation of TGF-beta-expressing DCs that remain immature. Parasite Immunol 33: 471-482. 
10.1111/j.1365-3024.2011.01303.x [doi]. 
 214.  Morelli AE, Thomson AW (2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nat 
Rev Immunol 7: 610-621. nri2132 [pii];10.1038/nri2132 [doi]. 
 215.  Maldonado RA, von Andrian UH (2010) How tolerogenic dendritic cells induce regulatory T cells. Adv 
Immunol 108: 111-165. B978-0-12-380995-7.00004-5 [pii];10.1016/B978-0-12-380995-7.00004-
5 [doi]. 
 216.  Yamazaki S, Inaba K, Tarbell KV, Steinman RM (2006) Dendritic cells expand antigen-specific Foxp3+ 
CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev 212: 314-
329. IMR422 [pii];10.1111/j.0105-2896.2006.00422.x [doi]. 
 217.  Yamazaki S, Patel M, Harper A, Bonito A, Fukuyama H, Pack M, Tarbell KV, Talmor M, Ravetch JV, 
Inaba K, Steinman RM (2006) Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ 
regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci U S 
A 103: 2758-2763. 0510606103 [pii];10.1073/pnas.0510606103 [doi]. 
145 
 
 218.  Fu S, Zhang N, Yopp AC, Chen D, Mao M, Chen D, Zhang H, Ding Y, Bromberg JS (2004) TGF-beta 
induces Foxp3 + T-regulatory cells from CD4 + CD25- precursors. Am J Transplant 4: 1614-
1627. 10.1111/j.1600-6143.2004.00566.x [doi];AJT566 [pii]. 
 219.  Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, 
Henderson WR, Jr., Muller W, Rudensky AY (2008) Regulatory T cell-derived interleukin-10 
limits inflammation at environmental interfaces. Immunity 28: 546-558. S1074-7613(08)00113-1 
[pii];10.1016/j.immuni.2008.02.017 [doi]. 
 220.  Maynard CL, Weaver CT (2008) Diversity in the contribution of interleukin-10 to T-cell-mediated immune 
regulation. Immunol Rev 226: 219-233. IMR711 [pii];10.1111/j.1600-065X.2008.00711.x [doi]. 
 221.  Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, Kronenberg M (2009) Interleukin 10 
acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive 
function in mice with colitis. Nat Immunol 10: 1178-1184. ni.1791 [pii];10.1038/ni.1791 [doi]. 
 222.  Yamashita J, Ohbayashi M, Konno S (1957) Studies on Echinococcosis VI: Secondary Echinococcosis 
multilocularis in Mice. Jpn J Vet Res 5: 197-202. 
 223.  Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W (2008) A critical function for TGF-beta signaling 
in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 9: 632-640. 
ni.1607 [pii];10.1038/ni.1607 [doi]. 
 224.  Dasch JR, Pace DR, Waegell W, Inenaga D, Ellingsworth L (1989) Monoclonal antibodies recognizing 
transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 
affinity purification. J Immunol 142: 1536-1541. 
 225.  Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS (2002) SB-
431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I 
activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74. 
 226.  Freitas TC, Jung E, Pearce EJ (2007) TGF-beta signaling controls embryo development in the parasitic 
flatworm Schistosoma mansoni. PLoS Pathog 3: e52. 06-PLPA-RA-0409R2 
[pii];10.1371/journal.ppat.0030052 [doi]. 
 227.  Kerstin Epping (2011) Molecular analysis of the hormonal host-parasite cross-communication via TGF-
beta cytokines during Alveolar echinococcosis.  [dissertation].  
 228.  Huber S, Stahl FR, Schrader J, Luth S, Presser K, Carambia A, Flavell RA, Werner S, Blessing M, Herkel 
J, Schramm C (2009) Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T 
cells into Foxp3+ induced regulatory T cells. J Immunol 182: 4633-4640. 182/8/4633 
[pii];10.4049/jimmunol.0803143 [doi]. 
 229.  Semitekolou M, Alissafi T, Aggelakopoulou M, Kourepini E, Kariyawasam HH, Kay AB, Robinson DS, 
Lloyd CM, Panoutsakopoulou V, Xanthou G (2009) Activin-A induces regulatory T cells that 
suppress T helper cell immune responses and protect from allergic airway disease. J Exp Med 206: 
1769-1785. jem.20082603 [pii];10.1084/jem.20082603 [doi]. 
 230.  Kingsley DM (1994) The TGF-beta superfamily: new members, new receptors, and new genetic tests of 
function in different organisms. Genes Dev 8: 133-146. 
 231.  Hosaka M, Nagahama M, Kim WS, Watanabe T, Hatsuzawa K, Ikemizu J, Murakami K, Nakayama K 
(1991) Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the 
constitutive secretory pathway. J Biol Chem 266: 12127-12130. 
146 
 
 232.  Herpin A, Lelong C, Favrel P (2004) Transforming growth factor-beta-related proteins: an ancestral and 
widespread superfamily of cytokines in metazoans. Dev Comp Immunol 28: 461-485. 
10.1016/j.dci.2003.09.007 [doi];S0145305X03001812 [pii]. 
 233.  Innis CA, Shi J, Blundell TL (2000) Evolutionary trace analysis of TGF-beta and related growth factors: 
implications for site-directed mutagenesis. Protein Eng 13: 839-847. 
 234.  Manfras BJ, Reuter S, Wendland T, Boehm BO, Kern P (2004) Impeded Th1 CD4 memory T cell 
generation in chronic-persisting liver infection with Echinococcus multilocularis. Int Immunol 16: 
43-50. 
 235.  Mejri N, Muller N, Hemphill A, Gottstein B (2011) Intraperitoneal Echinococcus multilocularis infection 
in mice modulates peritoneal CD4+ and CD8+ regulatory T cell development. Parasitol Int 60: 45-
53. S1383-5769(10)00153-4 [pii];10.1016/j.parint.2010.10.002 [doi]. 
 236.  Springer TA (1997) Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-
propeller domain. Proc Natl Acad Sci U S A 94: 65-72. 
 237.  Emery I, Liance M, Leclerc C (1997) Secondary Echinococcus multilocularis infection in A/J mice: 
delayed metacestode development is associated with Th1 cytokine production. Parasite Immunol 
19: 493-503. 
 238.  Matsumoto J, Muller N, Hemphill A, Oku Y, Kamiya M, Gottstein B (2006) 14-3-3- and II/3-10-gene 
expression as molecular markers to address viability and growth activity of Echinococcus 
multilocularis metacestodes. Parasitology 132: 83-94. S0031182005008632 
[pii];10.1017/S0031182005008632 [doi]. 
 239.  RAUSCH R (1954) Studies on the helminth fauna of Alaska. XX. The histogenesis of the alveolar larva of 
Echinococcus species. J Infect Dis 94: 178-186. 
 240.  Sakamoto T, Sugimura M (1970) [Studies on echinococcosis. 23. Electron microscopical observations on 
histogenesis of larval Echinococcus multilocularis]. Jpn J Vet Res 18: 131-144. 
 241.  DeGaffe G, Loker ES (1998) Susceptibility of Biomphalaria glabrata to infection with Echinostoma 
paraensei: correlation with the effect of parasite secretory-excretory products on host hemocyte 
spreading. J Invertebr Pathol 71: 64-72. S0022-2011(97)94710-8 [pii];10.1006/jipa.1997.4710 
[doi]. 
 242.  Serradell MC, Guasconi L, Cervi L, Chiapello LS, Masih DT (2007) Excretory-secretory products from 
Fasciola hepatica induce eosinophil apoptosis by a caspase-dependent mechanism. Vet Immunol 
Immunopathol 117: 197-208. S0165-2427(07)00089-X [pii];10.1016/j.vetimm.2007.03.007 [doi]. 
 243.  Shin MH, Seoh JY, Park HY, Kita H (2003) Excretory-secretory products secreted by Paragonimus 
westermani delay the spontaneous cell death of human eosinophils through autocrine production 
of GM-CSF. Int Arch Allergy Immunol 132: 48-57. 73264 [doi];73264 [pii]. 
 244.  Zahoor Z, Davies AJ, Kirk RS, Rollinson D, Walker AJ (2010) Larval excretory-secretory products from 
the parasite Schistosoma mansoni modulate HSP70 protein expression in defence cells of its snail 
host, Biomphalaria glabrata. Cell Stress Chaperones 15: 639-650. 10.1007/s12192-010-0176-z 
[doi]. 
 245.  Macintyre AR, Dixon JB, Green JR (2001) Mitosis and differentiation in T-cells under cytotoxic action of 
Echinococcus granulosus hydatid fluid. Vet Parasitol 96: 277-289. S0304401701003843 [pii]. 
147 
 
 246.  Gabrion C, Walbaum S, al NS, Mesnil M, Petavy AF (1995) Echinococcus multilocularis protoscoleces 
and hepatic cell activity in vitro. Int J Parasitol 25: 127-130. 0020-7519(94)00086-4 [pii]. 
 247.  Kizaki T, Ishige M, Kobayashi S, Bingyan W, Kumagai M, Day NK, Good RA, Onoe K (1993) 
Suppression of T-cell proliferation by CD8+ T cells induced in the presence of protoscolices of 
Echinococcus multilocularis in vitro. Infect Immun 61: 525-533. 
 248.  Kizaki T, Ishige M, Bingyan W, Day NK, Good RA, Onoe K (1993) Generation of CD8+ suppressor T 
cells by protoscoleces of Echinococcus multilocularis in vitro. Immunology 79: 412-417. 
 249.  Cox DA, Marshall-Clarke S, Dixon JB (1989) Activation of normal murine B cells by Echinococcus 
granulosus. Immunology 67: 16-20. 
 250.  Semnani RT, Liu AY, Sabzevari H, Kubofcik J, Zhou J, Gilden JK, Nutman TB (2003) Brugia malayi 
microfilariae induce cell death in human dendritic cells, inhibit their ability to make IL-12 and IL-
10, and reduce their capacity to activate CD4+ T cells. J Immunol 171: 1950-1960. 
 251.  Semnani RT, Venugopal PG, Mahapatra L, Skinner JA, Meylan F, Chien D, Dorward DW, Chaussabel D, 
Siegel RM, Nutman TB (2008) Induction of TRAIL- and TNF-alpha-dependent apoptosis in human 
monocyte-derived dendritic cells by microfilariae of Brugia malayi.  J Immunol 181: 7081-7089. 
181/10/7081 [pii]. 
 252.  Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating 
mammalian biology. Cell 104: 487-501. S0092-8674(01)00237-9 [pii]. 
 253.  Nat R, Radu E, Regalia T, Popescu LM (2002) Apoptosis in the immune system: 1. Fas-induced apoptosis 
in monocytes-derived human dendritic cells. J Cell Mol Med 6: 223-234. 006.002.07 [pii]. 
 254.  Chen A, Xu H, Choi Y, Wang B, Zheng G (2004) TRANCE counteracts FasL-mediated apoptosis of 
murine bone marrow-derived dendritic cells. Cell Immunol 231: 40-48. S0008-8749(04)00183-2 
[pii];10.1016/j.cellimm.2004.11.005 [doi]. 
 255.  Matsue H, Takashima A (1999) Apoptosis in dendritic cell biology. J Dermatol Sci 20: 159-171. 
S0923181198000784 [pii]. 
 256.  Brokaw JJ, White GW, Baluk P, Anderson GP, Umemoto EY, McDonald DM (1998) Glucocorticoid-
induced apoptosis of dendritic cells in the rat tracheal mucosa. Am J Respir Cell Mol Biol 19: 
598-605. 
 257.  Hoetzenecker W, Meingassner JG, Ecker R, Stingl G, Stuetz A, Elbe-Burger A (2004) Corticosteroids but 
not pimecrolimus affect viability, maturation and immune function of murine epidermal 
Langerhans cells. J Invest Dermatol 122: 673-684. 10.1111/j.0022-202X.2004.22324.x 
[doi];JID22324 [pii]. 
 258.  Abe M, Thomson AW (2006) Dexamethasone preferentially suppresses plasmacytoid dendritic cell 
differentiation and enhances their apoptotic death. Clin Immunol 118: 300-306. S1521-
6616(05)00330-X [pii];10.1016/j.clim.2005.09.019 [doi]. 
 259.  Fernandez Presas AM, Valdez RA, Willms K, Romano MC (2008) The key steroidogenic enzyme 3beta-
hydroxysteroid dehydrogenase in Taenia solium and Taenia crassiceps (WFU). Parasitol Res 103: 
847-852. 10.1007/s00436-008-1066-5 [doi]. 
 260.  Valdez RA, Hinojosa L, Gomez Y, Willms K, Romano MC (2012) Taenia crassiceps WFU cysticerci 
synthesize corticosteroids in vitro: metyrapone regulates the production. Gen Comp Endocrinol 
176: 409-414. S0016-6480(12)00040-8 [pii];10.1016/j.ygcen.2012.01.015 [doi]. 
148 
 
 261.  Kane CM, Jung E, Pearce EJ (2008) Schistosoma mansoni egg antigen-mediated modulation of Toll-like 
receptor (TLR)-induced activation occurs independently of TLR2, TLR4, and MyD88. Infect 
Immun 76: 5754-5759. IAI.00497-08 [pii];10.1128/IAI.00497-08 [doi]. 
 262.  Massacand JC, Stettler RC, Meier R, Humphreys NE, Grencis RK, Marsland BJ, Harris NL (2009) 
Helminth products bypass the need for TSLP in Th2 immune responses by directly modulating 
dendritic cell function. Proc Natl Acad Sci U S A 106: 13968-13973. 0906367106 
[pii];10.1073/pnas.0906367106 [doi]. 
 263.  Terrazas CA, Sanchez-Munoz F, Mejia-Dominguez AM, Amezcua-Guerra LM, Terrazas LI, Bojalil R, 
Gomez-Garcia L (2011) Cestode antigens induce a tolerogenic-like phenotype and inhibit LPS 
inflammatory responses in human dendritic cells. Int J Biol Sci 7: 1391-1400. 
 264.  Kuijk LM, Klaver EJ, Kooij G, van der Pol SM, Heijnen P, Bruijns SC, Kringel H, Pinelli E, Kraal G, de 
Vries HE, Dijkstra CD, Bouma G, van D, I (2012) Soluble helminth products suppress clinical 
signs in murine experimental autoimmune encephalomyelitis and differentially modulate human 
dendritic cell activation. Mol Immunol 51: 210-218. S0161-5890(12)00196-4 
[pii];10.1016/j.molimm.2012.03.020 [doi]. 
 265.  Howard M, O'Garra A (1992) Biological properties of interleukin 10. Immunol Today 13: 198-200. 0167-
5699(92)90153-X [pii];10.1016/0167-5699(92)90153-X [doi]. 
 266.  Rigano R, Buttari B, Profumo E, Ortona E, Delunardo F, Margutti P, Mattei V, Teggi A, Sorice M, 
Siracusano A (2007) Echinococcus granulosus antigen B impairs human dendritic cell 
differentiation and polarizes immature dendritic cell maturation towards a Th2 cell response. 
Infect Immun 75: 1667-1678. IAI.01156-06 [pii];10.1128/IAI.01156-06 [doi]. 
 267.  Kanan JH, Chain BM (2006) Modulation of dendritic cell differentiation and cytokine secretion by the 
hydatid cyst fluid of Echinococcus granulosus. Immunology 118: 271-278. IMM2375 
[pii];10.1111/j.1365-2567.2006.02375.x [doi]. 
 268.  D'Elia R, Else KJ (2009) In vitro antigen presenting cell-derived IL-10 and IL-6 correlate with Trichuris 
muris isolate-specific survival. Parasite Immunol 31: 123-131. PIM1088 [pii];10.1111/j.1365-
3024.2008.01088.x [doi]. 
 269.  Hartmann S, Lucius R (2003) Modulation of host immune responses by nematode cystatins. Int J Parasitol 
33: 1291-1302. S0020751903001632 [pii]. 
 270.  Chung EY, Kim SJ, Ma XJ (2006) Regulation of cytokine production during phagocytosis of apoptotic 
cells. Cell Res 16: 154-161. 7310021 [pii];10.1038/sj.cr.7310021 [doi]. 
 271.  Terrazas CA, Terrazas LI, Gomez-Garcia L (2010) Modulation of dendritic cell responses by parasites: a 
common strategy to survive. J Biomed Biotechnol 2010: 357106. 10.1155/2010/357106 [doi]. 
 272.  Matsuhisa T (1996) [The mechanism of distant metastases of alveolar hydatid disease]. Hokkaido Igaku 
Zasshi 71: 369-376. 
 273.  Yamaguchi Y, Tsumura H, Miwa M, Inaba K (1997) Contrasting effects of TGF-beta 1 and TNF-alpha on 
the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells 15: 144-
153. 10.1002/stem.150144 [doi]. 
 274.  Strobl H, Knapp W (1999) TGF-beta1 regulation of dendritic cells. Microbes Infect 1: 1283-1290. S1286-
4579(99)00256-7 [pii]. 
149 
 
 275.  Tada Y, Asahina A, Fujita H, Mitsui H, Torii H, Watanabe T, Tamaki K (2004) Differential effects of LPS 
and TGF-beta on the production of IL-6 and IL-12 by Langerhans cells, splenic dendritic cells, 
and macrophages. Cytokine 25: 155-161. 
 276.  Li T, Zhao JM, Zhang Y, Pai ZL, Zhang W, Tuxun TH, Bai L, Wu J, Wen H (2011) Suppression of acute 
rejective response following orthotopic liver transplantation in experimental rats infected with 
Echinococcus multilocularis. Chin Med J (Engl ) 124: 2818-2823. 
 277.  Ai Erken MH, Zhao JM, Guan XY, Wen H, Wang YH (2012) Immune responses on allograft heart 
transplantation in inbred rats infected with Echinococcosis multilocularis. Chin Med J (Engl ) 125: 
4412-4417. 
 278.  Hernandez JL, Leung G, McKay DM (2013) Cestode regulation of inflammation and inflammatory 
diseases. Int J Parasitol 43: 233-243. S0020-7519(12)00228-7 [pii];10.1016/j.ijpara.2012.09.005 
[doi]. 
 279.  Maizels R, Wiedermann U (2009) Immunoregulation by microbes and parasites in the control of allergy 
and autoimmunity. In: Rook G, editors. The Hygiene Hypothesis and Darwinian Medicine. 
Birkh+ñuser Basel. pp. 45-75. 
 280.  Whelan M, Harnett MM, Houston KM, Patel V, Harnett W, Rigley KP (2000) A filarial nematode-secreted 
product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J 
Immunol 164: 6453-6460. ji_v164n12p6453 [pii]. 
 281.  Goodridge HS, Marshall FA, Wilson EH, Houston KM, Liew FY, Harnett MM, Harnett W (2004) In vivo 
exposure of murine dendritic cell and macrophage bone marrow progenitors to the 
phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation 
to an anti-inflammatory phenotype. Immunology 113: 491-498. IMM1993 [pii];10.1111/j.1365-
2567.2004.01993.x [doi]. 
 282.  Segura M, Su Z, Piccirillo C, Stevenson MM (2007) Impairment of dendritic cell function by excretory-
secretory products: a potential mechanism for nematode-induced immunosuppression. Eur J 
Immunol 37: 1887-1904. 10.1002/eji.200636553 [doi]. 
 283.  MacDonald AS, Straw AD, Bauman B, Pearce EJ (2001) CD8- dendritic cell activation status plays an 
integral role in influencing Th2 response development. J Immunol 167: 1982-1988. 
 284.  Kane CM, Cervi L, Sun J, McKee AS, Masek KS, Shapira S, Hunter CA, Pearce EJ (2004) Helminth 
antigens modulate TLR-initiated dendritic cell activation. J Immunol 173: 7454-7461. 
173/12/7454 [pii]. 
 285.  Gomez-Escobar N, Gregory WF, Maizels RM (2000) Identification of tgh-2, a filarial nematode homolog 
of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in 
microfilarial and adult stages of Brugia malayi. Infect Immun 68: 6402-6410. 
 286.  Grainger JR, Smith KA, Hewitson JP, McSorley HJ, Harcus Y, Filbey KJ, Finney CA, Greenwood EJ, 
Knox DP, Wilson MS, Belkaid Y, Rudensky AY, Maizels RM (2010) Helminth secretions induce 
de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. J Exp 
Med 207: 2331-2341. jem.20101074 [pii];10.1084/jem.20101074 [doi]. 
 287.  Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N (2000) Consequences of cell 
death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the 
maturation of immunostimulatory dendritic cells. J Exp Med 191: 423-434. 
150 
 
 288.  Stuart LM, Lucas M, Simpson C, Lamb J, Savill J, Lacy-Hulbert A (2002) Inhibitory effects of apoptotic 
cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol 168: 1627-
1635. 
 289.  Mamuti W, Sako Y, Xiao N, Nakaya K, Nakao M, Yamasaki H, Lightowlers MW, Craig PS, Ito A (2006) 
Echinococcus multilocularis: developmental stage-specific expression of Antigen B 8-kDa-
subunits. Exp Parasitol 113: 75-82. S0014-4894(05)00323-1 [pii];10.1016/j.exppara.2005.12.007 
[doi]. 
 290.  Mamuti W, Sako Y, Nakao M, Xiao N, Nakaya K, Ishikawa Y, Yamasaki H, Lightowlers MW, Ito A 
(2006) Recent advances in characterization of Echinococcus antigen B. Parasitol Int 55 Suppl: 
S57-S62. S1383-5769(05)00111-X [pii];10.1016/j.parint.2005.11.008 [doi]. 
 291.  Oriol R, Williams JF, Perez Esandi MV, Oriol C (1971) Purification of lipoprotein antigens of 
Echinococcus granulosus from sheep hydatid fluid. Am J Trop Med Hyg 20: 569-574. 
 292.  Pulendran B, Tang H, Manicassamy S (2010) Programming dendritic cells to induce T(H)2 and tolerogenic 
responses. Nat Immunol 11: 647-655. ni.1894 [pii];10.1038/ni.1894 [doi]. 
 293.  Pulendran B (2004) Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen 
recognition receptors. Immunol Res 29: 187-196. IR:29:1-3:187 [pii];10.1385/IR:29:1-3:187 [doi]. 
 294.  Maldonado-Lopez R, Maliszewski C, Urbain J, Moser M (2001) Cytokines regulate the capacity of 
CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol 167: 
4345-4350. 
 295.  Josefowicz SZ, Lu LF, Rudensky AY (2012) Regulatory T cells: mechanisms of differentiation and 
function. Annu Rev Immunol 30: 531-564. 10.1146/annurev.immunol.25.022106.141623 [doi]. 
 296.  Taams LS, Akbar AN (2005) Peripheral generation and function of CD4+CD25+ regulatory T cells. Curr 
Top Microbiol Immunol 293: 115-131. 
 297.  Yadav M, Louvet C, Davini D, Gardner JM, Martinez-Llordella M, Bailey-Bucktrout S, Anthony BA, 
Sverdrup FM, Head R, Kuster DJ, Ruminski P, Weiss D, Von SD, Bluestone JA (2012) 
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell 
subsets in vivo. J Exp Med 209: 1713-1719. jem.20120822 [pii];10.1084/jem.20120822 [doi]. 
 298.  Blankenhaus B, Klemm U, Eschbach ML, Sparwasser T, Huehn J, Kuhl AA, Loddenkemper C, Jacobs T, 
Breloer M (2011) Strongyloides ratti infection induces expansion of Foxp3+ regulatory T cells 
that interfere with immune response and parasite clearance in BALB/c mice. J Immunol 186: 
4295-4305. jimmunol.1001920 [pii];10.4049/jimmunol.1001920 [doi]. 
 299.  Taylor MD, van der Werf N, Harris A, Graham AL, Bain O, Allen JE, Maizels RM (2009) Early 
recruitment of natural CD4+ Foxp3+ Treg cells by infective larvae determines the outcome of 
filarial infection. Eur J Immunol 39: 192-206. 10.1002/eji.200838727 [doi]. 
 300.  Rausch S, Huehn J, Kirchhoff D, Rzepecka J, Schnoeller C, Pillai S, Loddenkemper C, Scheffold A, 
Hamann A, Lucius R, Hartmann S (2008) Functional analysis of effector and regulatory T cells in 
a parasitic nematode infection. Infect Immun 76: 1908-1919. IAI.01233-07 
[pii];10.1128/IAI.01233-07 [doi]. 
 301.  Taylor MD, LeGoff L, Harris A, Malone E, Allen JE, Maizels RM (2005) Removal of regulatory T cell 
activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol 
174: 4924-4933. 174/8/4924 [pii]. 
151 
 
 302.  Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, 
Sparwasser T (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like 
disease. J Exp Med 204: 57-63. jem.20061852 [pii];10.1084/jem.20061852 [doi]. 
 303.  Lahl K, Sparwasser T (2011) In vivo depletion of FoxP3+ Tregs using the DEREG mouse model. Methods 
Mol Biol 707: 157-172. 10.1007/978-1-61737-979-6_10 [doi]. 
 304.  Zaccone P, Burton OT, Gibbs SE, Miller N, Jones FM, Schramm G, Haas H, Doenhoff MJ, Dunne DW, 
Cooke A (2011) The S. mansoni glycoprotein omega-1 induces Foxp3 expression in NOD mouse 
CD4(+) T cells. Eur J Immunol 41: 2709-2718. 10.1002/eji.201141429 [doi]. 
 305.  Brunner AM, Lioubin MN, Marquardt H, Malacko AR, Wang WC, Shapiro RA, Neubauer M, Cook J, 
Madisen L, Purchio AF (1992) Site-directed mutagenesis of glycosylation sites in the transforming 
growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within 
mature TGF beta 1: effects on secretion and bioactivity. Mol Endocrinol 6: 1691-1700. 
 306.  Antenos M, Stemler M, Boime I, Woodruff TK (2007) N-linked oligosaccharides direct the differential 
assembly and secretion of inhibin alpha- and betaA-subunit dimers. Mol Endocrinol 21: 1670-
1684. me.2007-0050 [pii];10.1210/me.2007-0050 [doi]. 
 307.  Xia Y, Schneyer AL (2009) The biology of activin: recent advances in structure, regulation and function. J 
Endocrinol 202: 1-12. JOE-08-0549 [pii];10.1677/JOE-08-0549 [doi]. 
 308.  Hashimoto O, Nakamura T, Shoji H, Shimasaki S, Hayashi Y, Sugino H (1997) A novel role of follistatin, 
an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic 
degradation of activin and its acceleration by follistatin associated with cell-surface heparan 
sulfate. J Biol Chem 272: 13835-13842. 
 309.  de Winter JP, ten DP, de Vries CJ, van Achterberg TA, Sugino H, de WP, Huylebroeck D, Verschueren K, 
van den Eijnden-van Raaij AJ (1996) Follistatins neutralize activin bioactivity by inhibition of 
activin binding to its type II receptors. Mol Cell Endocrinol 116: 105-114. 0303720795037055 
[pii]. 
 310.  Segerer SE, Muller N, Brandt J, Kapp M, Dietl J, Reichardt HM, Rieger L, Kammerer U (2008) The 
glycoprotein-hormones activin A and inhibin A interfere with dendritic cell maturation. Reprod 
Biol Endocrinol 6: 17. 1477-7827-6-17 [pii];10.1186/1477-7827-6-17 [doi]. 
 311.  Derdak SV, Kueng HJ, Leb VM, Neunkirchner A, Schmetterer KG, Bielek E, Majdic O, Knapp W, Seed B, 
Pickl WF (2006) Direct stimulation of T lymphocytes by immunosomes: virus-like particles 
decorated with T cell receptor/CD3 ligands plus costimulatory molecules. Proc Natl Acad Sci U S 
A 103: 13144-13149. 0602283103 [pii];10.1073/pnas.0602283103 [doi]. 
 312.  Lu L, Ma J, Wang X, Wang J, Zhang F, Yu J, He G, Xu B, Brand DD, Horwitz DA, Shi W, Zheng SG 
(2010) Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg. Eur 
J Immunol 40: 142-152. 10.1002/eji.200939618 [doi]. 
 313.  Bauder B, Auer H, Schilcher F, Gabler C, Romig T, Bilger B, Aspock H (1999) Experimental 
investigations on the B and T cell immune response in primary alveolar echinococcosis. Parasite 
Immunol 21: 409-421. pim241 [pii]. 
 314.  Harraga S, Godot V, Bresson-Hadni S, Mantion G, Vuitton DA (2003) Profile of cytokine production 
within the periparasitic granuloma in human alveolar echinococcosis. Acta Trop 85: 231-236. 
S0001706X02002188 [pii]. 
152 
 
 315.  Huber S, Schrader J, Fritz G, Presser K, Schmitt S, Waisman A, Luth S, Blessing M, Herkel J, Schramm C 
(2008) P38 MAP kinase signaling is required for the conversion of CD4+CD25- T cells into iTreg. 
PLoS One 3: e3302. 10.1371/journal.pone.0003302 [doi]. 
 316.  Velling T, Kusche-Gullberg M, Sejersen T, Gullberg D (1999) cDNA cloning and chromosomal 
localization of human alpha(11) integrin. A collagen-binding, I domain-containing, beta(1)-
associated integrin alpha-chain present in muscle tissues. J Biol Chem 274: 25735-25742. 
 317.  Steck E, Braun J, Pelttari K, Kadel S, Kalbacher H, Richter W (2007) Chondrocyte secreted CRTAC1: a 
glycosylated extracellular matrix molecule of human articular cartilage. Matrix Biol 26: 30-41. 
S0945-053X(06)00369-6 [pii];10.1016/j.matbio.2006.09.006 [doi]. 
 318.  Brizzi MF, Tarone G, Defilippi P (2012) Extracellular matrix, integrins, and growth factors as tailors of the 
stem cell niche. Curr Opin Cell Biol 24: 645-651. S0955-0674(12)00102-0 
[pii];10.1016/j.ceb.2012.07.001 [doi]. 
 319.  Ramos JW, Whittaker CA, DeSimone DW (1996) Integrin-dependent adhesive activity is spatially 
controlled by inductive signals at gastrulation. Development 122: 2873-2883. 
 320.  Na J, Marsden M, DeSimone DW (2003) Differential regulation of cell adhesive functions by integrin 
alpha subunit cytoplasmic tails in vivo. J Cell Sci 116: 2333-2343. 10.1242/jcs.00445 
[doi];jcs.00445 [pii]. 
 321.  Baneres JL, Roquet F, Martin A, Parello J (2000) A minimized human integrin alpha(5)beta(1) that retains 
ligand recognition. J Biol Chem 275: 5888-5903. 
 322.  Baneres JL, Roquet F, Green M, LeCalvez H, Parello J (1998) The cation-binding domain from the alpha 
subunit of integrin alpha5 beta1 is a minimal domain for fibronectin recognition. J Biol Chem 273: 
24744-24753. 
 323.  Kamata T, Tieu KK, Irie A, Springer TA, Takada Y (2001) Amino acid residues in the alpha IIb subunit 
that are critical for ligand binding to integrin alpha IIbbeta 3 are clustered in the beta-propeller 
model. J Biol Chem 276: 44275-44283. 10.1074/jbc.M107021200 [doi];M107021200 [pii]. 
 324.  Hayashi Y, Furue MK, Okamoto T, Ohnuma K, Myoishi Y, Fukuhara Y, Abe T, Sato JD, Hata R, 
Asashima M (2007) Integrins regulate mouse embryonic stem cell self-renewal. Stem Cells 25: 
3005-3015. 2007-0103 [pii];10.1634/stemcells.2007-0103 [doi]. 
 325.  Ellis SJ, Tanentzapf G (2010) Integrin-mediated adhesion and stem-cell-niche interactions. Cell Tissue Res 
339: 121-130. 10.1007/s00441-009-0828-4 [doi]. 
 326.  O'Reilly AM, Lee HH, Simon MA (2008) Integrins control the positioning and proliferation of follicle stem 
cells in the Drosophila ovary. J Cell Biol 182: 801-815. jcb.200710141 
[pii];10.1083/jcb.200710141 [doi]. 
 327.  Ali-Khan Z, Siboo R, Gomersall M, Faucher M (1983) Cystolytic events and the possible role of germinal 
cells in metastasis in chronic alveolar hydatidosis. Ann Trop Med Parasitol 77: 497-512. 
 328.  Woof JM, Mestecky J (2005) Mucosal immunoglobulins. Immunol Rev 206: 64-82. IMR290 
[pii];10.1111/j.0105-2896.2005.00290.x [doi]. 
 329.  Dang Z, Yagi K, Oku Y, Kouguchi H, Kajino K, Matsumoto J, Nakao R, Wakaguri H, Toyoda A, Yin H, 
Sugimoto C (2012) A pilot study on developing mucosal vaccine against alveolar echinococcosis 
(AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology. PLoS Negl Trop Dis 6: 
e1570. 10.1371/journal.pntd.0001570 [doi];PNTD-D-11-01156 [pii]. 
153 
 
 330.  Dang Z, Feng J, Yagi K, Sugimoto C, Li W, Oku Y (2012) Mucosal adjuvanticity of fibronectin-binding 
peptide (FBP) fused with Echinococcus multilocularis tetraspanin 3: systemic and local antibody 
responses. PLoS Negl Trop Dis 6: e1842. 10.1371/journal.pntd.0001842 [doi];PNTD-D-12-00476 
[pii]. 
 331.  Rausch RL, Wilson JF, Schantz PM, McMahon BJ (1987) Spontaneous death of Echinococcus 
multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. Am J 
Trop Med Hyg 36: 576-585. 
 332.  Romig T, Kratzer W, Kimmig P, Frosch M, Gaus W, Flegel WA, Gottstein B, Lucius R, Beckh K, Kern P 
(1999) An epidemiologic survey of human alveolar echinococcosis in southwestern Germany. 
Romerstein Study Group. Am J Trop Med Hyg 61: 566-573. 
 333.  Bresson-Hadni S, Laplante JJ, Lenys D, Rohmer P, Gottstein B, Jacquier P, Mercet P, Meyer JP, Miguet 
JP, Vuitton DA (1994) Seroepidemiologic screening of Echinococcus multilocularis infection in a 
European area endemic for alveolar echinococcosis. Am J Trop Med Hyg 51: 837-846. 
 334.  Yang YR, Sun T, Li Z, Zhang J, Teng J, Liu X, Liu R, Zhao R, Jones MK, Wang Y, Wen H, Feng X, Zhao 
Q, Zhao Y, Shi D, Bartholomot B, Vuitton DA, Pleydell D, Giraudoux P, Ito A, Danson MF, 
Boufana B, Craig PS, Williams GM, McManus DP (2006) Community surveys and risk factor 
analysis of human alveolar and cystic echinococcosis in Ningxia Hui Autonomous Region, China. 
Bull World Health Organ 84: 714-721. S0042-96862006000900014 [pii]. 
 335.  Steinman RM (2007) Dendritic cells: understanding immunogenicity. Eur J Immunol 37 Suppl 1: S53-S60. 
10.1002/eji.200737400 [doi]. 
 336.  Kato N, Nonaka N, Oku Y, Kamiya M (2005) Immune responses to oral infection with Echinococcus 
multilocularis protoscoleces in gerbils: modified lymphocyte responses due to the parasite antigen. 
Parasitol Res 96: 12-17. 10.1007/s00436-005-1307-9 [doi]. 
 
 
 
 
 
 
 
 
 
 
 
154 
 
6. SUPPLEMENTARY  FIGURES 
 
 
 
 
 
 
Supplementary Figure 1: Domains of the Echinococcus multilocularis putative Tumour 
Necrosis Factor Receptor in comparison to other functionally characterized TNFRs. Shown 
is a putative secreted TNFR retrieved from the genome sequencing project of Echinococcus multilocularis 
(EmuJ_000990500) in comparison to other membrane bound and soluble TNFRs functionally characterized. The 
domains were identified in sillico using SMART (http://smart.embl-heidelberg.de/).  
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Supplementary Figure 2: Echinococcus multilocularis Cystatins in comparison to other 
functionally characterized cystatins (cysteine protease inhibitors). Shown are three experimentally 
identified cystatins of Echinococcus multilocularis structurally clustered with functionally characterized cystatins. 
EmCYS1 (EmuJ_000159200) is shown as a stefin or intracellular cystatin. EmCYS2 appears a type 2 secreted 
cystatin whereas EmCYS3 (EmuJ_000849600) is an atypical type 3 multidomain cystatin. The domains were 
identified in sillico using SMART (http://smart.embl-heidelberg.de/).  
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Supplementary Figure 3: Echinococcus multilocularis bone morphogenetic proteins. Shown 
are two experimentally identified BMPs of Echinococcus multilocularis structurally related to the functionally 
characterized human BMP-2 and BMP-4. EmBMP-1a (EmuJ_000181200) is shown as primarily related to Human 
BMP-4 whereas EmBMP-2c (EmuJ_000460200) relates to Human BMP-2 as per reciprocal BLAST analysis 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). S. mansoni BMP-like protein is also depicted illustrating the possibility of 
secretion despite the absence of a N terminal signal sequence. The domains were identified in sillico by SMART 
analysis (http://smart.embl-heidelberg.de/).  
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Supplementary Figure 4: Echinococcus multilocularis T2- Ribonuclease or Omega-1 
orthologue. The domains were identified in sillico by SMART analysis (http://smart.embl-heidelberg.de/).  
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Supplementary Figure 5: Expression and secretion of EmACT by in vitro cultivated larvae 
of E. multilocularis. Shown in A is the level of EmACT expression within the parasite larvae lysates suggesting 
a complex post translational modification in a stage-specific manner. In B is depicted the detection of EmACT in the 
parasite secretions (PC: primary cells; MV: metacestode vesicles; Pro: protoscoleces) revealing EmACT secretion 
by all larvae in differently processed forms. PS: single experiment.  
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Supplementary Figure 6: Echinococcus multilocularis putative Follistatins.  Shown are E. 
multilocularis Follistatins i.e EmFST1 (EmuJ_000278400) and EmFST2 (Emu-J000189700) as referenced to 
Human follistatin or activin A inhibitor. The domains were identified in sillico by SMART analysis 
(http://smart.embl-heidelberg.de/).  
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7. LIST OF ABBREVIATIONS 
 
7-AAD 7-Amino-actinomycin D 
aa amino acid 
Ab Antibodies 
ABZ Albendazole 
AE  Alveolar Echinococcosis 
Ag Antigen 
ALK Activin receptor-like kinase 
APC Antigen-presenting Cell 
ATP Adenosine triphosphate 
BCA Bicinchoninic acid 
BMDC Bone marrow-derived DC 
BrdU Bromodeoxyuridine 
BZs Benzimidazoles 
CCL Chemotactic Cytokines Ligand 
CCR Chemotactic Cytokines Receptor 
CD Cluster of Differentiation 
cDNA complementary DNA 
CFSE Carboxyfluorescein succinimidyl ester 
Cov. Coverage 
DAMPs Damage Associated Molecular Patterns 
DC Dendritic Cell (s) 
DMEM Dulbecco's Modified Eagle Medium 
E/S Excretory/Secretory or Excretions/Secretions 
ELISA Enzyme-linked immunosorbent assay 
EmACT Echinococcus multilocularis activin  
EmAP Echinococcus multilocularis Alkaline Phosphatase 
EmTIP Echinococcus multilocularis T-cell Immunomodulatory Protein 
FACS Fluorescence Activated Cell Sorting 
FBS Fetal Bovine Serum 
FCS Fetal Calf Serum 
FG-GAP Phenyl-alanyl-glycyl - glycyl-alanyl-proline  
GM-CSF Granulocyte-macrophage colony-stimulating factor 
HEK Human Embryonic Kidney  
HIV Human Immunodeficiency virus 
Id. Identity 
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Ig Immunoglobulin 
LPS Lipopolysaccharide 
MBZ Mebendazole 
MHC  Major Histocompatibility Complex 
Mult Meriones unguiculatus 
MV Metacestode Vesicle (s) 
OD Optical density 
OVA Ovalbumin 
p.i Post infection 
PAGE Polyacrylamide gel electrophoresis 
PAMPs Pathogen Associated Molecular Patterns 
PBS Phosphate Buffer Saline 
PC Primary Cell (s) 
PCR Polymerase Chain Reaction 
Pro Protoscolex (ces) 
RH- Rat reuber Hepatoma  
RPMI Roswell Park Memorial Institute Medium 
SCID Cevere Combined Immunodeficiency 
SD Standard Deviation 
SDS Sodium Dodecyl Sulfate 
Sim. Similarity 
TCR T Cell Receptor 
Teff Effector T cells 
TGF-β Transforming Growth Factor 
Th T helper 
Tregs Regulatory T cells 
UV Ultraviolet 
Vs. Versus 
WHO World Health Organization 
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